JCRB No. Cell Name ANIMAL TISSUE GENETICS CHARACT AyuK10A10 Cdc42se1-K1 mouse embryo Cdc42se1, CDC42 smallpCMT-SAhygpA-NP21 effector 1 AyuK10C05 Map2k1-K1 mouse embryo Map2k1, mitogen activatedpCMT-SAhygpA-NP21 protein kinase kinase 1 AyuK10C08 Gatad2a-K1 mouse embryo Gatad2a, GATA zincpCMT-SAhygpA-NP21 finger domain containing 2A AyuK10D02 Ubr5-K1 mouse embryo Ubr5, ubiquitin proteinpCMT-SAhygpA-NP21 ligase E3 component n-recognin 5 AyuK10D10 Ppp2r2d-K1 mouse embryo Ppp2r2d, protein phosphatasepCMT-SAhygpA-NP21 2, regulatory subunit B, delta isoform AyuK10H01 Mapk1ip1l-K1 mouse embryo Mapk1ip1l, mitogen-activatedpCMT-SAhygpA-NP21 protein kinase 1 interacting protein 1-like AyuK10H04 Cbx3-K1 mouse embryo Cbx3, chromobox homologpCMT-SAhygpA-NP21 3 (Drosophila HP1 gamma) AyuK11B06 Atf1-K1 mouse embryo Atf1, activating transcriptionpCMT-SAhygpA-NP21 factor 1 AyuK11C02 Ahsa1-K1 mouse embryo Ahsa1, AHA1, activatorpCMT-SAhygpA-NP21 of heat shock protein ATPase homolog 1 (yeast) AyuK11D09 Zfp568-K1 mouse embryo Zfp568, zinc finger proteinpCMT-SAhygpA-NP21 568 AyuK11E04 Csnk2a1-K1 mouse embryo Csnk2a1, casein kinasepCMT-SAhygpA-NP21 2, alpha 1 polypeptide AyuK11E11 Wdr4-K1 mouse embryo Wdr4, WD repeat domainpCMT-SAhygpA-NP21 4 AyuK12A07 Saps3-K1 mouse embryo Saps3, SAPS domainpCMT-SAhygpA-NP21 family, member 3 AyuK12A12 Mipol1-K1 mouse embryo Mipol1, mirror-image pCMT-SAhygpA-NP21polydactyly gene 1 homolog (human) AyuK12C03 Fryl-K1 mouse embryo Fryl, furry homolog-likepCMT-SAhygpA-NP21 (Drosophila) AyuK12C11 Ctdspl2-K1 mouse embryo Ctdspl2, CTD (carboxy-terminalpCMT-SAhygpA-NP21 domain, RNA polymerase II, polypeptide A) small phosphatase like 2 AyuK12C12 Igsf9b-K1 mouse embryo Igsf9b, immunoglobulinpCMT-SAhygpA-NP21 superfamily, member 9B AyuK12D06 Ccdc58-K1 mouse embryo Ccdc58, coiled-coil domainpCMT-SAhygpA-NP21 containing 58 AyuK12E07 Trip10-K1 mouse embryo Trip10, thyroid hormonepCMT-SAhygpA-NP21 receptor interactor 10 AyuK12E09 Rad51ap1-K1 mouse embryo Rad51ap1, RAD51 associatedpCMT-SAhygpA-NP21 protein 1 AyuK12E12 Thrap3-K1 mouse embryo Thrap3, thyroid hormonepCMT-SAhygpA-NP21 receptor associated protein 3 AyuK12F03 Anks3-K1 mouse embryo Anks3, ankyrin repeatpCMT-SAhygpA-NP21 and sterile alpha motif domain containing 3 AyuK12H05 Atad1-K1 mouse embryo Atad1, ATPase family,pCMT-SAhygpA-NP21 AAA domain containing 1 AyuK13A11 Rap1b-K1 mouse embryo Rap1b, RAS relatedpCMT-SAhygpA-NP21 protein 1b AyuK13C12 Jrk-K1 mouse embryo Jrk, jerky pCMT-SAhygpA-NP21 AyuK13E11 Cbx5-K1 mouse embryo Cbx5, chromobox homologpCMT-SAhygpA-NP21 5 (Drosophila HP1a) AyuK13F02 Tarbp2-K1 mouse embryo Tarbp2, TAR (HIV) RNApCMT-SAhygpA-NP21 binding protein 2 AyuK13F05 Phf20-K1 mouse embryo Phf20, PHD finger proteinpCMT-SAhygpA-NP21 20 AyuK13G03 Zfp206-K1 mouse embryo Zfp206, zinc finger proteinpCMT-SAhygpA-NP21 206 AyuK13G06 BC024479-K1 mouse embryo BC024479, cDNA sequencepCMT-SAhygpA-NP21 BC024479 AyuK14A05 Trerf1-K1 mouse embryo Trerf1, transcriptionalpCMT-SAhygpA-NP22 regulating factor 1 AyuK14C04 Fubp3-K1 mouse embryo Fubp3, far upstreampCMT-SAhygpA-NP22 element (FUSE) binding protein 3 AyuK14E01 Kntc1-K1 mouse embryo Kntc1, kinetochore associatedpCMT-SAhygpA-NP22 1 AyuK14E08 Pspc1-K1 mouse embryo Pspc1, paraspeckle pCMT-SAhygpA-NP22protein 1 AyuK14E11 Mllt6-K1 mouse embryo Mllt6, myeloid/lymphoidpCMT-SAhygpA-NP22 or mixed lineage-leukemia translocation to 6 homolog (Drosophila) AyuK14G01 Cdca7-K1 mouse embryo Cdca7, cell division cyclepCMT-SAhygpA-NP22 associated 7 AyuK14G12 Nr5a2-K1 mouse embryo Nr5a2, nuclear receptorpCMT-SAhygpA-NP22 subfamily 5, group A, member 2 AyuK15A08 Anp32e-K1 mouse embryo Anp32e, acidic (leucine-rich)pCMT-SAhygpA-NP22 nuclear phosphoprotein 32 family, member E AyuK15E07 Leo1-K1 mouse embryo Leo1, Leo1, Paf1/RNApCMT-SAhygpA-NP22 polymerase II complex component, homolog (S. cerevisiae) AyuK15F02 Deaf1-K1 mouse embryo Deaf1, deformed epidermalpCMT-SAhygpA-NP22 autoregulatory factor 1 (Drosophila) AyuK15G02 Kpna4-K1 mouse embryo Kpna4, karyopherin pCMT-SAhygpA-NP22(importin) alpha 4 AyuK15G06 Capza2-K1 mouse embryo Capza2, capping proteinpCMT-SAhygpA-NP22 (actin filament) muscle Z-line, alpha 2 AyuK15H03 Psmc3ip-K1 mouse embryo Psmc3ip, proteasomepCMT-SAhygpA-NP22 (prosome, macropain) 26S subunit, ATPase 3, interacting protein AyuK16A10 Fmnl2-K1 mouse embryo Fmnl2, formin-like 2 pCMT-SAhygpA-NP22 AyuK16C06 Dgcr8-K1 mouse embryo Dgcr8, DiGeorge syndromepCMT-SAhygpA-NP22 critical region gene 8 AyuK16C10 Gnb2-K1 mouse embryo Gnb2, guanine nucleotidepCMT-SAhygpA-NP22 binding protein, beta 2 AyuK16C12 Trim71-K1 mouse embryo Trim71, tripartite motif-containingpCMT-SAhygpA-NP22 71 AyuK16E07 Lrch4-K1 mouse embryo Lrch4, leucine-rich repeatspCMT-SAhygpA-NP22 and calponin homology (CH) domain containing 4 AyuK16E08 Rbpms-K1 mouse embryo Rbpms, RNA bindingpCMT-SAhygpA-NP22 protein gene with multiple splicing AyuK16H07 Nmnat2-K1 mouse embryo Nmnat2, nicotinamidepCMT-SAhygpA-NP22 nucleotide adenylyltransferase 2 AyuK17A06 Trim6-K1 mouse embryo Trim6, tripartite motifpT2F2-SAhygpA-NP21 protein 6 AyuK17A12 Lnx2-K1 mouse embryo Lnx2, ligand of numb-proteinpT2F2-SAhygpA-NP21 X 2 AyuK17B02 Tada2l-K1 mouse embryo Tada2l, transcriptionalpT2F2-SAhygpA-NP21 adaptor 2 (ADA2 homolog, yeast)-like AyuK17C03 Hspbap1-K1 mouse embryo Hspbap1, Hspb associatedpT2F2-SAhygpA-NP21 protein 1 AyuK17E05 Ptpn11-K1 mouse embryo Ptpn11, protein tyrosinepT2F2-SAhygpA-NP21 phosphatase, non-receptor type 11 AyuK17E10 Myh9-K1 mouse embryo Myh9, myosin, heavypT2F2-SAhygpA-NP21 polypeptide 9, non-muscle AyuK17G03 Gtf2h1-K1 mouse embryo Gtf2h1, general transcriptionpT2F2-SAhygpA-NP21 factor II H, polypeptide 1 AyuK17H08 Pcbp2-K1 mouse embryo Pcbp2, poly(rC) bindingpT2F2-SAhygpA-NP21 protein 2 AyuK18B07 Zfp518-K1 mouse embryo Zfp518, zinc finger proteinpT2F2-SAhygpA-NP21 518 AyuK18B08 Setd5-K1 mouse embryo Setd5, SET domain pT2F2-SAhygpA-NP21containing 5 AyuK18B12 Epn2-K1 mouse embryo Epn2, epsin 2 pT2F2-SAhygpA-NP21 AyuK18C02 1110007L15Rik-K1 mouse embryo 1110007L15Rik, RIKENpT2F2-SAhygpA-NP21 cDNA 1110007L15 gene AyuK18D01 Birc6-K1 mouse embryo Birc6, baculoviral IAPpT2F2-SAhygpA-NP21 repeat-containing 6 AyuK18E01 Ibtk-K1 mouse embryo Ibtk, inhibitor of BrutonpT2F2-SAhygpA-NP21 agammaglobulinemia tyrosine kinase AyuK18E04 Thumpd3-K1 mouse embryo Thumpd3, THUMP domainpT2F2-SAhygpA-NP21 containing 3 AyuK19B07 5930416I19Rik-K1 mouse embryo 5930416I19Rik, RIKENpT2F2-SAhygpA-NP21 cDNA 5930416I19 gene AyuK19D05 Fam49b-K1 mouse embryo Fam49b, family with pT2F2-SAhygpA-NP21sequence similarity 49, member B AyuK19F03 Nmt2-K1 mouse embryo Nmt2, N-myristoyltransferasepT2F2-SAhygpA-NP21 2 AyuK19F08 Tex19-K1 mouse embryo Tex19, testis expressedpT2F2-SAhygpA-NP21 gene 19 AyuK19G11 BC057627-K1 mouse embryo BC057627, cDNA sequencepT2F2-SAhygpA-NP21 BC057627 AyuK20B04 Tjp2-K1 mouse embryo Tjp2, tight junction proteinpT2F2-SAhygpA-NP21 2 AyuK20B09 Srpk1-K1 mouse embryo Srpk1, serine/arginine-richpT2F2-SAhygpA-NP21-Rev protein specific kinase 1 AyuK5F06 Eapp-K1 mouse embryo Eapp, E2F-associatedpCMT-SAhygpA-NP21 phosphoprotein AyuK6A05 Ranbp1-K1 mouse embryo Ranbp1, RAN bindingpCMT-SAhygpA-NP21 protein 1 AyuK6B03 G3bp2-K1 mouse embryo G3bp2, GTPase activatingpCMT-SAhygpA-NP21 protein (SH3 domain) binding protein 2 AyuK6B09 Tbrg4-K1 mouse embryo Tbrg4, transforming pCMT-SAhygpA-NP21growth factor beta regulated gene 4 AyuK6C01 Jagn1-K1 mouse embryo Jagn1, jagunal homologpCMT-SAhygpA-NP21 1 (Drosophila) AyuK6C07 5830457O10Rik-K1 mouse embryo 5830457O10Rik, RIKENpCMT-SAhygpA-NP21 cDNA 5830457O10 gene AyuK6D12 Smg5-K1 mouse embryo Smg5, Smg-5 homolog,pCMT-SAhygpA-NP21 nonsense mediated mRNA decay factor (C. elegans) AyuK6E04 Armet-K1 mouse embryo Armet, arginine-rich, pCMT-SAhygpA-NP21mutated in early stage tumors AyuK6F01 Gpatch4-K1 mouse embryo Gpatch4, G patch domainpCMT-SAhygpA-NP21 containing 4 AyuK6F07 Bat2d-K1 mouse embryo Bat2d, BAT2 domainpCMT-SAhygpA-NP21 containing 1 AyuK6F11 Rnf44-K1 mouse embryo Rnf44, ring finger proteinpCMT-SAhygpA-NP21 44 AyuK6G02 Eif4b-K1 mouse embryo Eif4b, eukaryotic translationpCMT-SAhygpA-NP21 initiation factor 4B AyuK6H07 Cbx1-K1 mouse embryo Cbx1, chromobox homologpCMT-SAhygpA-NP21 1 (Drosophila HP1 beta) AyuK7A06 Epb4.1l5-K1 mouse embryo Epb4.1l5, erythrocytepCMT-SAhygpA-NP21 protein band 4.1-like 5 AyuK7A07 Cxxc5-K1 mouse embryo Cxxc5, CXXC finger pCMT-SAhygpA-NP215 AyuK7B02 Avpi1-K1 mouse embryo Avpi1, arginine vasopressin-inducedpCMT-SAhygpA-NP21 1 AyuK7C09 Axin1-K1 mouse embryo Axin1, axin 1 pCMT-SAhygpA-NP21 AyuK7D01 Cfdp1-K1 mouse embryo Cfdp1, craniofacial developmentpCMT-SAhygpA-NP21 protein 1 AyuK7G08 Rbm5-K1 mouse embryo Rbm5, RNA binding pCMT-SAhygpA-NP21motif protein 5 AyuK7G10 Zfp280b-K1 mouse embryo Zfp280b, zinc finger pCMT-SAhygpA-NP21protein 280b AyuK7G11 Rsrc2-K1 mouse embryo Rsrc2, arginine/serine-richpCMT-SAhygpA-NP21 coiled-coil 2 AyuK7H06 Cnbp-K1 mouse embryo Cnbp, cellular nucleicpCMT-SAhygpA-NP21 acid binding protein AyuK8A06 Nmt1-K1 mouse embryo Nmt1, N-myristoyltransferasepCMT-SAhygpA-NP21 1 AyuK8B01 Ilf2-K1 mouse embryo Ilf2, interleukin enhancerpCMT-SAhygpA-NP21 binding factor 2 AyuK8C06 Cnot10-K1 mouse embryo Cnot10, CCR4-NOT pCMT-SAhygpA-NP21transcription complex, subunit 10 AyuK8C12 Gm561-K1 mouse embryo Gm561, gene modelpCMT-SAhygpA-NP21 561, (NCBI) AyuK8D01 Eno1-K1 mouse embryo Eno1, enolase 1, alphapCMT-SAhygpA-NP21 non-neuron AyuK8D05 Ccdc77-K1 mouse embryo Ccdc77, coiled-coil domainpCMT-SAhygpA-NP21 containing 77 AyuK8E11 Ube2c-K1 mouse embryo Ube2c, ubiquitin-conjugatingpCMT-SAhygpA-NP21 enzyme E2C AyuK8F07 Slc39a14-K1 mouse embryo Slc39a14, solute carrierpCMT-SAhygpA-NP21 family 39 (zinc transporter), member 14 AyuK8G02 Nosip-K1 mouse embryo Nosip, nitric oxide synthasepCMT-SAhygpA-NP21 interacting protein AyuK8G11 Nedd4-K1 mouse embryo Nedd4, neural precursorpCMT-SAhygpA-NP21 cell expressed, developmentally down-regulted gene 4 AyuK9B05 Zfp532-K1 mouse embryo Zfp532, zinc finger proteinpCMT-SAhygpA-NP21 532 AyuK9E04 AU019823-K1 mouse embryo AU019823, expressedpCMT-SAhygpA-NP21 sequence AU019823 AyuK9F02 Pml-K1 mouse embryo Pml, promyelocytic leukemiapCMT-SAhygpA-NP21 AyuK9F06 Ddx11-K1 mouse embryo Ddx11, DEAD/H (Asp-Glu-Ala-Asp/His)pCMT-SAhygpA-NP21 box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae) IFO50004 WISH human HeLa-contaminant Originally established from amnion, HeLa-contaminated. IFO50005 J-111 human HeLa-contaminantHeLa markers observed.originally established from acute monocytic leukemia, HeLa-contaminated IFO50006 M1 mouse hemo-lymphocytic spontaneous myeloid leukemia, differentiation into macrophage/granulocyte IFO50007 Ca Ski human uterine cervix cervical epidermoid cancer IFO50008 Mm1 mouse hemo-lymphocyticsubline of M-1 mousespontaneous leukemia cell myeloid line leukemia, M-1-derivative, macrophage-like phenotype IFO50009 G-361 human melanoma malignant melanoma IFO50010 C6/36 mosquito hatched larvae useful for replication of flavivirus IFO50011 HeLa S3 human uterine cervix cervical epithelioid carcinoma IFO50012 Pt K2 marsupial (potoroo,kidney rat kangar kidney, epithelial-like IFO50013 RPMI 8226 human hemo-lymphocytic myeloma, multiple IFO50015 F2408 rat embryo fibroblast-like IFO50016 Chang Liver human HeLa-contaminant originally established from liver, HeLa-contaminated IFO50017 \XC rat sarcoma useful for assay of murine leukemia virus IFO50018 NIL hamster, Syrianembryo transformed from hamster fibroblast IFO50019 NIH 3T3 p-7 cl-3 mouse embryo fibroblast, contact-inhibited IFO50020 SIRC rabbit cornea susceptible to rubella virus IFO50021 A31-714 C4 mouse embryo fibroblast, subclone of Balb/3T3 A31. This cell line exhibits contact inhibition. IFO50022 HL-60 human hemo-lymphocytic leukemia, acute promyelocytic, This strain is unable to induce differentiation. =JCRB0006 HL60RG IFO50025 IM-9 human hemo-lymphocytic B-lymphoblastoid cells, EB virus-transformed IFO50026 CCRF-SB human hemo-lymphocytic leukemia, acute lymphoblastic IFO50034 RBL-1 rat hemo-lymphocytic basophilic leukemia IFO50036 P388D1 mouse hemo-lymphocytic lymphoid neoplasm, derived from P388 IFO50037 RPMI 1788 human hemo-lymphocytic established from normal blood, IgM secreting IFO50038 U-937 human hemo-lymphocytic lymphoma, histiocytic IFO50039 NC-37 human hemo-lymphocytic lymphoblast, Contamination of Raji cells has been suspected. IFO50040 Namalwa human hemo-lymphocytic lymphoma, Burkitt's IFO50041 MBT2 mouse bladder bladder carcinoma IFO50042 C3H/MCA clone 15 mouse embryo 3-methylcholanthrene-transformed C3H/10T1/2 IFO50043 WiDr human colon adenocarcinoma IFO50046 Raji human hemo-lymphocytic lymphoma, Burkitt's IFO50067 LoVo human colon adenocarcinoma, carcinoembryonic antigen-producing IFO50069 Alexander cells human liver, gallbladder hepatoma, HBs antigen-positive IFO50070 Balb/3T3-A31-1-1 mouse embryo fibroblast, subclone of Balb/3T3-A31. This cell line exhibits contact inhibition. IFO50071 MDCK (NBL-2) dog kidney established from normal kidney, susceptible for many viral species IFO50072 MRC-9 human lung fetus lung normal diploid fibroblast IFO50073 MRC-5 human lung fetus lung normal diploid fibroblast IFO50074 HFL1 human lung fetus lung normal diploid fibroblast IFO50075 WI-38 human lung fetus lung normal diploid fibroblast IFO50076 IT-45R1 rat thymus T cell differentiation factor-producing IFO50077 IT-45R91 rat thymus thymic fibroblast IFO50078 IT-26R21 rat thymus T cell differentiation factor producing IFO50079 Flow7000 human skin skin normal diploid fibroblast IFO50080 NCTC clone 1469 mouse liver normal liver-derived IFO50081 Neuro-2a mouse neural neuroblastoma, Td = 20 hrs. IFO50082 V79 379A hamster, Chineselung lung, fibroblast, widely used in somatic genetics IFO50089 Flow2000 human lung fetus lung normal diploid fibroblast IFO50090 4G12 hybridoma mouse x humanantibody-producinghuman lymphoid hybridoma x mouse4G12 myelomaantibody, (P3U1)preferentially reacting with lung carcinoma-associated antigen IFO50098 F2408-No.3 rat embryo HGPRT-deficient HGPRT-deficient F2408 cell line IFO50099 F2408-B812 rat embryo HGPRT-deficient. TemperatureHGPRT-deficient sensitive cell whenline from this F2408.cell line This is transformed cell line exhibits by MSV. temperature sensitive phenotype for transformation by Moloney MSV. The transforming efficiency considerably decreases at 39 C compared to at 33 C. IFO50100 F2408-B993 rat embryo HGPRT(-), temperatureHGPRT-deficient sensitive when cell transformed line from F2408. by MSV. This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV. The transforming efficiency considerably decreases at 39 C compared to at 33 C. IFO50101 F2408-No.20 rat embryo thymidine kinase-deficientthymidine kinase-deficient F2408 cell line IFO50102 F2408-No.7 rat embryo HGPRT-deficient HGPRT-deficient F2408 cell line IFO50103 TuD-1 rat thymus thymic stroma, keratin-positive IFO50105 GH3 rat pituitary pituitary tumor, somatotrophin-secreting IFO50106 HOS human sarcoma osteosarcoma IFO50107 G-292 clone A141B1 human sarcoma osteosarcoma IFO50108 MG-63 human sarcoma osteosarcoma IFO50110 C6 rat neural glial tumor, GFAP-positive IFO50111 GRSL mouse hemo-lymphocytic thymic leukemia IFO50112 TaD-1 rat thymus thymoma, keratin-positive IFO50120 TaD-1-3 rat thymus thymoma, keratin-positive IFO50151 MEG-01 human hemo-lymphocytic leukemia, chronic megakaryoblastic IFO50152 TuD-1-3 rat thymus thymic stroma, keratin-positive IFO50153 A549 human lung (cancer) adenocarcinoma IFO50161 KT-5 mouse neural astrocyte cell line IFO50210 L2C guinea pig hemo-lymphocytic leukemic cell, maintainable only by transplantation IFO50221 N18-RE-105 mouse x ratneural N18TG2 x Fischer rat 18 day-embryonic neural retina IFO50248 IT-79MTNC3 mouse thymus thymic nurse cell IFO50267 PB-3c mouse hemo-lymphocytic mast cell line IFO50268 EHS mouse sarcoma chondrosarcoma, secreting basement membrane matrix IFO50269 GH1 rat pituitary pituitary tumor, somatotrophin-secreting IFO50270 6-23 clone 6 rat thyroid medullary thyroid carcinoma, neurotensin and calcitonin-producing IFO50271 HUV-EC-C human vascular system normal endothelial cell, umbilical cord IFO50276 A2058 human melanoma malignant melanoma, metastasis to lymph node IFO50277 5RP7 rat embryo fibroblast transformed by c-Ha-ras oncogene IFO50278 PC-12 rat neural pheochromocytoma, neuronal differentiation by NGF IFO50279 NKY113 mouse antibody-producing hybridoma MSW113 antibody, recognizing a cancer-associated olygosaccharide IFO50280 77N1 rat kidney transformant of NRK cells by avian sarcoma virus B77 IFO50282 RAT-2 rat embryo thymidine kinase deficient RAT-1 (F2408) cell line IFO50283 IMR-32 human neural N-myc amplification wastransplantable reported. to nude mice IFO50284 A2B5 clone 105 mouse antibody-producing hybridoma A2B5 antibody, recognizing a glycolipid expressed in neural tissue IFO50285 U-251 MG (KO) human neural astrocytoma, GFAP-positive IFO50286 SF126 human neural astrocytoma, GFAP-negative IFO50288 U-251 MG human neural GFAP-posotive, glioblastoma multiforme. IFO50289 Becker human neural astrocytoma, GFAP-negative IFO50293 MA-89 mouse neural normal mixed glial culture IFO50294 MEG-01SSF human hemo-lymphocyticserum-free adapted leukemia,subline of chronicMEG-01s megakaryoblastic, (IFO 50473) MEG-01s-derivative adapted to serum-free medium IFO50295 NB-1 human neural neuroblastoma, neuronal differentiation IFO50296 WEHI-3b mouse hemo-lymphocytic myelomonocyte IFO50297 HE-1 human embryo Normal diploid fibroblastswhole with fetus, limited normal life diploidspan. fibroblast IFO50298 Balb/c 3T3 A31-I-1 mouse embryo fibroblast, subclone of Balb/3T3 A31. This cell line exhibits contact inhibition. IFO50299 Balb/c 3T3 A31-1-13 mouse embryo fibroblast, subclone of Balb/3T3 A31. This cell line exhibits contact inhibition. IFO50303 T98G human neural glioblastoma IFO50308 SKG-I human uterine cervix cervical epidermoid cancer IFO50309 SKG-II human uterine cervix cervical squamous carcinoma IFO50310 SKG-IIIa human uterine cervix cervical epidermoid cancer IFO50311 SKG-IIIb human uterine cervix cervical epidermoid cancer IFO50312 SNG-II human uterus endometrial adenocarcinoma IFO50313 SNG-M human uterus endometrial adenocarcinoma IFO50314 SKN human uterus leiomyosarcoma IFO50315 RMG-I human ovary clear cell carcinoma IFO50317 RKN human ovary leiomyosarcoma IFO50320 RMUG-S human ovary mucinous cystadenocarcinoma IFO50321 GAK human melanoma malignant melanoma, metastasis to lymph node. 5-S-cysteinyldopa production. IFO50322 NJG human uterus gestational uterine choriocarcinoma IFO50323 BOKU human uterine cervix cervical squamous cell carcinoma IFO50350 Hs68 human skin The enzyme aspartoacylaseskin normal level diploid is low. fibroblast IFO50354 HT-1080 human sarcoma acetabulum, fibrosarcoma IFO50355 ONS-76 human neural medulloblastoma IFO50356 KNS-42 human neural glioma, GFAP-positive, S-100 and NSE-negative IFO50357 KNS-60 human neural glioma, GFAP, S-100 and NSE-negative IFO50358 KNS-62 human lung (cancer) bronchial squamous carcinoma, metastasis to brain IFO50359 KNS-81 human neural glioma, GFAP and S-100-positive, NSE-negative IFO50361 B2-17 human neural thymidine kinase-deficientastrocytoma, thymidine kinase-deficient mutant of U251 MG cells, GFAP-negative IFO50362 MOLT-4 human hemo-lymphocytic leukemia, acute lymphoblastic IFO50363 KU812 human hemo-lymphocytic leukemia, chronic myeloid IFO50364 L6 rat muscular system skeletal muscle myoblast IFO50367 SHOK hamster, Syrianembryo fibroblast, contact-inhibited IFO50368 no.10 human neural glioma, anaplastic, GFAP-positive IFO50369 no.11 human neural glioma, anaplastic, GFAP-positive IFO50373 TKC2 mouse kidney TG mouse harboringtubule tsSV40 cell, large tsSV40 T antigen large geneT-immortalized (ts mutant) IFO50374 TKD2 mouse vascular systemTG mouse harboringendothelial tsSV40 large cell, T tsSV40antigen large gene T-immortalized IFO50375 MSS31 mouse spleen spleen stromal cell line IFO50376 MSS62 mouse spleen spleen stromal cell line IFO50377 FLS3 mouse liver liver stromal cell line IFO50378 FLS5 mouse liver liver stromal cell line IFO50379 TLR2 mouse liver TG mouse harboringhepatocyte tsSV40 large immortalized T antigen withgene the tsSV40 large T antigen gene. Permissive temperature is 33 C. IFO50380 TLR3 mouse liver TG mouse harboringhepatocyte tsSV40 large immortalized T antigen bygene the tsSV40 large T antigen gene. Permissive temperature is 33 C. IFO50409 NCTC clone 929 mouse skin fibroblast, subclone of strain L IFO50411 A-431 human epidermoid carcinoma epidermoid carcinoma, high expression of EGF receptor IFO50412 CCRF-CEM human hemo-lymphocytic leukemia, acute lymphoblastic IFO50414 CHO-K1 hamster, Chineseovary widely used for production of recombinant proteins IFO50415 C3H/10T1/2-clone8 mouse embryo fibroblast, contact-inhibited IFO50416 3T3-L1 mouse embryo a substrain of 3T3-Swissfibroblast, albino 3T3-Swiss cell line derivative, adipocyte differentiation IFO50417 3T3-Swiss albino mouse embryo fibroblast, contact-inhibited IFO50418 ASF-4-1 human skin skin normal diploid fibroblast IFO50419 ASF-4-2 human skin skin normal diploid fibroblast IFO50421 PKS pig kidney susceptible to Vaccinia virus IFO50422 PKF pig kidney susceptible to Vaccinia virus IFO50423 PKR pig kidney susceptible to Vaccinia virus IFO50424 AP-16 mouse neural astrocyte-progenitor cell line IFO50425 C6-SF2 rat neural C6 subline adapted to serum-free medium IFO50426 NIL-SF2 hamster, Syrianembryo NIL subline adapted to serum-free medium IFO50428 CMK-86 human hemo-lymphocyticfrom patient with Down'sleukemia, syndrome acute megakaryoblastic IFO50430 CMK-11-5 human hemo-lymphocyticfrom patient with Down'sleukemia, syndrome acute megakaryoblastic IFO50431 KP-N-YN human neural neuroblastoma, from lymph node, smooth muscle marker-expressing IFO50432 KP-N-RT-BM-1 human neural neuroblastoma, from bone marrow, neuronal and Schwannian differentiation IFO50433 KP-N-SI9s human neural neuroblastoma, from lymph node, smooth muscle marker-expressing IFO50434 KALS-1 human neural glioma, GFAP, vimentin and CD13-positive IFO50435 KINGS-1 human neural astrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive IFO50436 KS-1 human neural glioblastoma IFO50444 KNS-81-FD human neural serum-free adapted glioma,subline derivativeof KNS-81 of (IFO KNS-81 50359) adapted to serum-free medium IFO50466 RC1 mouse antibody-producinghybridoma hybridoma (mouse spleenRC1 antibody, x mouse recognizingmyeloma NS-1) undifferentiated neural cell-specific antigen IFO50467 NMC-G1 human neural glioma, FGF-9-producing IFO50472 MEB5 mouse neural immortalized by E7 oncogeneCNS stem ofcell HPV line, type HPV 16 type 16 E7-immortalized IFO50473 MEG-01s human hemo-lymphocyticsuspension culture adaptedleukemia, subline chronic of megakaryoblastic, MEG-01 MEG-01-derivative IFO50474 NOMO-1 human hemo-lymphocytic leukemia, acute monocytic, promonocytic leukemia cells IFO50475 NOMO-1s human hemo-lymphocytica subline of NOMO-1leukemia, that adapted acute to monocytic, serum free NOMO-1-derivative medium adapted to serum-free medium IFO50476 NKM-1 human hemo-lymphocytic leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth IFO50477 FS-1 human bone marrow stroma bone marrow stromal cell from a myelogenous leukemia patient IFO50478 MEG-A2 human hemo-lymphocyticPhl. chromosome leukemia, chronic myelogenous, megakaryoblastic cell line IFO50479 NAGL-1 human hemo-lymphocytic leukemia, B cells IFO50480 NRK-52E rat kidney epithelioid clone of NRK cells IFO50481 NRK-49F rat kidney fibroblastic clone of NRK cells, useful for transformation assays IFO50483 CCD-33Co human colon established from normal colon, fibroblast IFO50484 DBC1.2 mouse olfactory epithelium dark (horizontal) basal cell-like, keratin-positive IFO50488 OUMS-27 human sarcoma mutation of the p53 chondrosarcoma,gene, heretoploid type 1, 2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing IFO50489 GB-1 human neural glioblastoma, MDR1 and P-glycoprotein-expressing. GFAP, vimentin and fibronectin-positive IFO50490 MDM2-RNB rat neural human MDM2 gene-introducedhuman MDM2 gene-introduced neonetal rat astrocyte, MDM2-expressing IFO50491 RNB rat neural neonatal rat astrocytes, GFAP-positive IFO50492 AM-38 human neural glioblastoma, GFAP and S-100-positive, ACNU (a cancer chemotherapy drug)-sensitive IFO50493 YH-13 human neural glioblastoma, GFAP and S-100-positive, ACNU (a cancer chemotherapy drug)-resistant IFO50495 Neuro-2aTG mouse neural HPRT-deficient neuroblastoma, HPRT-deficient Neuro-2a cell line IFO50496 PC-12TG rat neural HPRT-deficient pheochromocytoma, HPRT-deficient PC-12 cell line IFO50513 MTA human hemo-lymphocytic leukemia, natural killer-like T cell line IFO50516 TMD5 human hemo-lymphocytic leukemia, acute B lymphoblastic, double Philadelphia chromosomes IFO50518 KAI3 human hemo-lymphocytic NK-like cell line from a patient with severe chron ic active EBV infection, IL-2-dependent IFO50519 A1 mouse neural Established from p53(-/-)p53-deficient homozygote cell linemice from (strain; newborn 129/SvJ, mouse BDF1, brain, C57BL/6J). used for preparation of conditioned medium for MG5. IFO50520 MG5 mouse neural Established from p53(-/-)microglial homozygote cell line frommice p53-deficient(strain; 129/SvJ, mice BDF1, C57BL/6J). IFO50525 NCO2 human hemo-lymphocytic JCRB0001 F9-41 mouse teratoma cells are differentiated by retinoic acit or cAMP JCRB0003 C3H/10T1/2-clone 8 mouse embryo embryo contact sensitive cell line JCRB0004 A-431 human epidermoid epidermoidcarcinoma carcinomaepidermoid carcinoma JCRB0005 FRSK rat skin epidermal cells JCRB0006 HL60RG human hemo-lymphocyticDNA prifiling of this cellHL60 line RG is samegrow fasteras HL60. than HL60. Characteristics of the differentiation observed in the HL60 was lost in this cell line. JCRB0007 Pt K2 marsupial (potoroo,kidney ratkidney kangar PtK2 was used in study of chr.DNA replication. JCRB0009 P3/NS1/1-Ag4-1 mouse hemo-lymphocyticresistant to 10^-4 M non-secreting8-azaguanine(not mouse grow myeloma in HAT) (k-chain synthesized) JCRB0011 S.CET.M8.1.1 mouse antibody-producingIgG producing hybridoma hybridomaRelease cell. monoclonal anti-11-deoxycortisol antibody. JCRB0013 16-8 mouse antibody-producingProduce hybridomaIgM. AgglutinateProduce regardless monoclonal blood antibody type. to human erythrocyte. JCRB0014 19-7 mouse antibody-producingProducing hybridoma IgM. AgglutinateProducing regardless monoclonal blood antibody type. to human erythrocyte JCRB0016 P388-D1 mouse hemo-lymphocyticascitic form of P388 Used by the NCI cancer chemotherapy screening study. JCRB0017 P388 mouse hemo-lymphocyticLow level IL1 productionThis cell line is used in testing for antitumor activity by NCI. JCRB0018 J774.1 mouse hemo-lymphocyticProduce large amountCarry of lysozymereceptors andfor immunoglobulin IL-1. and complement. IL-1 productivity is different from the similar cell line, J774A.1 distributed from the ATCC. JCRB0019 K562 human hemo-lymphocytic Differentiate into erythrocytic, granurocytic & monocytic cells. JCRB0021 MOLT-4F human hemo-lymphocytic Rosettes formation. High TdT. No Ig no EBV produc. JCRB0023 RBL-2H3 rat hemo-lymphocyticmast cell line IgE mediated histamine release was reported. JCRB0024 IM-9 human hemo-lymphocyticB lymphoblasts synthesiz.Immunoglobulin IgGk(2.4mg/10^6 secreting cells/d). human lymphoblast. JCRB0025 BRL-3A rat liver liver Producing MSA protein (somatomedin-like). JCRB0030 CHL/IU(IVGT) Chinese hamsterlung Standard cell line for chromosome aberation test. JCRB0031 CCRF-HSB2 human hemo-lymphocytic Cultured in vitro from implanted tumor in Syrian hamster. JCRB0032 CCRF-SB human hemo-lymphocyticNormal human diploidThis karyotype. cell line was established from CCRF-HSB, this cell line doesn't have the passage history maintained as transplantable tumor in Syrian hamster. JCRB0033 CCRF-CEM human hemo-lymphocytic Near diploid, no Ig-secreting, free of virus particle. JCRB0034 RPMI 8226 human hemo-lymphocytic hematopoietic cell line, Lambda L chain secreting JCRB0035 RPMI 1788 human hemo-lymphocyticnormal IgM secreting(light chain), positive for HLA2.7 JCRB0041 HLCL-1 human hemo-lymphocytic peripheral lymphocyte JCRB0042 HEC-1 human uterus STR analysis in the cell bank indicated that the HEC-1 is the same cell line as the HEC-1-B (NIHS0480). JCRB0044 LU99A human lung (cancer) produce colony-stimulating factor JCRB0054 LU65A human lung (cancer) JCRB0055 LU65B human lung (cancer) JCRB0056 LU65C human lung (cancer)lung, carcinoma JCRB0057 LU99B human lung (cancer) JCRB0058 LU99C human lung (cancer) JCRB0060 LLC-PK1 pig kidney susceptible to viruses, rubella,vaccinia & herpes. JCRB0061 AZ-521 human stomach JCRB0062 HEL human hemo-lymphocytic JCRB0065 KG-1 human hemo-lymphocytic JCRB0066 Mewo human melanoma JCRB0068 Flow3000 human embryonic brainnormal fibroblast sensitive to CMV virus JCRB0070 MIA PaCa-2 human pancreas sensitive to asparginase. Dt=40hr, colony-formaing efficiency in soft agar = 19% JCRB0071 BALL-1 human hemo-lymphocytic JCRB0072 MiTen human skin JCRB0073 J-111 human HeLa-contaminantHeLa marker chromosomeAlthough observed an original {371}. description STR-PCR for showed this cell same line ispattern an acute as HeLamonocytic cells. leukemia, the cell line deposited to the cell bank anywhere in the world is a subline of the HeLa. See STR-PCR results. JCRB0074 VMRC-MELG human melanoma JCRB0075 SF-TY human skin normal normal skin fibroblast JCRB0076 A549 human lung (cancer)adenocarcinoma Y chr.invisible. Detected by Y specific DNA probe. JCRB0077 PC-3 human lung (cancer)intermediately differentiatednotice:different cell line from PC-3 ATCC CRL1435 JCRB0078 P-815 mouse hemo-lymphocyticmastocytoma target cell for cytotoxic T cell assay JCRB0079 LU65 human lung (cancer)c-Ki-ras2 mut. codonmany 12. ({3601,3602}) floating cells are observed JCRB0080 LU99 human lung (cancer) lung, carcinoma JCRB0081 RERF-LC-MS human lung (cancer)adenocarcinoma lung adenocarcinoma JCRB0083 4-8H mouse antibody-producinghybridoma hybridoma antibody to DNA polymerase alpha, IgG1 JCRB0084 4-2D mouse antibody-producinghybridoma, hybridoma producingantibody IgG antibody. to primase complexed withDNA polymerase a JCRB0085 HL60 human hemo-lymphocyticAPL DMSO,butyl.,HX.,TPA,act.D,& R.A. ind. differentiat JCRB0086 TALL-1 human hemo-lymphocyticT cell T cell lymphoblastic leukemia. mode=95-101 JCRB0090 MB86 mouse antibody-producingproducing hybridoma antibody torecognize mouse IgMIgh6-4 (b,e,z) JCRB0091 P31/FUJ human hemo-lymphocyticmonocyte, 47:XY, Dt=80hrPox+,PAS+,AcPase+,al-pase+,NACE+,aNBE+,NaF+,Pago- JCRB0094 P30/OHK human hemo-lymphocyticCD5-,CD2-,Ia+,CD20-(revisedPAS+,AcPase+,having to be negative pre at B2009/1/22),CD19+,J5+,TdT+,EBNA-,CD8+/- characteristic JCRB0095 P32/ISH human hemo-lymphocyticB cell characteristics,EBNA-,translocation Dt=40hr between chr.2 and chr.14, Ig gene JCRB0097 A4/Fuk human hemo-lymphocyticER-,PanT-,CD4+,PanB-,J5-,CD11-,CIg+,SIg+,TdT-,Ia+lymphoma cell line producing IgM,k, Dt=30hr JCRB0098 KURAMOCHI human ovary hyperdiploid Dt=24-27hr JCRB0101 A3/KAW human hemo-lymphocyticCD4+,Ia-,EBNA- Dt=20 hr JCRB0102 RERF-LC-FM human lung (cancer) create clusters on growth JCRB0103 VMRC-LCP human lung (cancer) lung squamous cell carcinoma JCRB0104 KU812 human hemo-lymphocyticPh1 chr., histamin(+),t(9;22)(q34;q11),i(17q)Dt=20-30hr, colony formation etc. on soft agar=30-50% JCRB0104.1 KU812E human hemo-lymphocyticPh1 chr., histamin(+),t(9;22)(q34;q11),i(17q)Dt=20-30hr, clonal isolation etc. of KU812 JCRB0104.2 KU812F human hemo-lymphocyticPh1 chr., histamin(+),t(9;22)(q34;q11),i(17q)Dt=20-30hr, clonal isolation etc. of KU812 JCRB0105 KY821 human hemo-lymphocyticDouble minute chromosomeDt=27-37 positive hr JCRB0105.1 KY821A3 human hemo-lymphocyticleukemia The cell was cloned from JCRB0105 by colony formation. JCRB0106 SCCH-26 human neural neuroblastoma neuroblastoma JCRB0108 SCCH-196 human sarcoma t(11;22) small round cell sarcoma JCRB0110 M1-T22 mouse hemo-lymphocyticcytologically determinedCells as are myeloblast differentiated by dexamethasone or etc. JCRB0112 THP-1 human hemo-lymphocyticFc,C3b receptors. HLA-A2,-A9,-B5,-DRW1,No immunoglobulins produced. & -DRW2. No EBV. JCRB0112.1 THP-1 human hemo-lymphocyticFc,C3b receptor.HLA-A2,-A9,-B5,-DRW1,-DRW2.No immuno glogulin productions. JCRB0113 PAI mouse hemo-lymphocytic non screeting type for IgE. JCRB0114 LC4-1 human hemo-lymphocyticpositive Ia,B4, negativeE-rossette B2,Tac,T3,T4,T8,T11 formation. D-J joinning. & M1 EBNA negative. JCRB0115 SCC-3 human hemo-lymphocyticLSG type. IL2 receptorsmonocytic were expressed.cell line. Negative for ATLA. Positive for EBVCA and negative for EBNA. JCRB0116.1 U937 cl1-14 human hemo-lymphocyticexpress monocyte-likehighly characteristics susceptible clone for HIV virus JCRB0116.2 U937 cl1-22 human hemo-lymphocyticexpress many monocyte-likelow susceptible characteristics clone for HIV virus JCRB0117 B104 human hemo-lymphocyticIgM and IgD are expressedThe cells on were the killedsurface by ofanti-IgM cells. but not IgD. JCRB0118 SKM-1 human hemo-lymphocyticMDS->RAEB.T->AMLMyeloperoxidase (MPO) release into cult.medium. JCRB0119 YG10003 hamster, Chineselung salmonella O-acetyltransferaseG418-r(500ug/ml), gene introduced pMAMneo cotransfected JCRB0120 YG10007 hamster, Chineselung human monomorphicG418-r(500ug/ml), N-acetyltransferase pMAMneo introduced co-transfected JCRB0121 YG10008 hamster, Chineselung human polymorphic G418-r(500ug/ml),N-acetyltransferase pNAMneo transfected co-transfected JCRB0123 KO52 human hemo-lymphocyticCD12,CD33,CD2,CD5,CD7,HLA-DR.N-ras mutation: G->C chr=17p-, in codon MDR1 13. exp. JCRB0124 Takigawa human stomach Densly packed ilet-like colonies with small polygonal cells and high AFP production observed. JCRB0125 L alpha mouse skin Mouse L tk- cell line Thiswas celltransformed line expresses by cDNA poliovirus of poliovirus receptor receptor and sensitive protein alpha.to the poliovirus. JCRB0126.1 KOSC-2 cl3-43 human oral Moderately differentiated squamous-cell carcinoma. JCRB0129.0 RCR-1.P3 rat neural GFAP (glial fibrillary acidicCells having protein) characteristics detected. of astrocyte cells. These cells are grown in serum free condition. JCRB0129.1 RCR-1 rat neural GFAP (glial fibrillary acidicCells having protein) chracteristics detected. of astrocyte cells. This cell line is a parental cells of the RCR-1.P3. JCRB0129.2 RCR-1.P3 rat brain GFAP (glial fibrillary acidicCells having protein) characteristics detected by anti-GFAPof astrocyte serum. cells when cell culture started. These cells are grown in serum free condition for long passages. Passage number was extreamly increased as compared with the JCRB0129.0 RCR-1.P3. Serum free culture started 1991. JCRB0130 PC-12.P3 rat neural Derivative of the PC-12Cells cells. adapted to grow in serum free medium. JCRB0130.1 PC12.P3 rat neural JCRB0131 RL-33 rabbit lung HSV,VSV sensitive.GoodCell growth to study inhibited anti-viral by agents.cell-cell contact. JCRB0132.1 AH601(JTC27) rat liver hepatoma transplantable rat ascites tumor cell line. Rat established on 1952 and tumor was maintained by transplantation. Primary cell culture was established on 1971. Serum free cell line was established on 1972. JCRB0132.2 AH601.P3(JTC27) rat liver AH-601 cells adaptedtransplantable to a serum free rat ascitesmedium. tumor Serum P3 free cell cellline culture established on 1972. Low passage number. JCRB0132.3 AH601.P3(JTC27) rat liver AH-601 cells aduptedtransplantable to a serum free rat ascitesmedium. tumor P3 cell line and cells have been cultured continuously for long period in the serum free medium. Teromerase positive and a length of telomere is 5.1 kb. Td=50 hrs. JCRB0133 KHM-1B human hemo-lymphocyticHLA-DR,CD2,CD10,CD20,PCA-1,sIgAmylase and IgA were productions positive. were positively elevated. JCRB0134 MCF-7 human mammary dome formation observed JCRB0136.1 CHO(pMAM-luc) hamster, Chineseovary Plasmid pMAM-luc transfectedLuciferase CHO-K1gene under cells. control Luciferase of MMTV-LTR activated in by plasmid. dexamethasone(2uM) at 37C, 5 hrs. JCRB0136.2 CHO(pMAM-HSluc) hamster, Chineseovary pMAM-HSluc transfectedHSP 70BCHO-K1 gene cells. promoter Luciferase and luciferase activated geneat 42/43 included C for several minutes. JCRB0137 RERF-LC-KJ human lung (cancer) Transplantable to SCID mice and frequently metastasize to SCID mouse lymph nodes. JCRB0138 KHM-3S human lung (cancer)No OKT11,OKT4,OKT8,B1,&HTLV-1 positive B4 found. small NKH-1, cell lung rearranged cancer cells. T cell receptor and HTLV-1 integration observed. JCRB0139 TASK1 human neural NSE,vimentin, & MIC2Primitive positive, neuroectodermal NF & N-CAM negative tumor (Askin's tumor). JCRB0140 NCE16 human uterine cervixE6/E7 expressed. TelomeraseNormal ecto-cervical expression keratinocyte observed. cells immortalized by HPV16. Growth is dependent to EGF. JCRB0141 PHK16-0b human skin E6/E7 expressed andCells telomerase immortalized positive. with HPV16 and the growth is dependent to EGF. Over 95% cells are diploid. JCRB0143.0 F2408 pZipNeo rat embryo No expression of thefibroblast-like EBNA2 products. JCRB0143.1 F2408 EBNA2 cl-9 rat embryo Expression of the EBNA2fibroblast-like was strong. JCRB0143.2 F2408 EBNA2 cl-16 rat embryo Expression of the EBNA2fibroblast-like was strong. JCRB0143.3 F2408 EBNA2 cl-18 rat embryo Expression of the EBNA2fibroblast-like is strong. JCRB0143.4 F2408 EBNA2 cl-24 rat embryo Expression of the EBNA2fibroblast-like was strong. JCRB0143.5 F2408 EBNA2 cl-14 rat embryo Expression of the EBNA2fibroblast-like was weak. JCRB0143.6 F2408 EBNA2 cl-23 rat embryo Expression of the EBNA2fibroblast-like was weak. JCRB0143.7 F2408 EBNA2 cl-28 rat embryo Expression of the EBNA2fibroblast-like was weak. JCRB0144.1 LYM-1.P3 rat lymph node Sticky cell from lymph node. Serum free cell culture. JCRB0144.1B LYM-1.P3B rat lymph nodeSubclone of the LYM-1.P3.Culture fruidMorphologys of the LYM-1 and karyotypesstrongly inhibited were different a growth from of AH-7974 the LYM-1.P3D. and other Karyotype several cellis near lines. triploid. The inhibition was strongly suppressed by heating. JCRB0144.1D LYM-1.P3D rat lymph nodeSubclone of the LYM-1.P3.Culture fruidMorphologys of the LYM-1 and karyotypesstrongly inhibited were different a growth from of AH-7974 the LYM-1.P3B. and other Karyotype several cellis lower lines. diploid. The inhibition was strongly suppressed by heating. JCRB0144.2D LYM-1.P3D rat lymph nodeSubclone of the LYM-1.P3.Culture fruidMorphologys of the LYM-1 and karyotypesstrongly inhibited were different a growth from of AH-7974 the LYM-1.P3B. and other Karyotype several cellis lower lines. diploid. The inhibition was strongly suppressed by heating. JCRB0145 MEB 5 mouse neural cells immortalized byMultipotent E7 oncogene CNS of stem HPV cell type line. 16 Differentation in to neurons, astrocytes and oligodendrocytes. Epitherial-like morphology can be observed when the cells are cultured on the coated dishes. JCRB0146 MLMA human hemo-lymphocytic47 X,-X (X,0) IgD, IgM positive, hairy B-cell line JCRB0147 JKT-beta-del human hemo-lymphocyticDeletion of rearrangedJurkat T-cell cell receptor(TCR) clone with a lackC beta of surface gene expresshion of TCR alpha/beta/CD3 complex {5012, 5010} JCRB0148 KHM-5M human thyroid Cells are derived fromNeutrophil thyroid. chemotactic factor (inter leukin 8) producing cell line. JCRB0149 Bhas 42 mouse embryo H-ras gene transfectedGrowth BALB/c on the 3T3 dish cell isline. inhibited by cell to cell contact. Phorbol ester alone is enough to induce cellular transformation. JCRB0150 P53LMACO1 mouse vascular systemp53 deficient(-/-) smooth muscle cell line from p53 knock out mouse aorta JCRB0151 T-Ag-MOSE mouse ovary pEF321-T plasmid introducedimmortalized cell by line, T antigen laminin containingpositive. plasmid pEF321-T, tumorigenic in nude mice JCRB0151.1 p53-def-MOSE mouse ovary p53 gene was homozygouslynon-tumorigenic deleted, in lamininnude mice positive. JCRB0152.1 M rat liver 4-dimethylaminoazobenzene(DAB)Morphological changes transformed observed and remarkable cell line by changesDAB treatment. were found Historical in the cell biochemical line produced properties. by Nagisa culture and DAB treatment. JCRB0152.2 M.P3 rat liver 4-dimethylaminoazobenzene(DAB)Morphological changes transformed observed and remarkable cell line by changesDAB treatment. were found Historical in the cell biochemical line produced properties. by Nagisa culture and DAB treatment. JCRB0152.3 M.P3 rat liver 4-dimethylaminoazobenzene(DAB)Morphological changes transformed observed and remarkable cell line by changesDAB treatment. were found Historical in the cell biochemical line produced properties. by Nagisa culture and DAB treatment. JCRB0153.1 tsJT663 rat embryo A ts mutant for cell cycleMNNG-mutagenized progression from 3Y1 G1 cellto S derivatives phase. with ts mutation grows at 34 C but the growth is arrested at 40 C. JCRB0153.2 tsJT16 rat embryo A ts mutant for cell cycleMNNG-mutagenized progression from rat G0 3Y1 and derivative G1 to S. cell line with ts mutation. Cells grows at 34 C but is lethal at 40 C. JCRB0153.3 tsJT60 rat embryo A ts mutant for cell cycle3Y1 derivedprogression ts mutant from G0cell toline S phase.with MNNG treatment. Cells grow at 34 C and are arrested at G0 at 40 C. Cells continue proliferation at both temperatures in cell cycle. JCRB0154 NB(TU)1-10 human neural N-myc aberration observed.Neuroblastoma Genetically cell lineinstable with cellgenetically line. Pseudo-diploid. instable feature established from stage III case of tumor. JCRB0156 KHYG-1 human hemo-lymphocyticp53 point mutation andhigh cytogenetic NK/LAK activity, characteristics IFN gamma production etc. JCRB0157 TK human hemo-lymphocyticCD10, CD19, CD20,A HLA-DR rare large positive. B-cell Anon-Hodgkin's codon 180 of lymphoma the p53 mutated having a(GAG near-triploid -> GAT). cell Near-triploid population. chromosomes with t(14;18)(q32;q21), add(17)(p22). JCRB0158.0 MY human hemo-lymphocyticChimeric BCR/ABL, BCRBone exon marrow e1 mononuclearand ABL exon cells. a3. der(9)t(9;22), t(2;3)(p16;q29). JCRB0158.1 MY-M12 human hemo-lymphocyticChimeric BCR/ABL, BCRBone exon marrow e1 mononuclearand ABL exon cells. a3. only t(2;3)(p16;q29) observed by FISH analysis. JCRB0158.2 MY-M13 human hemo-lymphocyticChimeric BCR/ABL, BCRBone exon marrow e1 mononuclearand ABL exon cells. a3. der(9)t(9;22), t(2;3)(p16,q29). JCRB0159 SLVL human hemo-lymphocyticClonal rearrangementsB cell are line observed with cytoplasmic in IgH and villi TCR from behta a patient genes. with splenic lymphoma with circulating villious lymphocytes. JCRB0160 LI90 human liver, gallbladderKaryology: 47XX, 6q-, +22 JCRB0161 Kasumi-4 human blood t(9:22:11), overexpressionCD34+, of CD33+, Evi-1 gene CD13+ JCRB0162 NEC14 human testis testicular germ cell tumor,testicular 26 year-old,germ cell maletumor, 26 year-old, male JCRB0163 HL60(S) human hemo-lymphocyticAPL DMSO, butyl, HX., TPA, active vitamine D3, and Retinoic Acid induce differentiation efficiently. JCRB0164 HTC/C3 human thyroid thyroid carcinoma, female,thyroid 44-year-oldcarcinoma, female, 44-year-old JCRB0165 KHM-10B human hemo-lymphocyticHLA-DR,CD19 and surfaceBukitt's immunoglobulin(myu,kappa)lymphoma, ALL-L3 cell line. positive. Ig gene rearrangements observed. JCRB0166 HMC-1-8 human mammary HMC-1-8 is a target cell of the T-cell killer clone T(cHMC-1) derived from breast cancer established from pleural effusion. JCRB0167 RCN-9 rat colon DMH induced colonicDMH cancer. induced Male colonic F344/DuCrj cancer. rat. Male F344/DuCrj rat. JCRB0168 c-WRT-7-LR rat hemo-lymphocyticSurface markers: RT-1,c-WRT-7 Thy-11, cells Peroxidase, were differentiated were positive. by LPS, TPA and retinoic acid. JCRB0169 Lu-134-B human lung (cancer)Activities of gamma-enolaseDerived fromand aromaticsmall cell L-aminolung carcinoma, acid decarboxylase classic type. are Cells high are significantly. prepared from Hypertetraploid heterotransplantation chromosome of the pattern. tumor M=85,into athymic Td=85 BALB/c hrs mice. Dense cored granule (neurosecretory granule) observed unde EM. JCRB0170 Lu-135 human lung (cancer)Neuron specific enolase(NSE),Hard to observe creatin dense kinase core isoenzyme(CKBB) granules (neurosecretory were indicated granules) to be under high activityelectron but microscopic aromatic L-amino observation. acid decarboxylase(AADC)Doubling time was 45 hourshad low reported activity. originally. JCRB0172 RMG-I human ovary tumor markers = CA-125,Doubling TPA, time BFP, = 60Behta-micro-globulin. hrs. Colonyformation Mode rate of= 81chrosomosome %. = 47. JCRB0172.1 RMG-II human ovary Chromosomes are observedDoubling as time triploid. is around Tumor 58 markers, hours. Passage LA-125, numberTPA were is overobserved. 73 at deposit. JCRB0173 SKN human uterus Mode of chromosomeHistochemical = 104-112. characteristics = PP2, PP6, PP7 JCRB0174.0 NCC16-P11 human uterine cervixE6/E7 positive. TelomeraseColumnar positive. epitherium cells immortalized. No tumor formation observed in nude mice. JCRB0176 RKN human ovary mode of chromosome=74Doubling time=31.2 hours. JCRB0178.0 KP-3 human pancreas A metastasis of adenosquamous carcinoma of the pancreatic duct. JCRB0178.1 KP-3L human pancreas Tissue was classifiedCells as a were metastasis established of adenosquamous from the resulting carcinoma tumor nodules of the pancreatic in the liver duct.of mouse, into the spleen where KP-3 cells had been injected. JCRB0179 SNG-M human uterus Mordal No. of chromosomeintermediately is 40, Colony differentiated formation adenocarcinoma rate is 40%, Doubling time is 30 hours indicated by Nozawa,S. JCRB0180 GAK human melanoma Mode of chromosomeThe is 67.cell DT=72line GAK hours. has anTumor activity marker of 5-S-CD = 5-S-cysteinyldopa. production. JCRB0181 KP-2 human pancreas Mode of chromosomeThe No.=142 tumor cell at passageline is derived 20. CEA, from CA, pancreatic SLX were tissue positive(passage27). originally. Adeno carcinoma cell line. The cells can be transplantable to nude mouse. JCRB0182 KP-4 human pancreas Tumor cell line secreting parathyroid hormone-related peptide (PTHrP). Transplantable to nude mice. JCRB0183 QGP-1 human pancreas Modal chromosome Cellnumber line isproduces 50. CEA carcinoembryonic production. antigen (CEA). Cells create irregular cell aggregates, and grow as a confluent monolayer with piling up of cells in some area. Population doubling time is 3.5 days. Useful to study the regulation mechanisms of SRIF. JCRB0186 OV3121ras4 mouse ovary v-Ha-ras gene transfected.Ovarian pBW1160 granulosa was cell introducedline with v-Ha-ras by electropolation gene. Doubling method. time = 13 hrs. JCRB0187 OV3121ras7 mouse ovary v-Ha-ras gene transfected.Ovarian pBW1160 granulosa was cell introducedline with v-Ha-ras by electropolation gene. Doubling method. time mRNA= 35 hrs. of MMP2 expressed. JCRB0191 OCUG-1 human liver, gallbladderChromosome numberOnly distribute TA-4 antigen in a broad detected range in from the 52spent to 139. medium while high levele SLX, CA19-9, SPan-1 and TA-4 were observed in the serum of patient. JCRB0192 OCUM-1 human stomach karyotype=mode 50,This near cell diploid line produces carcinoembryonic antigen(CEA), carbohydrate antigen 19-9 (CA19-9), cancer-associated antigen SPan-1, and expresses EGF receptor. Tumorigenic to nude mice (intramusclar transplantation). JCRB0193 WB-F344 rat liver Normal diploid cell line.Normal Mode rat of liver chromosome epitherial cellnumber line grew is 40+XY in a monolayer. at passage Population 6. doubling was 20-23 hrs at beggining but became 12.5 hrs later. Cells did not accumulate cytoplasmic glycogen, negative for glucose-6-phosphatase. JCRB0194 KON human oral Mode of chromosome=62.5Td=32.5 (53-68). hrs. Colony forming unit = 3%. Expression of proteins at 67, 58 and 54 kDa and keratin were observed. 21 kDa protein from ras P21 was observed. JCRB0195 RP-1 mouse antibody-producingRat neutrophil hybridoma specificThis IgG1 cell production.line is producing X-63 IgG1parent. against the rat neutrophil. No harmfull effect against the neutrophil. This IgG1 is used for the histochemical staining of the neutrophil. JCRB0196 RP-3 mouse antibody-producingHybridoma hybridoma X63 as parent.Mouse Ratcell neutrophilline producing specific IgM IgM antibody production. against the rat neutrophil. The antibody is harmfull to the rat neutrophil in vivo or in vitro with complement. JCRB0197 OSC-20 human oral Cells grew in cobblestone pattern. Electron microscopy revealed a presence of tonofilaments and desmosomes. This cells secreted GST-pai into the culture medium. JCRB0198 OSC-19 human oral EGF receptor. EGF (1-100ng/ml) inhibited the cell growth. The cell could not grow in soft agar but the EGF stimulated colony formation in the soft agar. JCRB0199 huH-1 human liver, gallbladderModal chromosome Thenumber huH-1 is 69. cell line produce tumors in nude mice. Cells are producing HBs-antigen continuously in culture medium. Tyrosine aminotransferase activity was induced by dexamethasone as well as by butyryl c-AMP. JCRB0200 KMLS-1 human retroperitoneum JCRB0202 B16 melanoma mouse melanoma melanoma positive for melanin pigment production but large portion of cells are amelanotic JCRB0203 PCC4 TypeIII mouse x ratcybrid PCC4/L6TG Cap-r PCC4/L6TG Cap-r JCRB0206 PCC4 AG mouse teratoma testis, AG-r testis, AG-r. Cells originally contaminated with mycoplasmas but decotanimated by MC210 in the JCRB cell bank. JCRB0207 CaR-1 human rectum JCRB0208 CCK-81 human colon large intestine carcinoembryonic antigen producing. JCRB0209 L6TG rat muscular systemmyeloblast, TG-r myeloblast, TG-r JCRB0210 L6TG Cap rat muscular systemrat skeletal muscle myoblast,rat skeletal TG-r, muscle Cap-r myoblast, TG-r, Cap-r JCRB0211 A9 mouse skin HPRT and APRT deficient.skin fibroblast, AG-r JCRB0212 B82 mouse skin skin fibroblast, BrdU-rfibroblast JCRB0213 HeLa AG human uterine cervixcervix, AG-r cervix, AG-r JCRB0214 HeLa TG human uterine cervixcervix, TG-r cervix, TG-r JCRB0215 HeLa TG Cap human uterine cervixcervix, TG-r, Cap-r cervix, TG-r, Cap-r JCRB0216 PCC4 AG Cap mouse teratoma testis, AG-r, Cap-r testis, AG-r, Cap-r JCRB0217 DSPT200 hamster, Syrianembryo fetus fibroblast transformedfetus fibroblast cell transformed cell JCRB0218 CHO/HGPRT hamster, Chineseovary HPRT deficient HTRT deficient mutant of CHO cells JCRB0219 V79-6TG hamster, Chineselung lung, 6TG-r lung, 6TG-r JCRB0220 NTI-4 human embryo fetus body fetus, half body, bottom/fibroblast JCRB0221 HT100 hamster, Syrianlung lung, new born lung, new born JCRB0222 NTI-5 human embryo fetus, half a body Normal human cells. JCRB0224 WiDr human colon colon, adenocarcinomacolon, adenocarcinoma JCRB0225 COLO320 DM human colon colon, adenocarcinomacolon, adenocarcinoma JCRB0226 COLO201 human colon colon, adenocarcinomacolon, adenocarcinoma JCRB0227 C32TG human melanoma amelanotic melanoma,amelanotic 6TG-r melanoma, 6TG-r JCRB0228 A-172 human neural glioblastoma glioblastoma JCRB0229 EGV-4T rat lung immortal cell line fromrat MNNG-transformed tracheal epithelial cellscells JCRB0230 SCC-131 rat squamous cellsquamous carcinoma cell carcinomasquamous cell carcinoma JCRB0231 SCC-158 rat squamous cellsquamous carcinoma cell carcinomasquamous cell carcinoma JCRB0232 SKG-IIIa human uterine cervixcervix Growth rate is slow. JCRB0232.1 SKG-IIIb human uterine cervixtumor markers, TA-4,The hCG, cell behta-hCG, line was expected PP7 to be derived from an intermedially differentiated squamous cell carcinoma. Growth of the cell line SKG-IIIb was suppressed at 39 C. JCRB0233.0 BALB-MC mouse mammary mammary cancer mammary cancer JCRB0233.1 BALB-MC.D3 mouse mammary mammary cancer mammary cancer JCRB0233.2 BALB-MC.E12 mouse mammary mammary cancer mammary cancer JCRB0234.0 TYK-nu human ovary ovary, undifferentiatedovary, carcinoma undifferentiated carcinoma JCRB0234.1 TYK-nu.CP-r human ovary ovary, undifferentiatedovary, carcinoma. undifferentiated STR-PCR carcinoma results showed that this cell line is same as JCRB0234.0. JCRB0235 Lu-134-A-H human lung (cancer)small cell carcinoma small cell carcinoma, classic type JCRB0236 KG-1-C human neural mixed glioma mixed glioma JCRB0238 B8/3 mouse hemo-lymphocytic JCRB0239 TCO-1 human thyroid non differenciated cancer JCRB0240 MCAS human ovary JCRB0241 Shay rat hemo-lymphocytic JCRB0242 RMT-1 E4 rat mammary rat mammary carcinoma, DMBA induced JCRB0243 B-1 mouse testis estrogen dependent Leydig cell tumor JCRB0245 RMT-1 M2 rat mammary rat mammary myoepithelialCells were tumor prepared cells. from the tumor. JCRB0246 RC-1 rabbit cornea cornea cornea JCRB0247 RL-34 rat liver liver Cell growth stopped once adhered to collagen base. JCRB0248 ARLJ301-3 rat liver liver epithelial cell liver epithelial cell JCRB0249 FAA-HTC1 rat liver 2-AAF induced hepatocellular2-AAF induced carcinoma hepatocellular carcinoma JCRB0250 NEC8 human testis testicular germ cell tumor,testicular 24 year-old,germ cell maletumor, 24 year-old, male JCRB0251 SCH human stomach stomach, choriocarcinoma,stomach, 46 choriocarcinoma, year-old male 46 year-old male JCRB0252 MKN1 human stomach stomach, adenosquamousstomach, carcinoma, adenosquamous 72 year-old carcinoma, male 72 year-old male JCRB0254 MKN45 human stomach stomach, 62 year-oldstomach, female. 62 year-old female. JCRB0255 MKN74 human stomach JCRB0256 RCM-1 human rectum rectum, adenocarcinoma,rectum, well adenocarcinoma, differentiated well differentiated JCRB0257 CoCM-1 human colon descending colon, adenocarcinomaModerately differentiated adenocarcinoma from descending colon. JCRB0258 LC-1 sq human lung (cancer)lung, squamous carcinomalung, squamous carcinoma JCRB0259 MSK rat sarcoma 32P-induced osteosarcoma,32P-induced F344 osteosarcoma, rat, female F344 rat, female JCRB0260 SAS human oral tongue, squamous carcinomatongue, squamous carcinoma JCRB0261 T.Tn human esophagusHigh alkaline phosphataseSquamous activity. carcinoma. Cells established via mouse being transplanted. JCRB0262 T.T human esophagussquamous carcinoma3p-, 6q- Mode=85-87(chr) JCRB0263.1 PC12HS.P3 rat neural Serum free cell cultureCells derived are differentiated from NGF-highly into sympatheticsensitive clone neuron-like (HS) extensions when they are exposed to NGF. JCRB0266 PC12HS rat neural NGF-highly sensitiveCells clone are (HS) differentiated into sympathetic neuron-like extentions when they are exposed to NGF. JCRB0267 PC12MS rat neural NGF-moderately sensitiveCells are clone differentiated (MS) into sympathetic neuron-like extensions when they are exposed to NGF. JCRB0268 PC12IS rat neural NGF-insensitive cloneCells (IS) are differentiated into sympathetic neuron-like extensions when they are exposed to NGF. JCRB0401 HUH-6 Clone 5 human liver, gallbladderhepatoblastoma, HBsAgProduces negative, albumin, 16ug/ml prealbumin, CEA fibrinogen ect. JCRB0402 RLN-B2 rat liver normal liver JCRB0403 HuH-7 human liver, gallbladderdifferenciated hepatomahepatoma (differenciated), age 57, (M) JCRB0404 HLE human liver, gallbladderhepatoma (non-differentiated),hepatoma (non-differentiated),age 68, (M) age 68, (M) JCRB0405 HLF human liver, gallbladderhepatoma, non-differentiated,hepatoma, age non-differentiated, 68, male age 68, male JCRB0406 PLC/PRF/5 human liver, gallbladderLoss of D & G groupG6PD=Type chromosomes, A. Tumorswith marker developed chr. in hamster(imn.sup). JCRB0407 RLN-J-5-2 rat liver normal liver, 7 days normal liver, 7 days JCRB0408 Ac2F rat liver normal liver, diploid normal liver, diploid JCRB0409 dRLa-74 Clone 2 rat liver liver adenoma liver adenoma JCRB0410 dRLh-84 rat liver hepatoma hepatoma JCRB0411 AH66tc rat liver Yoshida ascites hepatomaYoshida ascites hepatoma JCRB0412 AH70Btc rat liver AH70B Yoshida ascitesAH70B hepatoma Yoshida ascites hepatoma JCRB0413 HuO-3N1 human sarcoma osteosarcoma, age 15,osteosarcoma, (F) age 15, (F) JCRB0414 RLN-8 rat liver normal liver, 9 days normal liver, 9 days JCRB0415 RLN-10 rat liver normal liver, 14 daysnormal liver, 14 days JCRB0416 Ac2F(DT) rat liver liver, normal liver, normal JCRB0417 Ac2F(ST) rat liver liver, normal liver, normal JCRB0418 dRLN-4 rat liver liver after treatment byliver 0.06 after % treatment DAB by 0.06 % DAB JCRB0419 dRLN-9 rat liver liver after treatment byliver 0.06 after % treatment DAB for 33 by days0.06 % DAB for 33 days JCRB0420 dRLN-6 rat liver liver after treatment byliver 0.06 after % treatment DAB for 62 by days0.06 % DAB for 62 days JCRB0421 3'-mRLN-30 rat liver liver after 3'-Me-DABliver treatment after 3'-Me-DAB for 55 days treatment for 55 days JCRB0422 3'-mRLN-31 rat liver liver after 3'-Me-DABliver treatment after 3'-Me-DAB for 61 days treatment for 61 days JCRB0423 RS-A rat spleen spleen, spontaneouslyspleen, transformed spontaneously cells transformed cells JCRB0424 JTC-11 mouse ascites JTC-11 (K strain) is an invitro-adapted strain of Ehrlich ascites carcinoma. JCRB0425 HuCCT1 human liver, gallbladderbile duct carcinoma bile duct carcinoma JCRB0426 HuH28 human liver, gallbladderbile duct carcinoma (liver)bile duct carcinoma (liver) JCRB0427 HuO9 human sarcoma Liver/bone/kidney-typeSecretes alkaline osteocalcin phosphatase. & responds to vitamin D3. JCRB0428 HuO9N2 human sarcoma Vitamin D3 responsiveTumorigenic ALP production. cell line. Growth rate is very slow. JCRB0429 KMS-12-BM human hemo-lymphocyticlate stage of B-cell differentiationNon tumorigenic, PCA-1(+),CD38(+),OKT9(+) JCRB0430 KMS-12-PE human hemo-lymphocyticlate stage B-cell differentiation,non-producing, EBV transferrin Ag.negative receptors psitive JCRB0431 3'-mRLh-2 rat liver Gamma-glutamyl transpeptidaseA dexamethasone-responsive producing cell line. tyrosine aminotramsferase is expressed in this cell line. JCRB0432 KMS-6 human embryo Normal diploid cell fibroblast, normal diploid JCRB0433 KMST-6 human embryo fibroblast, immortalizedindefinite by 60Co growth irradiation, and non-tumorigenic derivative of KMS-6 JCRB0435 JHH-4 human liver, gallbladderHBV integration is notAlpha-phetoprotein observed. and albumin-producing cell line. HBs antigen-negative. HCV was not detected by an RT-PCR method tested in the HSRRB. JCRB0501 TIG-1-20 human fetus lung fetal lung, (F) fetal lung, normal diploid fibroblast, TIG-1 JCRB0502 TIG-1-30 human fetus lung fetal lung, (F) fetal lung, normal diploid fibroblast, TIG-1 JCRB0503 TIG-1-40 human fetus lung fetal lung, (F) fetal lung, normal diploid fibroblast, TIG-1 JCRB0504 TIG-1-50 human fetus lung fetal lung, (F) fetal lung, normal diploid fibroblast, TIG-1 JCRB0505 TIG-1-60 human fetus lung fetal lung, (F) fetal lung, normal diploid fibroblast, TIG-1 JCRB0506 TIG-3-20 human fetus lung fetal lung, (M) fetal lung, normal diploid fibroblast, TIG-1 JCRB0506.1 SVts-8 human lung TIG-3 cells(JCRB0506)Human containing normal SV40 fibroblast early with gene immortal with ts lifemutation. span by the introduction of the SV40 early gene. JCRB0511 TIG-7-20 human fetus lung fetal lung, (M) fetal lung, normal diploid fibroblast, TIG-1 JCRB0518 WI-38-40 human lung lung, normal diploid lung,fibroblast normal diploid fibroblast JCRB0519 IMR-90-40 human lung JCRB0521 MRC-5-30 human fetus lung lung,normal diploid fibroblastfetal lung, normal diploid fibroblast, TIG-1 JCRB0525 TIG-2M-30 human muscular systemmuscle, normal diploidmuscle, fibroblast normal diploid fibroblast JCRB0526 TIG-101 human skin skin, normal diploid fibroblastskin, normal diploid fibroblast JCRB0527 TIG-102 human skin skin, normal diploid fibroblastskin, normal diploid fibroblast JCRB0528 TIG-103 human skin skin,normal diploid fibroblastskin,normal diploid fibroblast JCRB0532 TIG-107 human skin skin, normal diploid fibroblastskin, normal diploid fibroblast JCRB0533 TIG-112 human skin Normal diploid, 2N=46.Normal skin fibroblast cells. PD at distribution, 15-20 PDL. JCRB0534 TIG-114 human skin Normal diploid 2N=46.Normal human skin fibroblast cells. JCRB0535 TIG-118 human skin normal JCRB0536 TIG-121 human skin normal diploid JCRB0537 TIG-108 human skin normal diploid, 2n = normal46, XX. fibroblast JCRB0538 TIG-109 human skin normal fibroblast, 2n=46,normal XX. diploid human skin JCRB0539 TIG-113 human skin 2n=46, XX Maximum PD = 53. Cells may be distributed around PD15-PD20. JCRB0540 TIG-119 human skin 2N=46, XY Maximum PD = 48. Cells may be distributed around PD15 - PD20. JCRB0541 TIG-111 human skin normal diploid fibroblastnormal (2n-46, diploid XX) JCRB0542 TIG-120 human skin normal diploid (2n=46,XX)normal diploid fibroblast JCRB0543 TIG-110 human skin 2n=46, XX normal diploid fibroblast, PD35 JCRB0544 TIG-3S human skin 2n=46, XY lifespan PD67 JCRB0601 BALB/3T3 A31-1-1 mouse embryo whole embryo contact inhibited mouse cell line JCRB0603 V79 hamster, Chineselung lung lung JCRB0605 L.P3(S) mouse skin Serum free cell line established by Katsuta but later cells have been maintained with serum. JCRB0606 HeLa.P3(S) human uterine cervixcervix cervix, grow in serum free medium but later serum was used to maintain this cell line which is different from the serum free cell culture. JCRB0608 JTC19 rat lung lung lung JCRB0609.1 Mm2T.P3 Indian Muntjakthymus Choromosome analysisCells showes grew when the cell started line isat derived 1977 but from did Muntjac. not grow Chromosome for 2 years after number then. is Cells7. Telomere were kept length by changing is 7.7 kb. medium for two years and finally cells started to grow again. Now cells are growing well. Medium was converted to serum free at 1991. JCRB0610 IAR-20 rat liver adult liver Non-transformed rat liver epitherial cell line from adult liver. Non-tumorigenic in newborn rats and in nude mice, Metabolizes benzo(a)pyrene. JCRB0611 KATOIII human stomach stomach cancer, signetstomach ring cell cancer, carcinoma signet ring cell carcinoma JCRB0612 GOTO human neural neuroblastoma neuroblastoma JCRB0612.1 GOTO.P3 human neural neroblastoma GOTO cells cultured with serum free medium for long period by serial subcultures. JCRB0613 ITO-II human testis F9-like antigen and class I MHC antigen is expressed. Low amount of beta-human gonadotropin is produed. Alpha-phetoprotein was detected when transplanted to nude mice. JCRB0614 NY human sarcoma osteosarcoma osteosarcoma JCRB0615 NIH/3T3 clone 5611 mouse embryo whole embryo whole embryo, contact inhibited JCRB0618 TGW human neural neuroblastoma JCRB0618.1 TGW.P3 human neural JCRB0621 NB-1 human neural neuroblastoma (M) Differentiate by (But)2cAMP (1mM). JCRB0622 HSC-2 human oral This cell line has neither invasive nor metastatic potential and grew in synthetic medium PF86-1. JCRB0623 HSC-3 human oral squamous carcinoma,squamous tongue, agecarcinoma, 64, (M) tongue, age 64, (M) JCRB0624 HSC-4 human oral squamous carcinoma,squamous tongue, agecarcinoma 64, (M) JCRB0625 Ca9-22 human oral gingival carcinoma gingival carcinoma JCRB0626 TG1 hamster, Chineselung lung, V79 delivertive,lung, 6TG V79 resistant delivertive, 6TG resistant JCRB0627 KYM-1 human sarcoma neck tumor, rhabdomyosarcomaneck tumor, rhabdomyosarcoma JCRB0628 MRK-nu-1 human mammary mammary carcinoma,mammary globular carcinoma JCRB0648 L.P3 mouse skin skin This cell line was surpplied from Riken Genebank for the replacement to the JCRB0605. JCRB0649 HeLa.P3 human uterine cervix This cell line is surpplied from Riken Genebank for the replacement to the JCRB0606:HeLa.P3(S). JCRB0649.1 HeLa.P3 human uterine cervix This cell line was deposited from Takaoka,T. directly which have been mainted under serum free condition. JCRB0650.1 Mm2T12.P3 Indian Muntjakthymus The Mm2T12.P3 has different characteristics from the original strain. An addition of 2% FCS induces chromosomal averation to the Mm2T12.P3 cell line. Chromosoma digestion observed at the beginning and later chrosomosome number increases. JCRB0701 FM3A mouse mammary mammary carcinoma,mammary spontaneously carcinoma, obtained spontaneously obtained JCRB0702 FM3A HPRT~ mouse mammary mammary carcinoma,mammary HPRT deficient. carcinoma JCRB0703 FM3A APRT~ mouse mammary mammary carcinoma,mammary APRT-deficient. carcinoma JCRB0704 FM3A TK~ mouse mammary mammary carcinoma,mammary thymidine carcinoma kinase deficient. JCRB0705 ts85 mouse mammary FM3A derivative,ubiquitation of protein is unusual JCRB0706 tsFT101 mouse mammary FM3A derivative Cytokinesis is blocked at 39 C. JCRB0707 V79 HPRT~ hamster, Chineselung lung (M) HPRT~ cells. JCRB0708 P3U1 mouse hemo-lymphocyticmyeloma myeloma JCRB0709 L5178Y mouse hemo-lymphocyticleukemia culturable derivative of L5178+ JCRB0709.1 L5178Y TK+/-3.7.2c mouse hemo-lymphocyticleukemia TK+/- heterozygotic subline of the L5178Y JCRB0710 EJ-1 human bladder STR-PCR data indicatedHa-ras that mutation the EJ-1 reported. is the same cell line as the T24. JCRB0711 T24 human bladder urinary bladder carcinomaurinary bladder carcinoma JCRB0712 MCA-TCL16 mouse embryo C3H10T1/2 cl-8, transformedC3H10T1/2 by cl-8,methylcholanthrene transformed by methylcholanthrene JCRB0713 HeLa S3 (sc) human uterine cervixcervix, can grow in suspensioncervix, can culturegrow in suspension culture JCRB0714 JTC-16 P3 rat liver ascites hepatoma, serum not required. Low amount of serum added. JCRB0714.1 AH-7974.P3 rat liver Ascites hepatoma, serum free cell culture. JCRB0718 RLC-10.P3 rat liver liver, no serum required JCRB0718.1 RLC-10.P3 rat liver Telomelase was negative and a length of telomere was 2.0 Kbases. JCRB0719 FSthy21 mouse thymidylatecomplete defective defective straincomplete of thymidylate defective strainsynthase of thymidylate synthase JCRB0720 OTT6050 mouse teratoma teratocarcinoma teratocarcinoma JCRB0721 F9 mouse teratoma teratocarcinoma teratocarcinoma JCRB0722 L cl 1D mouse skin TK~ skin fibroblast, TK~,(M) JCRB0723 L5178Y ts2 mouse hemo-lymphocyticAbnormal Cell divisionAbnormal observed Cell at divisionnon perm. observed temp. at non perm. temp. JCRB0724 L5178Y ts39 mouse hemo-lymphocyticA ts cell line. PermissiveMicronucleation temperature observed is 33 C and when non cells permissive are exposed temperature to the non-permissive is 39 C. temperature(39 C). JCRB0726 A9(NTI8)-2 human chromosome-introducedhuman chromosomalThe cell line hybrid containscontains human humanchromosome chromosome #7 #7 JCRB0727 A9(An4)-2 human chromosome-introducedhuman chromosomalcontains human hybrid chromosomecontains human #1 chromosome #1 JCRB0728 A9(7151)-3 human chromosome-introducedhuman chromosomalcontains human hybrid chromosome 17pter>17q11::Xq11>Xqter JCRB0729 A9(3884)-1 human chromosome-introducedhuman chromosomalcontains human hybrid chromosomecontains human 16pter>16q24::Xq26>Xqter chromosome 16pter>16q24::Xq26>Xqter JCRB0730 A9(2621)-4 human chromosome-introducedhuman chromosomalcontains human hybrid chromosomeHAT selection 12pter>12q24::Xq22>Xqter required JCRB0731 A9(3552)-2 human chromosome-introducedhuman chromosomalcontains human hybrid chromosome 11pter>11q23::Xq26>Xqter JCRB0732 A9(0439)-1 human chromosome-introducedhuman chromosomalcontains human hybrid chromosomecontains human Xpter>Xq26::3p12>3pter chromosome Xpter>Xq26::3p12>3pter JCRB0733 PC-12 rat neural Cells are differentiated into sympathetic neuron-like cells, when exposed to nerve growth factor. JCRB0734 3Y1-B Clone 1-6 rat embryo Ref{4007}showed thiswhole cell lineembryo is mixed population JCRB0735 SV-3Y1-C66 rat embryo whole embryo, SV40SV40 transformed transformed subline subline of 3Y1 of 3Y1 JCRB0736 Py-3Y1-S2 rat embryo whole embryo, mousewhole polyoma embryo, virus-transformed mouse polyoma 3Y1. virus-transformed 3Y1. JCRB0737 Ad12-3Y1-Z19 rat embryo whole embryo, Ad12-transformedwhole embryo, 3Y1 Ad12-transformed subline 3Y1 subline JCRB0738 E1A-3Y1-1 rat embryo whole embryo, transformedwhole embryo, 3Y1 by transformedE1A of Ad12 3Y1 virus by E1A of Ad12 virus JCRB0739 NG-3Y1-T15L rat embryo whole embryo, transformedwhole embryo, 3Y1 by transformedMNNG treatment 3Y1 by MNNG treatment JCRB0740 NG-3Y1-T308 rat embryo whole embryo,transformedwhole embryo,transformed3Y1 by MNNG treatment 3Y1 by MNNG treatment JCRB0741 NG-3Y1-T6R rat embryo whole embryo, transformedwhole embryo, 3Y1 by transformedMNNG treatment 3Y1 by MNNG treatment JCRB0742 SR-3Y1-2 rat embryo whole embryo,transformedwhole embryo,transformed3Y1 by Rous sarcoma 3Y1 virus by Rous sarcoma virus JCRB0743 HR-3Y1-2 rat embryo whole embryo, transformedwhole embryo, 3Y1 by transformedv-H-ras cDNA 3Y1 by v-H-ras cDNA JCRB0746 YKG-1 human neural GFA and S-100 proteinhuman identified. glioma HSRcell line on establishedmarker chromosome from a surgical identified. specimen alpha- of & abehta-TGFs patient with expressed glioblastoma JCRB0801 Caki-1 human kidney renal cancer renal cancer JCRB0810 ME-180 human uterine cervixuterus, cervical canceruterus, cervical cancer JCRB0813 VMRC-RCW human kidney renal cell carcinoma renal cell carcinoma JCRB0814 VMRC-LCD human lung (cancer)adenocarcinoma adenocarcinoma JCRB0815 ABC-1 human lung (cancer)adenocarcinoma adenocarcinoma JCRB0818 SBC-3 human lung (cancer)small cell carcinoma small(Oat cell type)carcinoma (Oat cell type) JCRB0819 SBC-5 human lung (cancer)small cell carcinoma small(intermediate) cell carcinoma (intermediate) JCRB0820 EBC-1 human lung (cancer)squamous cell carcinomasquamous cell carcinoma JCRB0821 NUGC-2 human stomach gastric cancer gastric cancer JCRB0822 NUGC-3 human stomach gastric cancer gastric cancer JCRB0823 YMB-1 human mammary breast cancer breast cancer JCRB0824 8305C human thyroid C:G->T:A mutation atthyroid codon anaplastic 273 of p53 carcinoma, gene undifferentiated JCRB0825 YMB-1-E human mammary breast cancer breast cancer JCRB0826 8505C human thyroid C:G->G:C transversion at codon 248 of p53 gene JCRB0827 VMRC-RCZ human kidney renal cancer renal cancer JCRB0828 HO-1-u-1 human oral squamous cell carcinoma JCRB0829 LK-2 human lung (cancer)low molecular weight thiol protease inhibitor JCRB0830 PEER human hemo-lymphocyticNegative for B cell markers,acute lymphocytic and EBV(EBNA). leukemia from a case of T cell JCRB0831 HO-1-N-1 human oral squamous cell carcinoma JCRB0832 NH-6 human neural neuroblastoma cell line from primary tumor JCRB0833 NH-12 human neural neroblastoma cell line JCRB0834 NUGC-4 human stomach signet ring cell carcinoma JCRB1001.1 MS-653-A rat sarcoma MS-653-A is highly tumorigenic clone from AS 653-HM tumor. JCRB1001.2 MS-653-G rat sarcoma Rat fibrosarcoma cell line induced by methylcholanthrene. MS-653-G, a variant clone isolated by serial passage in low serum from MS-653-A, is less tumorigenic comared to clone A. JCRB1002 K562/ADM human hemo-lymphocyticchronic myelogenousChronic leukemia, myelogenous adriamycin leukemia resistant cell line, resistant to adriamycin (300ng/ml), induction of p-glycoprotein by addition of sodium butyrate (10ng/ml). JCRB1003 Kasumi-1 human hemo-lymphocytict(8:21), AML-ETO fusionMPO+, gene CD34+, CD13+ JCRB1004 Kasumi-3 human hemo-lymphocytict(3:7) Overexpression of Evi-1 protein, CD34+, CD7+ JCRB1005 NCC-IT-A3 human teratocarcinomaCells are expressingteratocarcinoma HST-1 oncogene from anterior mediastinum JCRB1006.0 OUMS-36 human embryo normal cell normal fibroblast JCRB1006.1 OUMS-36T-1 human embryo 10^5 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (50ng/ml) by 3hTRT times gene with (pMXpuro).the electroporation. JCRB1006.1F OUMS-36T-1F human embryo P201 JCRB1006.2 OUMS-36T-2 human embryo 10^7 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells trnasfected (50ng/ml) by twicehTRT with gene electroporation. (pMXpuro). JCRB1006.2F OUMS-36T-2F human embryo OUMS-36T series P200 JCRB1006.3 OUMS-36T-3 human embryo 10^6 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (100ng/ml) by hTRT twice genewith electroporation. (pMXpuro). JCRB1006.3F OUMS-36T-3F human embryo P206 JCRB1006.4 OUMS-36T-4 human embryo 10^6 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (200ng/ml) by hTRT twice genewith electroporation. (pMXpuro). JCRB1006.4F OUMS-36T-4F human embryo P202 JCRB1006.5 OUMS-36T-5 human embryo 10^6 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (50ng/ml) by 4hTRT times gene with (pMXpuro).electroporation. JCRB1006.5F OUMS-36T-5F human embryo P196 JCRB1006.6 OUMS-36T-6 human embryo 10^6 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (200ng/ml) by hTRT 4 times gene with (pMXpuro). electroporation. JCRB1006.6F OUMS-36T-6F human embryo P210 JCRB1006.7 OUMS-36T-7 human embryo 10^6 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (200ng/ml) by hTRT 3 times gene with (pMXpuro). electroporation. JCRB1006.7F OUMS-36T-7F human embryo Cells deposited at P196. JCRB1006.8 OUMS-36T-8 human embryo 10^7 cells/well were normaltransfected human with embryo pMXpuro-hTRT cells transfected (200ng/ml) by hTRT 4 times gene with (pMXpuro). electroporation. JCRB1006.8F OUMS-36T-8F human embryo OUMS-36T-8F/5F/2FP203 are similar patterns analyzed by the STR-PCR method. JCRB1008 HFb16d human skin Cells transfected by NormalHPV16 fibroblastDNA. No humantelomerase cells activity. with HPV16 Cells DNA.can be passaged over 25 generations at 1/5 split ratio. JCRB1009 RERF-GC-1B human stomach Gastric adenocarcinoma cell line established from metastatic tumor tissue of pyloric lymph nodes. JCRB1010 KMRC-1 human kidney VHL gene alterationClear observed. cell renal carcinoma cell line JCRB1011 KMRC-2 human kidney VHL gene alterationClear observed. cell renal carcinoma cell line. JCRB1012 KMRC-3 human kidney VHL gene alterationCear observed. cell renal carcinoma cell line JCRB1014 KMRM-M1 human kidney JCRB1015 HSC-1 human skin excess expression ofSkin the squamousEGF recepters carcinoma observed. cell line. Modal number of chromosome is reported to be 80. JCRB1016 HSC-5 human skin Modal number of chromosomeThe cells lost is reportedtheir ability to beto defferentiate76. to keratinize. The cells express cytokeratins 5, 8, 13, 18 and 19 {5064}. JCRB1017 HKA-1 human skin Chromosome is hypertriploidyA giant keratoacanthoma. with modal number Cells of 78.grow in a monolayer and are epithelioid with anaplastic feature. JCRB1018 HMY-1 human melanoma Modal number of chromosomeMelanoma iscell 66. line established from metastasised lymph node. Pigments were observed at early stages but faded later when established as a cell line. JCRB1019 RERF-LC-Sq1 human lung (cancer) Established from human lung squamous carcinoma tissue grown in SCID mice. JCRB1020 RERF-LC-Ad1 human lung (cancer) lung cancer (adeno carcinoma) cell line JCRB1021 RERF-LC-Ad2 human lung (cancer) human lung cancer, adenocarcinoma cell line. JCRB1022 OUMS-23 human colon Expression of the APCCells gene express decreased heat-stable to one-half placental-type compared APase with the and normal carcinoembryonic fibroblast cells. antigen. No mutaion Chromosomes at codons are 12 between and 61 53of H-,and K-, 118. and Cells N-ras can proto grow oncogenes. in soft agar at cloning efficiency of 6.5%. The cells form tumors in the nude mice diagnosed as differentiated adenocarcinoma. JCRB1024 Kasumi-6 human hemo-lymphocytic45,XY,-9,add(12)(p11),add(13)(p11)Mononuclear cells (20 separated metaphase by ficollcells conrayscored). gradient. CG transitional mutation at 1063 of the C/EBP alpha gene producing P42 and P30 isoform endogenously. JCRB1025 MKN7 human stomach stomach, well differentiatedstomach,well tubular differentiated adenocarcinoma tubular adenocarcinoma JCRB1026 OV3121 mouse ovary Non-metastatic epithelial tumor cells from granulosa cell of mouse irradiated with 60-Co-gamma rays. Cells are producing estradiol and angiogenesis was observed when transplanted to mice. Cells grow in monolayer with 28-30 hrs' population doubling. JCRB1027 SAT human oral MMP and TIMP-1 wereCells examined grow in monolayerby the originator with doubling {5086}. time of 72 hrs. Non-metastatic characteristics. JCRB1028 JHH-2 human liver, gallbladderIntegration of the HBV-DNAhepatoma was (Ed.II). not observed. HBs-Ag(-). The cells can be transplantable to nude mice. Mode of chromosome is 70. JCRB1029 JHH-5 human liver, gallbladderIntegration of the HBV-DNAHepatocellular was not carcinoma observed. Ed.I. Human albumin secretion and AFP(110ng/ml/48hrs) observed in the supernatant of the cell culture. HBs-Ag(-). JCRB1030 JHH-6 human liver, gallbladderHBV-DNA was not integratedUndifferentiated morphology observed. Albumin, AFP and CEA were not observed in the supernatant of the cell culture but ferritin was observed (6.7 ng/ml). HBs-Ag(-), HBs-Ag(-). JCRB1031 JHH-7 human liver, gallbladderHBV-DNA integration observed. 6.0/2.5Kb bands by HindIII were observed. JCRB1032 OZ human liver, gallbladderNo. of chromosome,Cells 51. Td=48 were established hrs. from ascites of the patient whose bile duct was emphraxed by mucinous materials produced by adenocarcinoma cells. Cells produce CEA, BMG. High levels of P1-P, r-GTP, LDH were observed in cells. PAS (+). Transplantalbe to nude mice. JCRB1033 NOZ human liver, gallbladderNo. of chromosome Dt=48= 46. hrs. Plating efficiency is 14-19%. Cells are transplantable to nude mice and the morphology of the transplanted tumor was similar to the original one. JCRB1034 OUS-11 human lung Cells are derived from normal tissue of lung cancer patient. JCRB1039 SKN-3 human oral Cells were estabished through xenotransplanted tumor in nude mice JCRB1040 FF101 rat liver Cells have characteristicsThe cells of hepatoma are expected and tocholangioma. produce FF-GF (unidentified growth factor, 70KDa). Sup. of the cell culture have growth activating activity(AH66, K562, Y3, YAC-1,BALB/c,3T3,NS-1). Cells have been cultured with serum-free medium from the primary cuture. JCRB1041 SEKI human melanoma Cells are consisted from both melanin containig and melanin non-containing cells. Cells can be cloned by soft agar method. Melanin granules are observed in cells. JCRB1043 OVISE human ovary ER(-), PR(-) / tumourCells markers, are transpantableCA19-9, CA125, on TPA.mouse hypodermic but not abdominal. JCRB1044 OVKATE human ovary ER(6.2 fmol/mg), PR(-),Cells tumor are transplantablemarkers under to investigation. both mouse hypodermis and abdominal. JCRB1045 OVMANA human ovary ER(-), PR(-) / tumourCells markers, are transplantableCA125, SLX, TPA(o).to mouse hypodermis but not to abdominal. JCRB1046 OVSAHO human ovary PR(-) / tumour markers,Cells SLX, are TPA(x).transplantable to both mouse hypodermis and abdominal. JCRB1047 OVSAYO human ovary ER(-), PR(-) / tumourCells markers, were CA125, not transplantable SLX, TPA(x). to mouse. JCRB1048 OVTOKO human ovary ER(-), PR(-) / tumourCells markers are nottransplantable identified. to both mouse hypodermis and abdominal. JCRB1049 OVMIU human ovary ER(-) / tumor markers,Cells CA125, are not CA19-9, transplantable TAP, SLX, to LDH,mouse. ALP E2, E1, DHEA. JCRB1050 OVMIU-II human ovary tumour markers, CA125,Experiments ALP. on mouse transplantation have not been done. JCRB1051 OUMS-24/P6\X human embryo Human normal cells Lifeimmortalized span of theby pCDM8-p53OUMS24 was and extended X-ray irradiation. to 79th and chromosome abnormality observed(OUMS24/P6). Cells were immortalized by the X-ray treatment (OUMS24/P6X). JCRB1052 PA-1/6TG-r human teratocarcinoma6TG resistant (HGPRTTeratocarcinoma negative) was cellintroduced line with by 6TG-r, the depositor. the cell line 87% show cells significant have near alterations diploid chromosomes. in various malignancy-related phenotypes along extended passages in cell culture. JCRB1053 STC 1 human lung (cancer) JCRB1054 Hep G2 human liver, gallbladder Hepatoma cell line. alpha-fetoprotein (+), HLA-A 02/2402. JCRB1065 Ki-JK human hemo-lymphocyticPositive markers, CD15,CD25,CD30,CD45,CD45RO,EMA,Macrophage,HLA-ABC,HLA-DR,Tf-R,Ki-6,Anti-lysozymeMononuclear cells with multiple nucleoli. No growth in soft agar. JCRB1066 KMH-2 human thyroid Chromosome No. 92-108.doubling time is 58 hours and multidrug registance. JCRB1067 CPT-K5 human hemo-lymphocytic Camptothecin resistant cell line. Purified DNA topoisomerase I was resistant to the camptothecin. JCRB1069 NOMO-1/ADM human hemo-lymphocytic Adriamycin-registant derived from NOMO-1 (IFO50474). JCRB1070 HSGc-C5 human HeLa-contaminant Raddiation sensitivity D0=2.7Gy, D10=4.1Gy, alpha=0.31Gy^-1, beta=0.062Gy^-2 (200kVp X ray). Td=23hr. Plating efficiency=75-85%. JCRB1071 KMRC-20 human kidney JCRB1073 ASH-3 human thyroid Chromosome numberDoubling was 79-89. time is 84 hours and multidurg registance cell line. JCRB1074 FU97 human stomach Td = 95 hrs. AFP production and tumorigenesity is maintained in the cell line. JCRB1075.0 IM95 human stomach Modal chromosome Td=25number hrs. = 46. CEA related antigen observed. HGF production and tumorigenesity is maintained in the cell line. JCRB1075.1 IM95m human stomach Clone from the IM95. A clone from the IM95, produces higher level of HGF & VEGF. JCRB1077 DD-762 mouse mammary MuMTV is positive. DD-762 was isolated directly from DD-761 established from the mouse mammary tumor. Td=80. Modal No. of chromosome=80. JCRB1078 TMH-1 human thyroid Choromosome No. ditributesDoubling fromtime 40is 74 to hours.120. Multidrug resistance. JCRB1079 IHH-4 human thyroid Doubling time = 42 hrs,Original Chromosome tumor appeared number in = thyroid. 41 - 47 Cells(46). are adherent monolayer with small polygonal shaped. Multidrug registance. JCRB1080.0 HARA human lung (cancer) This cell line expresses PTHrP highly and the bone metastasis is induced extensively by the injection to the heart chamber of nude mouse. Hypercalcemia is induced in mice by hypodermic transplantation of the cell. JCRB1080.1 HARA-B human lung (cancer)originally human cellDelivertive but the cell of line the estableshed HARA cell. This from cell metastatic line expresses organ (bone)PTHrP ofhighly mouse and the bone metastasis is induced extensively by the injection to the heart chamber of nude mouse. Hypercalcemia is induced in mice by hypodermic transplantation of the cell. JCRB1081 MS-1-L human lung (cancer)Chromosome distributionCells isare between producing 49 PTHrP.and 52. 1p+, 3q-, 6p-, 14p+, 17p+. JCRB1088 RI-T rat liver SV40 antigen positive,The desmin, cells were and established type IV collagen by the were transfection detected of in a cytoplasms.pRSV-T. The cell line has both morphologilal and functional characteristics of HSC. JCRB1090 NCE 16IIA human uterine cervixteromerase positive,HPV16 HPV16, transformed p75 NTR positive. noraml human cells from cervix JCRB1091 NCE SVIIA3 human cervix SV40 ori(-), teromeraseSV40 positive, transformed P75NTR human positive. keratinocyte from cervix. JCRB1092 NCE SVIA6 human cervix teromerase positive SV40 transformedori(-), p75NTR keratinocyte positive. cell JCRB1093 PSVK1 human foreskin Cells transfected by HumanpSV40 primaryori. Teromerase cell line immortalizedactivity is maintained. by pSV40 gene. JCRB1094 SUIT-2 human pancreas Mode of chromosome=45PDL=38.2 (34-176) hrs JCRB1096 hs-103-3 hamster, Chineselung Temperature sensitiveanchorage mutant, whichindependent are transformed cell line treated below 34.5by MNNG C(heat sensitive). JCRB1097 hs-164-2 hamster, Chineselung Temperature sensitiveAnchorage mutant, which independent are transformed cell line transformed below 34.5 C(heatby MNNG. sensitive). JCRB1098 hs-171-1 hamster, Chineselung Temperature sensitive mutant, which are transformed below 34.5 C (heat sensitive). JCRB1099 hs-172-3 hamster, Chineselung Temperature sensitive mutant, which are transformed below 34.5 C (heat sensitive). JCRB1100 hs-211 hamster, Chineselung Temperature sensitiveAnchorage mutant, which independent are transformed cell line transformed below 34.5 Cby (heat MNNG. sensitive). JCRB1101 hs-222-3 hamster, Chineselung temperature sensitiveAnchorage mutant, which independent are transformed cell line transformedbelow 34.5 C by (heat MNNG. sensitive). JCRB1102 cs-17-25 hamster, Chineselung Temperature sensitiveAnchorage mutant, which independent are transformed cell line transformed above 39.5 byC (coll MNNG. sensitive). JCRB1103 cs-19-36 hamster, Chineselung Temperature sensitiveAnchorage mutant, which independent are transformed cell line transformed above 39.5 byC (cool MNNG. sensitive). JCRB1104 cs-20-5 hamster, Chineselung Temperature sensitiveAnchorage mutant, which independent are transformed cell line transformed above 39.5 byC (cool MNNG. sensitive). JCRB1105 AIG hamster, Chineselung Anchorage independent cell line transformed by MNNG. JCRB1107 UCBTERT-21 human mesenchymalHuman stem umbilical cell cord** blood-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the hTERT. JCRB1108 UCB408E6E7-31 human mesenchymalHuman stem umbilical cell cord** blood-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6 and E7. JCRB1109 UCB408E7-32 human mesenchymalHuman stem umbilical cell cord** blood-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E7. JCRB1110 UCB408E6E7TERT-33 human mesenchymalHuman stem umbilical cell cord** blood-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1117 HEC-1-A human uterus endometrial carcinomaendometrial carcinoma JCRB1118 HEC-6 human uterus endometrial adenoacanthomaendometrial adenocarcinoma JCRB1119 KUSA-A1 mouse bone marrow JCRB1120 HEC-59 human uterus endometrial carcinomaendometrial carcinoma JCRB1121 HEC-88nu human uterus endometrial carcinomaendometrial carcinoma JCRB1122 HEC-151 human uterus endometrial carcinomaendometrial carcinoma JCRB1123 HEC-108 human uterus endometrial adenocarcinoma JCRB1124 HEC-116 human uterus JCRB1129 KUSA-H1 mouse bone marrow JCRB1131 UE6E7T-1 human bone marrowHuman bone marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1132 KUSA-0 mouse bone marrow JCRB1133 UE6E7T-2 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1134 KUM3 mouse bone marrow JCRB1135 KUM4 mouse bone marrow JCRB1136 UE6E7T-3 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1137 UE6E7TC-4 human bone marrowHuman bone marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1138 NRG mouse bone marrow JCRB1139 KUM9 mouse bone marrow JCRB1140 UBE6T-6 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the bmi-1, E6, and hTERT. JCRB1141 HEC-251 human uterus endometrial carcinomaendometrial carcinoma JCRB1142 HEC-265 human uterus endometrial carcinomaendometrial carcinoma JCRB1143 UBE6T-7 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the bmi-1, E6, and hTERT. JCRB1145 HEC-50B human uterus endometrial carcinomaendometrial carcinoma JCRB1146 RSMG-1 rat submandibular gland Growth of the RSMG-1 cells are inhibited by activin A, while accelarated by follistatin. The RSMG-1 cells shows a stem cell like characteristics. JCRB1147 UE7T-9 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E7 and hTERT. JCRB1148 KMBC-2 human bladder ****** Doubling time for about 60 hours. A round cell proliferates like stripes. Because vacuoles are recognizable in the cytoplasm, secretion production is suggested. JCRB1149 UE6E7T-11 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7 and hTERT. JCRB1150 KMPC-3 human kidney ****** Doubling time for about 40 hours. The cell of the spindle type and the small-round type exist together. Cell's adhesion is a little weak. JCRB1151 UE6E7T-12 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7 and hTERT. JCRB1152 RSMG-2 rat submandibular gland Growth of the RSMG-2 cells are inhibited by activin A, while accelarated by follistatin. The RSMG-2 cells shows a stem cell like characteristics. JCRB1153 HCA-1 human uterine cervixendocervical adenocarcinomaendocervical adenocarcinoma JCRB1154 UE7T-13 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E7 and hTERT. JCRB1159 UBE6T-15 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the bmi-1, E6 and hTERT. JCRB1160 UE6E7-16 human mesenchymalHuman stem bone cell marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6 and E7. embryoni JCRB1166 NCR-G1 human Complex type germ cell tumor of human embryonic testis origin. c testis embryoni JCRB1167 NCR-G2 human Complex type germ cell tumor of human embryonic testis origin. c testis embryoni JCRB1168 NCR-G3 human Complex type germ cell tumor of human embryonic testis origin. c testis JCRB1170 SKNO-1 human hemo-lymphocytict(8;21), monosomy17,MPO+, p53 mutation.CAE+, NBE-. embryoni JCRB1175 NCR-G4 human Complex type germ cell tumor of human embryonic testis origin. c testis JCRB1176 KUM10 mouse bone marrow JCRB1178 KUM5 mouse bone marrow JCRB1179 KMS-11 human hemo-lymphocytict(4;14)(p16.3;q32.3)small round-cell morphology, part is multinucleate cell. JCRB1180 KMM-1 human hemo-lymphocytict(8;14)(q24;q32), t(6;14)(p25;q32)small round-cell morphology, part is multinucleate cell. JCRB1181 9-15c mouse bone marrow JCRB1182 NCC-RbC-51 human neural familial bilateral retinoblastoma JCRB1183 NCC-RbC-54 human neural Bilateral retinoblastoma JCRB1185 KMS-21BM human hemo-lymphocytict(11;14)(q13;q32) small round-cell morphology, part is multinucleate cell. JCRB1186 NCC-RbC-59 human retina Bilateral retinoblastoma JCRB1187 KMS-26 human hemo-lymphocytict(4;14)(p16.3;32.3), smallt(14;16)(q32.3;q23) round-cell morphology, part is multinucleate cell. JCRB1188 KMS-27 human hemo-lymphocytict(11;14)(q16.3;q32) small round-cell morphology, part is multinucleate cell. JCRB1189 F56 mouse antibody-producingMonoclonal hybridoma antibodyProducing against CD307(IRTA2/FcRH5/FCRL5). IgG1 JCRB1190 NCC-RbC-57 human neural Unilateral retinoblastoma JCRB1191 KMS-28PE human hemo-lymphocytict(4;14)(p16.3;q32.3)small round-cell morphology, part is multinucleate cell. JCRB1192 KMS-28BM human hemo-lymphocytict(4;14)(p16.3;q32.3)small round-cell morphology, part is multinucleate cell. JCRB1193 HEC-1-B human uterus endometrial carcinomaendometrial carcinoma JCRB1195 KMS-34 human hemo-lymphocytict(4;14)(p16.3;32.3) small round-cell morphology, part is multinucleate cell. JCRB1196 KMS-20 human hemo-lymphocytic small round-cell morphology, part is multinucleate cell. JCRB1198.01 GP8 mouse skin cell line having the human behta-galactosidase gene JCRB1199 R201C mouse skin JCRB1200 NCC-RbC-53 human retina Unilateral retinoblastoma JCRB1201 GCH-nu-YS human uterus choriocarcinoma hCG production JCRB1202 KUM6 mouse bone marrow JCRB1203 HCS-2 human uterine cervixsquamous cell carcinmasquamous cell carcinoma JCRB1204 KUM7 mouse bone marrow JCRB1205 HCSC-1 human uterine cervixsmall cell carcinoma small cell carcinoma JCRB1206 TK human hemo-lymphocytic45,X,-Y,del(2)(q21q23),t(3;?)(p25;?),t(7;?)(p21;?),-8,11q+,18q+,+marTK cells grow in suspension forming clumps. EBNA negative. JCRB1207 SV mouse skin behta-gal gene deficient JCRB1208 HM-1 hamster, Syrianhemo-lymphocytichamster cell macrophage JCRB1212 NCC-RbC-56 human neural Bilateral retinoblastoma JCRB1213.2 DIG222.4D.5 mouse antibody-producing hybridoma Producing anti Digoxin IgG2b (k) isotype (RIA 170/46000) JCRB1213.3 DIG104.10H.1 mouse antibody-producing hybridoma Producing anti Digoxin IgG1 (k) isotype (RIA 120/130000) JCRB1214 NCC-RbC-67 human neural Unilateral retinoblastoma JCRB1221 NCC-RbC-92 human neural Unilateral retinoblastoma JCRB1222.01 HGH1.1.3 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.02 HGH1.6.5 mouse antibody-producing hybridoma Producing IgG gamma2a, and k. JCRB1222.03 HGH1.17.2 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.04 HGH1.35.2 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.05 HGH2.6.1 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.06 HGH1.9.3 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.07 HGH1.8.1 mouse antibody-producing hybridoma Producing IgG gamma2b and k JCRB1222.08 HGH1.11.1 mouse antibody-producing hybridoma Producing IgG gamma2b and k JCRB1222.09 HGH1.15.3 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.10 HGH1.41.1 mouse antibody-producing hybridoma Producing IgG gamma2b and k JCRB1222.11 HGH1.46.1 mouse antibody-producing hybridoma Producing IgG gamma2b and k JCRB1222.12 HGH1.31.3 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.13 HGH1.32.4 mouse antibody-producing hybridoma Producing IgG gamma2a and k JCRB1222.14 HGH1.37.3 mouse x mousehybridoma Producing IgG gamma 2a and k JCRB1222.15 HGH2.4.2 mouse antibody-producing hybridoma Producing IgG gamma1 and k JCRB1222.16 HGH2.15.4 mouse antibody-producing hybridoma Producing IgG gamma1 and lambda JCRB1223 NCC-RbC-T1 human neural Bilateral retinoblastoma JCRB1225 I51T mouse skin JCRB1226 GHBP116 mouse antibody-producing hybridoma Producing IgG1(k) JCRB1228 NCC-StC-K140 human stomach JCRB1301 SC78.H81.C81.A9 mouse antibody-producing hybridoma Producing IgG1(k) JCRB1303 NCC-RbC-83 human retina Unilateral retinoblastoma JCRB1304 MT-45-5-3 mouse antibody-producing hybridoma Producing IgG1(K) JCRB1305 NCC-RbC-39 human neural Unilateral retinoblastoma JCRB1308 NCC-OvC-K119 human ovary Ovarian carcinoma JCRB1311 ZEN mouse antibody-producing hybridoma Producing IgG1 lambda. JCRB1314 HPSV178-4-3 mouse antibody-producingProducing hybridoma IgG2b(K)producing mAb HPSV178, against the C-terminal portion of PrPSV (residues 214-230). JCRB1316.1 OHP57.G6.1 mouse antibody-producing hybridoma Producing IgG k. JCRB1316.2 OHP101.B11.1 mouse antibody-producing hybridoma Producing IgG k. JCRB1316.3 OHP138.H8.1 mouse antibody-producing hybridoma Producing IgG k. JCRB1316.4 OHP1E9.3.1 mouse antibody-producing hybridoma Producing IgG k. JCRB1316.5 OHP4B2.2.3 mouse x mousehybridoma Producing IgG k. JCRB1316.6 OHP7D7.2.3 mouse antibody-producing hybridoma Producing IgG k. JCRB1317 KCL-22 human hemo-lymphocyticPh1-positive. JCRB1318 HeLa9903 human uterine cervix JCRB1319 PL-21 human hemo-lymphocytic13q+, A marker chromosomeImmature incells a group with azurophilic G observed. granules. JCRB1320 NCC-CoC-K115P human colon colon carcinoma JCRB1322 m5S mouse skin Near-diproid chromosomenormal number, contact inhibition, non-tumorigenic. Karyotype : 42,X,+15,+der(6)t(6;13)(D;B),+der(8)t(8;8)(E2;A2) JCRB1323 F25 mouse antibody-producing hybridoma Producing IgG2a JCRB1324 F119 mouse antibody-producing hybridoma Producing IgG2b JCRB1325 MKPL-1 human hemo-lymphocytic47,X,-Y,-21,+3mar. Dt = 30 hr. Large primitive blasts with giant cells carrying multilobed nuclei. JCRB1326 NCC-RbC-60 human retina Bilateral retinoblastoma JCRB1328 AR-EcoScreen hamster, Chineseovary This cell is that stably express human androgen receptor, reportor gene (androgen response element linked to luciferase), and Renilla luciferase gene. JCRB1330 Ty-82 human thymus 46XX,t(15;19)(q15;p13).Thymic carcinoma. JCRB1332 NALL-1 human hemo-lymphocyticEB virus was not detected.The cell The line cellis negative line lacks for both E-rosettes T-cell and and B-cell surface markers. immunoglobulin. JCRB1333 NCC-CoC-K115L human colon Metastatic colon carcinoma JCRB1334 RC-K8 human hemo-lymphocytic46XY, with t(11;14)(q23;q32).Dt=48-60hr. The cell line produces plasminogen activator. JCRB1335 HD-70 human hemo-lymphocyticCD30+, CD15+, CpIG-kappa+,Dt=28 hr. CD71+, EB virus negative. JCRB1337 DL-40 human hemo-lymphocyticCells are positive forCells acid growphosphatase without forming and negative clumps for with peroxidase, Dt=72 hrs. EBNA and HTLV-1 antigen. JCRB1339 NCC-CoC-K115B human colon B-cell lymphocyte transformed by EBV. JCRB1340 RS-2 human brain JCRB1342.01 MOR8.2.1 mouse antibody-producing hybridoma Producing IgG1k. JCRB1342.02 MOR35.4.12 mouse antibody-producing hybridoma Producing IgG1k. JCRB1342.03 MOR39.3.9 mouse x mousehybridoma Producing IgG1lambda. JCRB1342.04 MOR76.7F.16 mouse x mousehybridoma Producing IgG1 k. JCRB1342.05 MOR83.3.10 mouse antibody-producing hybridoma Producing IgG1 k. JCRB1342.06 MOR115.1.13 mouse x mousehybridoma Producing IgG1 lambda. JCRB1342.07 MOR124.2.2 mouse x mousehybridoma Producing IgG1 k. JCRB1342.08 MOR131.5.13 mouse x mousehybridoma Producing IgG1 lambda. JCRB1342.09 MOR158.1.3 mouse x mousehybridoma Producing IgG1 k. JCRB1342.10 MOR33.2.9 mouse x mousehybridoma Producing IgG1 k. JCRB1342.11 MOR180.2.4 mouse x mousehybridoma Producing IgG1 lambda. JCRB1342.12 MOR44.4.1 mouse x mousehybridoma Producing IgG1 k. JCRB1343 OKa-C-1 human lung (cancer)Chromosome numbersThe are cell 75 line and was 78 established with complex from structural the transplanted abnormality. Balb 3T3 mouse. The cell line have a characteristics of inducing leukocytosis and hypercalcemia with high G-CSF and PTHrP levels. Td=95 hrs. Adherent to the culture flasks. JCRB1344 delta-47 human hemo-lymphocyticThe cell line expressesCells CD4 are & secreting CD38. Aneuploid IgD. karyotype including 1q+, 2p+ & 14q+. JCRB1345 PALL-2 human hemo-lymphocyticSingle Ph1 chromosome observed. JCRB1346 FLAM-76 human hemo-lymphocyticHypodiploid chromosomekappa with IgG t(11;14)(q13;q32). (nonsecretory), CD38, CD44, and CD54 are positive. JCRB1347 KML-1 human hemo-lymphocyticNon-Hodgkin's lymphoma of large-cell type. Loss of chromosome 18 observed. JCRB1348 3LL mouse lung Cell line having high metastasis potencial to lung. JCRB1349 Ex-3LL mouse lung Lewis lung carcinoma derived cell line enhanced lung metastasis ability. JCRB1350 EL-4 mouse lymphoma JCRB1351 Int-3LL mouse lung Lewis lung carcinoma derived cell line enhanced intravasating ability. JCRB1352 EL-4ad mouse lymphoma adhered to a tissue culture dish JCRB1353 TER-119 mouse x rathybridoma Producing rat IgG 2b and kappa JCRB1354 HSC-3-M3 human tongue squamous carcinoma,Highly tongue, metastatic age 64, cell (M) line. JCRB1355 1-1ras1000 mouse embryo Fibroblast, subclone of Balb/3T3-A31. JCRB1356 A31-1-1 mouse embryo whole embryo fibroblast, subclone of Balb/3T3-A31. This cell line exhibits contact inhibition. JCRB1357 1-1src mouse embryo Fibroblast, subclone of Balb/3T3-A31. JCRB1358.01 SRBC-P13-7-3 mouse x mousehybridoma Producing IgM(k) Recloned from P13-7. JCRB1358.02 SRBC-P18-3-8 mouse x mousehybridoma Producing IgM(k). Recloned from P18-3. JCRB1358.03 SRBC-P20-13-13 mouse x mousehybridoma Producing IgM(k). Recloned from P20-13. JCRB1358.04 SRBC-F12-1-19 mouse x mousehybridoma Producing IgM(k). Recloned from F12-1. JCRB1358.05 SRBC-F12-18-7 mouse x mousehybridoma Producing IgM(k). Recloned from F12-18. JCRB1358.06 SRBC-F23-20-22 mouse x mousehybridoma Producing IgM(k). Recloned from F23-20. JCRB1358.07 SRBC-F31-2-11 mouse x mousehybridoma Producing IgM(k). Recloned from F31-2. JCRB1358.08 SRBC-F31-19-1 mouse x mousehybridoma Producing IgM(k). Recloned from F31-19. JCRB1358.09 SRBC-RP8-2-4 mouse x mousehybridoma Producing IgG1(k). Recloned from RP8-2. JCRB1358.10 SRBC-RP8-18-15 mouse x mousehybridoma Producing IgG1(k). Recloned from RP8-18. JCRB1358.11 SRBC-RF29-1-3 mouse x mousehybridoma Producing IgG1(k). Recloned from RF29-1. JCRB1359 HAC-2 human ovary Ovarian clear cell adenoClear carcinoma, cell carcinoma. tetraploid. Td = 46.8 hrs, CA-125 positive, M type LDH, PAS, Alcian blue positive, mirror ball pattern observed. JCRB1361 Vn1919 mouse brain GFAP (glial fibrillary acidic protein) positive, NF-L and NF-H (neurofilament) positive. JCRB1362 HCT-2 hamster, Syrianhemo-lymphocyticHTLV-1 positive but TheHTLV-1 cells is are not forming produced. loosely aggregated cell clumps. Hamster T-cell antigen positive. 44, XX(hamster). JCRB1365 Vn1919 cl4 mouse brain GFAP (glial fibrillary acidic protein) positive, NF-L and NF-H (neurofilament) positive. JCRB1367 Vn1919 cl49 mouse brain GFAP (glial fibrillary acidic protein) positive, NF-L and NF-H (neurofilament) positive. JCRB1368 Vn1919 cl59 mouse brain GFAP (glial fibrillary acidic protein) positive, NF-L and NF-H (neurofilament) positive. JCRB1370 TAS-5 mouse x rathybridoma Producing rat IgG 2b and kappa JCRB1371 GS-3A4-HepG2 human liver human glutamine synthetase and CYP3A4 introduced JCRB1372 MCF-7-Luc human breast pMSCV-luc transfected MCF-7 cells. Luciferase stably expressing cell line. JCRB1373 BT-549-Luc human breast pMSCV-luc transfected BT-549 cells. Luciferase stably expressing cell line. JCRB1375 Hs578T-Luc human breast pMSCV-luc transfected Hs578T cells. Luciferase stably expressing cell line. JCRB1376 SK-MEL-28-Luc human melanoma pMSCV-luc transfected SK-MEL-28 cells. Luciferase stably expressing cell line. JCRB1377 COLO 679-Luc human melanoma pMSCV-luc transfected COLO 679 cells. Luciferase stably expressing cell line. JCRB1378 MM-RU-Luc human melanoma pMSCV-luc transfected MM-RU cells. Luciferase stably expressing cell line. JCRB1379 MKN45-Luc human stomach pMSCV-luc transfected MKN45 cells. Luciferase stably expressing cell line. JCRB1380 HBs320 mouse x mousehybridoma hybridoma producing monoclonal antibody against HBs antigen. JCRB1381 HBs128 mouse x mousehybridoma hybridoma producing monoclonal antibody against HBs antigen JCRB1382 DLD-1 clone#1-Luc human colon pMSCV-luc transfected DLD-1 clone#1 cells. Luciferase stably expressing cell line. JCRB1383 HT-29-Luc human colon pMSCV-luc transfected HT-29 cells. Luciferase stably expressing cell line. JCRB1384 STR-428 human ascites IgH, c-Myc, BCL2 rearrangements,Immunophenotypic complicated characterization; karyotypes CD3-,CD4-,CD5-,CD8-,CD10+,CD19+,CD20+,CD22+,CD30-,CD38+,HLA-DR+, including t(14:18)(q32;q21), der(8)t(3;8)(q27;q24) Viral status; HIV(-), HHV-8(-), EBV(-). JCRB1385 CAS-9 mouse x rathybridoma Producing rat IgG 2b and kappa JCRB1386 U-251 MG-Luc human glioblastomapMSCV-luc transfectedastrocytoma, U-251 MG GFAP-posotive cells. Luciferase stably expressing cell line. JCRB1387 DU-145-Luc human prostate pMSCV-luc transfected DU-145 cells. Luciferase stably expressing cell line. JCRB1388 A-498-Luc human renal pMSCV-luc transfected A-498 cells. Luciferase stably expressing cell line. JCRB1389 KM12-Luc human colon pMSCV-luc transfected KM12 cells. Luciferase stably expressing cell line. JCRB1390 G-401-Luc human renal pMSCV-luc transfected G-401 cells. Luciferase stably expressing cell line. JCRB1391 KMS-33 human melanoma small round-cell morphology, part is multinucleate cell. Feeder cells (mouse fibloblast) treated with Mitomycin-C (#PMEF-H;Millipore) and IL-6 are necessary for proliferation. JCRB1392 AS17 mouse x mousehybridoma Producing mouse IgG 2b and kappa JCRB1393 SK-MEL-2-Luc human melanoma pMSCV-luc transfected SK-MEL-2 cells. Luciferase stably expressing cell line. JCRB1394 KHM-2B human leukemia t(8;14)(q24;q32) andHLA-DR, t(14;18)(q32;q21) CD10, CD20, and CD19 were positive and CD2 was negative. JCRB1395 Kasumi-2 human leukemia t(1;19)(q23;p13), E2A-PBX fusion gene JCRB1396 Mewo-Luc human melanoma pMSCV-luc transfected Mewo cells. Luciferase stably expressing cell line. JCRB1397 786-0-Luc human renal pMSCV-luc transfected 786-0 cells. Luciferase stably expressing cell line. JCRB1398 Kasumi-5 human leukemia t(4;11)(q21;p15), RAP1GDS1-NUP98CD7+, CD10+, CD56+, fusion CD38+, gene CD3-, CD4-, CD8- JCRB1399 SW620-Luc human colon pMSCV-luc transfected SW620 cells. Luciferase stably expressing cell line. JCRB1400 Caki-1-Luc human renal pMSCV-luc transfected Caki-1 cells. Luciferase stably expressing cell line. JCRB1401 Kasumi-7 human leukemia del (9p), [der(9)t(9;9)(p13;?),CD10+, CD19+, der(4)t(4;9)(q21;?)] CD20+, HLA-DR+, CD33+ JCRB1402 K562-Luc human leukemia pMSCV-luc transfected K562 cells. Luciferase stably expressing cell line. JCRB1403 Kasumi-8 human leukemia t(9;22)(q32;q11), bcr-ablPh1 positivefusion gene JCRB1404 Minami-1 human lymphoma t(14;18)(q32;q21), bcl gene rearrangement JCRB1405 Minami-2 human lymphoma del(13q), add(18)(q24)CD10+, (no EBV) CD19+, CD20+, CD22+, HLADR+ JCRB1406 PC-3-Luc human prostate pMSCV-luc transfected PC-3 cells. Luciferase stably expressing cell line. JCRB1407 NCI-H460-Luc human lung pMSCV-luc transfected NCI-H460 cells. Luciferase stably expressing cell line. JCRB1408 HCT-116 clone#2-Luc human colon pMSCV-luc transfected HCT-116 clone#2 cells. Luciferase stably expressing cell line. JCRB1409 Kasumi-9 human leukemia normal karyotype (no EBV) JCRB1410 Kasumi-10 human leukemia t(11;19)(q23;p13.3), MLL gene rearrangement JCRB1411 KasumiA-541 human leukemia nomal karyotype (noCD34+, EBV) CD33+, CD10+, CD19+, HLA-DR+ JCRB1413 ST 13 mouse mammary glanddifferentiate to adipocyte JCRB1414 A549-Luc human lung pMSCV-luc transfected A549 cells. Luciferase stably expressing cell line. JCRB1415 KasumiA-568 human leukemia 45, XY, del(2)(q?), -13,CD13+, -16, -19,CD33+, add(19)(q13.1) c-kit+, GPA+ JCRB1416 KasumiA-554 human leukemia t(11;19)(q23;p13.1),CD33+, MLL gene CD15+, rearrangement, CD4+, CD56+, no HTLV1 HLA-DR+ integration JCRB1433 MKN-1/CMV-Luc human stomach Luciferase stably expressing cell line (MKN1; Human stomach, adenosquamous carcinoma cell line). JCRB1435 TK6(IVGT) human spleen This line is derivative of the WIL-2 cell line. The cells are heterozygous at the thymidine kinase (TK) locus, and can be used to quantitatively detect forward mutation at 3 loci. JCRB1438 BT-20/CMV-Luc human mammary Luciferase stably expressing cell line (BT-20; Human breast cancer cell line). JCRB1447 4T1-Luc mouse mammary pMSCV-luc transfected. Luciferase stably expressing cell line. 6-thioguanine resistant cell line. JCRB1448 BxPC-3-Luc#2 human pancrea pMSCV-luc transfected.Cellular Luciferase Products: stably mucin; expressing pancreas cell cancer line. specific antigen (pancreas cancer associated antigen); carcinoembryonic antigen (CEA), The cells do not express the cystic fibrosis transmembrane conductance regulator (CFTR). JCRB1450 BT-474/CMV-Luc human mammary Luciferase stably expressing cell line (BT-474; Human breast cancer cell line). JCRB1451 COLO 205/CMV-Luc human colon pLL3.7-luc transfected.Cellular Luciferase Products: stably carcinoembryonic expressing cell antigenline. (CEA) 1.5 to 4.1 ng/10 exp6 cells/10 days; keratin; interleukin 10 (IL-10, interleukin-10) JCRB1453 CLAC dog lung This cell line including cancer stem cells (0.75%). JCRB1454 AsPC-1/CMV-Luc human pancreas Luciferase stably expressing cell line (AsPC-1; human pancreatic adenocarcinoma cell line). JCRB1458 HUEhT-1 human umbilical veinHUEhT-1 was establishedCell culture by electroporation in collagen I coatedof pIRES-hTERT-hygr. dish. JCRB1459 HUEhT-2 human umbilical veinHUEhT-2 was establishedCell culture by electroporation in collagen I coatedof pIRES-hTERT-hygr. dish. JCRB1466 HCC-1419-Luc human breast pMSCV-luc transfected.The Luciferasecells are poorly stably differentiated. expressing cell The line. cells overexpress Her2-neu but are negative for expression of p53. The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR). JCRB1471 MKN-7/CMV-Luc human stomach pLL3.7-luc transfected. Luciferase stably expressing cell line. JCRB1473 MKN-74/CMV-Luc human stomach Luciferase stably expressing cell line (MKN74; Human moderately differentiated tubular adenocarcinoma cell line). JCRB1474 B16-F0-Luc mouse melanoma pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1475 Nalm-6-MSH+ human leukemia MSH+, POL(WT), TK+/- JCRB1476 HCC-1954-Luc human breast pMSCV-luc transfected.HCC1954 Luciferase is positive stably for expressing the epithelial cell line.cell specificOncogene: marker her2/neu Epithelial + (overexpressed) Glycoprotein 2 and for cytokeratin 19, and is negative for expression of estrogen receptor (ER) and progesterone receptor (PR). JCRB1478 NCI-H1650-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1479 HCT-15-Luc#1 human colon pMSCV-luc transfected.Cellular Luciferase Products: stably carcinoembryonic expressing cell antigen line. (CEA), keratin JCRB1484 JMU-RTK-2 human kidney highly aggressive malignancy JCRB1485 IM95/CMV-Luc human stomach Luciferase stably expressing cell line (IM95; Human gastric cancer cell line). JCRB1486 NCI-H1975-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1487 KATOIII/CMV-Luc human stomach tetraploid, pLL3.7-lucDerived transfected. from stomach Luciferase cancer, stably signet expressing ring cell cell carcinoma. line. Tumorigenic in the cheek pouches of immunosupressed hamsters and tumor developed was diagnosed as poorly-differentiated adenocarcinoma. JCRB1489 POLZ D2781N human peripheral bloodMSH+, POLZ D2781N/D2781N,Human cell line TK+/- derived from B cell leukemia. (MSH+, POLZ low activity, TK+/-) JCRB1490 POLZ L2618M human peripheral bloodMSH+, POLZ L2618M/L2618M,Human cell line TK+/- derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) JCRB1491 KP-2/CMV-Luc human pancrea pLL3.7-luc transfected.The Luciferase tumor cell linestably is derivedexpressing from cell pancreatic line. tissue originally. Adenocarcinoma cell line. The cells can be transplantable to nude mouse. JCRB1492 NCI-H2228-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1494 POLZ KO MSH- human peripheral bloodMSH-, POLZ KO/KO,Human TK+/+ cell line derived from B cell leukemia. (MSH-, POLZ KO/KO, TK+/+) JCRB1496 Colon26-Luc mouse colorectal pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1497 NCI-H441/CMV-Luc human lung pLL3.7-luc transfected. Luciferase stably expressing cell line. JCRB1498 POLZ CD MSH- human peripheral bloodMSH-, POLZ catalyticallyHuman dead cell (=D2781/3A), line derived from TK+/+ B cell leukemia. (MSH-, POLZ CD/CD, TK+/+) JCRB1502 MDA-MB-361-Luc#1 human breast Luciferase stably expressing cell line (MDA-MB-361; Human breast carcinoma cell line). JCRB1503 NIH3T3/ATCC/CMV-Luc mouse embryo Luciferase stably expressing cell line (NIH/3T3; Mouse embryonic skin cell line JCRB1504 hTf2-9F mouse x mousehybridoma hybridoma This cell line produces monoclonal antibody against human transferrin. JCRB1505 Ishikawa 3-H-12 human Endometrium JCRB1506 POLK KO-comp human peripheral bloodMSH+, POLK KO->complemented,Human cell line TK+/-derived from B cell leukemia. (MSH+, POLK KO->steable transfectant of pEF6-Polk, TK+/-) JCRB1508 HCC-1937/CMV-Luc human breast pLL3.7-luc transfected.The Luciferase cells are negative stably expressing for expression cell line. of estrogen Oncogene: receptor BRCA1 (ER) (mutated, and progesterone insertion C receptor at nucleotide (PR) 5382), her2/neu -, p53 - JCRB1509 NCI-H23-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. Oncogene: myc +; src +; abl +; erb +; ras +; sis - JCRB1510 POLZ Y2779F human peripheral bloodMSH+, POLZ Y2779F/Y2779F,Human cell lineTK+/- derived from B cell leukemia. (MSH+, POLZ low activity, TK+/-) JCRB1514 POLK KO homo MSH- human leukemia MSH-, POLK KO/KO, TK+/+ JCRB1515 POLZ L2618F human peripheral bloodMSH+, POLZ L2618F/L2618F,Human cell TK+/-line derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) JCRB1516 HCC-827-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. This lung adenocarcinoma has an acquired mutation in the EGFR tyrosine kinase domain (E746 - A750 deletion). JCRB1517 POLK F171A MSH- human leukemia MSH-, POLK KO/F171A, TK+/+ JCRB1518 POLK KO hetero MSH- human leukemia MSH-, POLK KO/+, TK+/+ JCRB1523 POLK CD MSH- human peripheral bloodMSH-, POLK catalyticallyHuman dead cell (=D198A/D199A),line derived from B TK+/+ cell leukemia. (MSH-, POLK catalytically dead, TK+/+) JCRB1524 POLK CD human peripheral bloodMSH+, POLK catalyticallyHuman dead cell line(=D198A/D199A), derived from B TK+/- cell leukemia. (MSH+, POLK catalytically dead, TK+/-) JCRB1525 NCI-H650-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1526 POLK KO-CD comp human peripheral bloodMSH+, POLK KO->complemented,Human cell line TK+/-derived from B cell leukemia. (MSH+, POLK KO->stable transfectant of pEF6-Polk D198A/D199A, TK+/-) JCRB1529 NCI-H2009-Luc human lung pMSCV-luc transfected. Luciferase stably expressing cell line. JCRB1531 MEFs Mouse embryo Mouse embryonic fibroblasts (control MEFs). JCRB1533 293 TRE/Cont human kidney G418 resistance JCRB1534 IKK-i-DEF mouse embryo Mouse embryonic fibroblasts prepared from IkB kinase (IKK-i) deficient mice. JCRB1535 TBK1-DEF mouse embryo Mouse embryonic fibroblasts prepared from TANK-binding kinase 1 (TBK1) deficient mice. JCRB1536 EPC-1 human uterine Human uterine endometrium vascular endothelial progenitor-derived immortalized cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1537 LoVo-Luc#2 human colorectal pMSCV-luc transfected.Carcinoembryonic Luciferase stably antigen-producing expressing cell line. JCRB1538 EMC100 human uterine Human uterine endometrium vascular endothelial progenitor-derived immortalized cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1539 HAC-2 human ascites Human ovary cancer cell line derived from mesonephros. JCRB1542 KP-3L-Luc#5 human pancreas pMSCV-luc transfected.Tissue Luciferase was classified stably asexpressing a metastasis cell line.of adenosquamous carcinoma of the pancreatic duct. JCRB1544 EMC214 human uterine Human uterine endometrium vascular endothelial progenitor-derived immortalized cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1545 EM-E6/E7/hTERT-2 human uterine Human uterine endometrium vascular endothelial progenitor-derived immortalized cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1546 UCB408E7-TERT34 human umbilical cordImmortalized blood human umbilical cord blood-derived mesenchymal stem cells. JCRB1548 H-1A(H123) mouse bone marrow JCRB1549 SK-OV-3-Luc human ovary Luciferase stably expressing cell line (SK-OV-3; Human ovarian cancer cell line). JCRB1550 HAdpc-25-Bmi-1-TERT human mesenchymalImmortalized stem cell human adipose tissue-derived mesenchymal stem cells. JCRB1551 KKU-055 human liver, gallbladderHuman poorly differentiated cholangiocarcinoma cell line established from biliary tract. JCRB1552 HARA-B4 human human lungoriginally human cellDelivertive but the cell of line the estableshed HARA cell. This from cell metastatic line expresses organ (bone)PTHrP ofhighly mouse and the bone metastasis is induced extensively by the injection to the heart chamber of nude mouse. Hypercalcemia is induced in mice by hypodermic transplantation of the cell. JCRB1554 MMNK-1 human liver, gallbladderExpressing catalytic subunit of human telomerase reverse transcriptase (hTERT) and enhanced green fluorescent protein (EGFP). JCRB1555 HAdpc-26-E6-Bmi-1-TERT human adipose tissueHuman umbilical cord blood-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, Bmi-1, and hTERT. JCRB1557 KKU-213 human biliary tract Mixed papillary and non-papillary cholangiocarcinoma JCRB1558 RERF-LC-KJ/CMV-Luc human lung Luciferase stably expressing cell line (RERF-LC-KJ; Human lung cancer cell line). JCRB1559 MDA-MB-231-Luc human mammary glandpLVSIN-luc transfected MDA-MB-231 cells. Luciferase stably expressing cell line. JCRB1563 HAdpc-29-E7-TERT human adipose tissueHuman adipocite-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E7 and hTERT. JCRB1564 TMNK-1 human liver, gallbladderImmortalized human-liverExpressed endothelial factor cellVIII, line VEGF with receptorsSV40T and (flt-1, hTERT. KDR/Flk-1), (Note: andrecommended CD34. medium is very specific.) JCRB1566 NP 2 human glioma P53 mutation, P14/P15/P16- deletion JCRB1567 NP 3 human glioma P53 mutation, P14/P16- deletion, PTEN mutation JCRB1568 KKU-100 human biliary tract poorly differentiated cholangiocarcinoma JCRB1569 NP 5 human glioma P53 mutation, P14/P15/P16- deletion, PTEN mutation JCRB1570 H-1D(H162) mouse bone marrowMouse bone marrow-derived osteoblast-like cell line. JCRB1571 F6B3 mouse brain SR-RSV-induced brainGFAP tumor (glial cells fibrillary acidic protein positive) JCRB1572 HAdpc-28-E6E7-TERT human adipocyte Human adipocyte-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. JCRB1574 RSV-M mouse brain SR-RSV-induced brain tumor cells JCRB1575 Onda 7 human glioma P14/P15/P16 deletion, PTEN mutation JCRB1576 Onda 9 human glioma P14/P15/P16 deletion,- PTEN mutation JCRB1577 HSC-1-Luc human skin Luciferase stably expressing cell line. (HSC-1: A cell line of a squamous cell carcinoma of human skin.) JCRB1578 Onda 8 human glioma P53 mutation, P14/P15/P16- deletion JCRB1579 Ishikawa 3-H-12-Luc human uterus pLVSIN-luc transfected Ishikawa cells. JCRB1580 SR-CDF1 DBT mouse brain SR-RSV-induced brainsensitive tumor tocells mouse conoravirus infection JCRB1582 TWNT-1 human liver Expressing catalytic Immortalizedsubunit of human human telomerase hepatic stellate reverse cell transcriptase line (established (hTERT) from and LI90). enhanced green fluorescent protein (EGFP). JCRB1583 Onda 9R human glioma - JCRB1585 ACI-RCC rat renal Semi-floating cells JCRB1586 HSC-5-Luc human skin Luciferase stably expressing cell line. (HSC-5 : A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features.) JCRB1588 ACI-RCC-ffLuc rat kidney Luc expressing rat renal cell carcinoma cell line. JCRB1591 HLF-Luc human liver Luciferase stably expressing cell line (HLF; Human Hepatoma Cell Line). JCRB1592 Hep G2-Luc human liver Luciferase stably expressing cell line (Hep G2: Human Hepatoma Cell Line). JCRB1594 SK-OV-3/CMV-Luc human ovary pLL3.7-luc transfected.SK-OV-3 Luciferase cells arestably resistant expressing to tumor cell necrosisline. factor and to several cytotoxic drugs including diphtheria toxin, cis-platinum and adriamycin. JCRB1596 ACI-RCC-cbLuc rat kidney Luc expressing rat renal cell carcinoma cell line. JCRB1599 hTf30-8H mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1600 HuH-7-Luc human liver, gallbladderpLVSIN-luc transfected HuH-7 cells. Luciferase stably expressing cell line. JCRB1601 EMTOKA human Uterine bodyHuman cell line derived from uterine carcinosarcoma. JCRB1602 hTf30-8H/sf mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1603 hTf18-10C mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1605 Onda 11 human brain Human cell line derived from human glioma. JCRB1606 Onda 10 human brain Human cell line derived from human glioma. JCRB1607 Onda 9R-B12 human brain Human clonal cell line derived from human recurred glioma. JCRB1608 NP 8 human brain Human cell line derived from human glioma. JCRB1609 OVCAR-3/CMV-Luc human ovary Luciferase stably expressing cell line (OVCAR-3; human ovarian cancer). JCRB1610 HLE-Luc human liver Luciferase stably expressing cell line (HLE; Human Hepatoma Cell Line). JCRB1611 hTf18-10C/sf mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1612 HuS-L12/10 human lung Human immortalized cell line derived from MRC-5 cells. JCRB1613 hTf26-9B mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1614 hTf26-9B/sf mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1616 hTf/CHO-S #17 hamster, Chineseovary pREP4-hTf transfectedThis CHO-S cell line cells. produce human transferrin. JCRB1617 hTf9-11E mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1620 hTf/CHO-S #29 hamster, Chineseovary pREP4-hTf transfectedThis CHO-S cell line cells. produce human transferrin. JCRB1621 hTf2-9F/sf mouse x mousehybridoma hybridoma This cell line produce monoclonal antibody against human transferrin. JCRB1626 pREP4 cont/CHO-S #5 hamster, Chineseovary pREP4-cont transfectedThis CHO-Scell line cellsproduce (cell humanfreezed transferrin. by 10% DMSO + 90% FBS). JCRB1627.1 SK-BR-3-Luc human mammary Luciferase stably expressing cell line (SK-BR-3 : breast cancer cell line) JCRB1629 hTf/CHO-S #17/sf hamster, Chineseovary pREP4-hTf transfectedThis CHO-S cell line cells. produce human transferrin. JCRB1629.01 hTf/CHO-S #17/sf hamster, Chineseovary pREP4-hTf transfectedThis CHO-S cell line cells. produce human transferrin. JCRB1630 DR-EcoScreen mouse liver, gallbladderDR-EcoScreen is for evaluation of a rapid in vitro aryl hydrocarbon receptor tarnscriptional activation assay. JCRB1631 hTf/CHO-S #29/sf hamster, Chineseovary pREP4-hTf transfectedThis CHO-S cell line cells. produce human transferrin. JCRB1631.01 hTf/CHO-S #29/sf hamster, Chineseovary pREP4-hTf transfectedThis CHO-S cell line cells. produce human transferrin. JCRB1632 VV-1H831 mouse x mousehybridoma Mouse hybridoma producing mAb (IgG1) to hemagglutinine (HA) of vaccinia virus. JCRB1633 HuH-6-Luc human liver, gallbladderLuciferase stably expressing cell line (HuH-6; Human Hepatoma Cell Line). JCRB1634 VV-B2D10 mouse x mousehybridoma Mouse hybridoma producing mAb to hemagglutinine (HA) of vaccinia virus JCRB1636 pREP4 c/CHO-S #5/sf chinese hamsterovary pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). JCRB1636.01 pREP4 c/CHO-S #5/sf chinese hamsterovary pREP4-cont transfected CHO-S cells (cell freezed by Cryoprotective Medium). JCRB1638 JHH-5-Luc human liver, gallbladderLuciferase stably expressing cell line (JHH-5; Human hepatocellular carcinoma (Ed.I) established from small liver cancer). JCRB1642 KMS-11/BTZ human pleural effusionbortezomib-resistant maultiple myeloma cell line. JCRB1647 28SC-ES human peripheral boodendotoxin sensitive human peripheral blood cell line (Believed to be derived from U937 cells). JCRB1648 ICH-ERMS-1 human pelvic tumorHuman cell derived from anaplastic embryonal rhabdomyosarcoma. JCRB1651 VV-B6F4 mouse x mousehybridoma hybridoma Mouse hybridoma producing mAb to vaccinia virus JCRB1657 HuCCA-1 human intrahepatic bile duct Human cell line derived from cholangiocarcinoma. JCRB1658 vdR2-4 mouse embryo Control cell line used for the establishment of mouse homo mutant ES cell lines. JCRB1670 HT-1080/CMV-Luc human sarcoma The cells contain activated N-ras oncogene. pLVSIN-luc transfected HT-1080 cells. Luciferase stably expressing cell line. JCRB1674 HOS/CMV-Luc#2(c-1) human sarcoma pLVSIN-luc transfectedosteosarcoma HOS cells. Luciferase stably expressing cell line. JCRB1675 B16-F10/CMV-Luc#2 mouse melanoma pLVSIN-luc transfected B16-F10 cells. Luciferase stably expressing cell line. JCRB1679 HeLa/CMV-Luc human uterine cervixpLVSIN-luc transfectedfirst HeLaestablish cells. cell Luciferase line in vitro stably from expressing human cell line. JCRB1680 B16-F10/EF1a-Luc#1 Mouse Skin pLVSIN-luc transfectedLuciferase B16-F10 stably cells. expressing Luciferase cell stably line expressing (B16-F10; Mousecell line. Melanoma Cell Line). JCRB1681 MIA PaCa-2/CMV-Luc human pancrea pLVSIN-luc transfected MIA PaCa-2 cells. Luciferase stably expressing cell line. JCRB1683 HARA CMV-Luc human lung cancer JCRB1685 HSC-3 CMV-Luc human oral pLVSIN-luc transfectedsquamous HSC-3 cells.carcinoma, Luciferase tongue, stably age expressing 64, (M) cell line. JCRB1686 4T1 CMV-Luc #6 mouse mammary tumorpMSCV-luc transfected. Luciferase stably expressing cell line. 6-thioguanine resistant cell line. JCRB1687 G-361/CMV-Luc#2(c-2.5) human melanoma malignant melanoma, melanin production, pLVSIN-luc transfected G-361 cells. Luciferase stably expressing cell line. JCRB1691 RERF-Luc-Sq1CMV-Luc human lung squamous carcinoma Established from human lung squamous carcinoma tissue grown in SCID mice. JCRB1692 HuO9 CMV-Luc human osteosarcomaLiver/bone/kidney-typeSecretes alkaline osteocalcin phosphatase. & responds to vitamin D3. JCRB1716 Ex-3LL/CMV-Luc#1 mouse lung pLVSIN-luc transfectedLewis Ex-3LL lung carcinomacells. Luciferase derived stably cell line expressing enhanced cell lung line. metastasis ability. JCRB1718 H1781/CMV-Luc#6 human lung pLVSIN-luc transfected H1781 cells. Luciferase stably expressing cell line. JCRB1725 KIK4 Human skin intron 12, c.1845+2 HumanT>C, Homozygote fibroblast cell (born Line from with consanguineous mutation of LDL marriage)receptor JCRB1727 YS2 human skin LDL receptor mutationLDL (intron receptor 12, mutation,c.1845+2 IntronT>C, Homozygote 12, c.1845+2 (born T>C, from Homozygote consanguineous (born from marriage)) consanguineous marriage), Receptor negative type JCRB1729 RMG-V human ovary Human ovarian clear cell adenocarcinoma cell line. JCRB1731 293_hEcad/hSyn2 human kidney G418 resistant (0.5mg/mL), p3 x FLAG CMV-10(Sigma) JCRB1733 293_hEcad Human kidney Puromycin resistant 293(1ug/mL). cell line pBApoK2-hCDH1-RS6His into which human E-Cadherin gene has been transfected. JCRB1735 293_hSyn4 human kidney G418 (0.5mg/mL) & Puromycin (1ug/mL) resistant. pBApoK2-hCDH1-RS6His (for hE-cadherin), p3 x FLAG CMV-10 (Sigma)(for hSyndecan-2) JCRB1736 293_Syn1 Human kidney G418 resistant (0.5mg/mL),293 cell p3line x intoFLAG which CMV-10(Sigma) human Syndecan-1 gene has been transfected. JCRB1738 XYFMGG01A human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1742 Vn-324 Syrian hamsterbrain Choroid plexus papilloma cell line of Syrian hamster induced by BK virus. JCRB1743 XYFMGG18B human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1744 XYFMGG03D human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1745 XYFMGG23G human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1746 XYFMGG24K Human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1747 XYFMGC50H human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1748 XYFMGG06K Human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1750 XYFMGC07K human blood 46, XY, r(9) EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1751 XYFMGG19M Human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1752 XYFMGG16M Human blood 46, XY EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1753 XYFMGC44W Human blood 46, X, Y fragment EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1754 XYFMGC10S Human blood 46, X, idic(Yp) EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1756 XYFMGG04DM Human blood Parent of XYFMGG04DEBV transformed B-cell lymphoblastoid cell line from parent of human XY female (XYFMGG04D). JCRB1757 XYFMGG04DP Human blood Parent of XYFMGG04DEBV transformed B-cell lymphoblastoid cell line from parent of human XY female (XYFMGG04D). JCRB1760 XYFMGG04D Human blood 46, X, i(Yq) EBV transformed B-cell lymphoblastoid cell line from human XY female. JCRB1761 AR-EcoScreen GR KO M1 Chinese hamsterovary This cell is that stablyAR-EcoScreen express human is forandrogen evaluation receptor, of a rapid reportor in vitro gene androgen (androgen receptor response tarnscriptional element linked activation to luciferase), assay. Furthermore, and Renilla thisluciferase cell line gene.Furthermore, specifically knocked this out cell the line glucocorticoid specifically knocked receptor out (GR) the gene. glucocorticoid receptor (GR) gene. JCRB1771 KKK-D049 human liver, gallbladder Human well differentiated tubular adenocarcinoma cell line established from biliary tract. JCRB1772 KKU-452 human bile duct Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. JCRB1775 KKK-D068 human liver, gallbladder Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci) JCRB1776 OCUG-1-Luc#5 human liver, gallbladderChromosome numberLuciferase distribute stably in a broad expressing range cellfrom line 52 (OCUG-1;to 139. human gall bladder carcinoma). JCRB1777 KKK-D131 human liver, gallbladder Human well differentiated tubular adenocarcinoma cell line established from biliary tract. JCRB1778 KKU-023 human bile duct Human well differentiated cholangiocarcinoma cell line established from biliary tract. JCRB1779 KKK-D138 human liver, gallbladder Human adenosquamous carcinoma cell line established from biliary tract. JCRB1780 BLACK-93A Human Pleural effusion Burkitt lymphoma cell line JCRB1781 TREE-92 Human Pleural effusion Burkitt lymphoma cell line JCRB1782 BALM-7 human blood B cell leukemia cell line JCRB1783 BALM-6 human bone marrowKaryotype informationB cellincluded leukemia in established cell line papers JCRB1784 BALM-8 human blood B cell leukemia cell line JCRB1785 BALM-9 human blood B cell leukemia cell line JCRB1787 BALM-9K human blood B cell leukemia cell lineImmnoglobulin phenotype kappa+,lamda- JCRB1788 BALM-9KL human blood B cell leukemia cell lineImmnoglobulin phenotype kappa+,lamda+ JCRB1790 BALM-9N human blood B cell leukemia cell lineImmnoglobulin phenotype kappa-,lambda- JCRB1791 BALM-13 human bone marrowKaryotype informationB cellincluded leukemia in established cell line papers JCRB1792 KU-Lu-MPPt3 human lung EGFR exon19 del E746-A750Human lung adenocarcinoma cell line with a micropapillary pattern. JCRB1794 BALM-9L human peripheral bloodKaryotype informationB cellincluded leukemia in established cell line papers JCRB1795 BALM-16 human blood B cell leukemia cell line,lacking Ig negative, expression ALL-L3 of immunoglobulin cell line, t(8;22)(q24;q11), chains. hypercalcemia, mRNA expression of PTHrP JCRB1796 BALM-18 human peripheral bloodKaryotype informationB cellincluded leukemia in established cell line, Ig papers negative, ALL-L3 cell line, t(8;14)(q24;q32) JCRB1797 BALM-20 human blood B cell leukemia cell lineImmnoglobulin phenotype and cell surface marker information are included in established paper. JCRB1803 BALM-26 human bone marrow B cell leukemia cell line, ALL-L2 cell line, hypercalcemia JCRB2201 A9(Neo1) human chromosome-introducedhuman monochromosomal93.6% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #1 at humandeposit. chromosome #1. JCRB2202 A9(Neo2) human chromosome-introducedhuman monochromosomal82.8% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #2 at humandeposit. chromosome #2. JCRB2203 A9(Neo3) human chromosome-introducedhuman monochromosomal88.6% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #3 at humandeposit. chromosome #3. JCRB2204 A9(Neo4) human chromosome-introducedhuman monochromosomal93.8% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #4 at humandeposit. chromosome #4. JCRB2205 A9(Neo5) human chromosome-introducedhuman monochromosomal90.4% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #5 at humandeposit. chromosome #5. JCRB2206 A9(Neo6) human chromosome-introducedhuman monochromosomal76.3% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #6 at humandeposit. chromosome #6. JCRB2207 A9(Neo7) human chromosome-introducedhuman monochromosomal93.2% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #7 at humandeposit. chromosome #7. JCRB2208 A9(Neo8) human chromosome-introducedhuman monochromosomal98.7% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #8 at humandeposit. chromosome #8. JCRB2209 CHO(His9) human chromosome-introducedhuman monochromosomal70.2% cells included hybridCells intact panel include human human chromosome chromosome #9 at #9.deposit. JCRB2210 A9(Bsr10) human chromosome-introducedhuman monochromosomal93.3% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #10 at human deposit. chromosome #10. JCRB2211 A9(neo11) human chromosome-introducedhuman monochromosomal91.5% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #11 at human deposit. chromosome #11. JCRB2212 A9(Neo12) human chromosome-introducedhuman monochromosomal85.4% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #12 at human deposit. chromosome #12. JCRB2213 A9(Hygro13) human chromosome-introducedhuman monochromosomal94.7% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #13 at human deposit. chromosome #13. JCRB2214 A9(Hygro14) human chromosome-introducedhuman monochromosomal90.4% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #14 at human deposit. chromosome #14. JCRB2215 A9(Neo15) human chromosome-introducedhuman monochromosomal96.3% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #15 at human deposit. chromosome #15. JCRB2216 A9(Neo16) human chromosome-introducedhuman monochromosomal89.3% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #16 at human deposit. chromosome #16. JCRB2217 A9(Neo17) human chromosome-introducedhuman monochromosomal42.7% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #17 at human deposit. chromosome #17. JCRB2218 A9(Neo18) human chromosome-introducedhuman monochromosomal100% cells included hybrid skinintact panel fibroblast, human chromosome AG-r. Cells include #18 at human deposit. chromosome #18. JCRB2219 A9(Neo19) human chromosome-introducedhuman monochromosomal90.0% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #19 at human deposit. chromosome #19. JCRB2220 A9(Neo20) human chromosome-introducedhuman monochromosomal79.0% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #20 at human deposit. chromosome #20. JCRB2221 A9(Hygro21) human chromosome-introducedhuman monochromosomal93.3% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #21 at human deposit. chromosome #21. JCRB2222 A9(Hygro22) human chromosome-introducedhuman monochromosomal91.4% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include #22 at human deposit. chromosome #22. JCRB2223 A9(Bsr\X) human chromosome-introducedhuman monochromosomal28.0% cells included hybridskin intact panel fibroblast, human chromosomeAG-r. Cells include X when human deposited. chromosome #23. JCRB9002 BW5147.G.1.4.OUA-R.1 mouse hemo-lymphocyticT cell lymphoma JCRB9003 NCTC Clone 929 mouse skin connective tissue, cloneconnective of strain tissue, L. clone of strain L. JCRB9004 HeLa human uterine cervix first establish cell line in vitro from human JCRB9005 BALB/3T3 clone A31 mouse embryo contact inhibited JCRB9008 MRC-5 human fetus lung embryonal lung, diploid,fetal male.lung, normal diploid fibroblast JCRB9009 A-431 human epidermoid epidermoidcarcinoma carcinomaepidermoid carcinoma JCRB9010 HeLa S3 human uterine cervixepitheloid carcinoma,adaptable cervix. to a suspension culture JCRB9012 RAJI human hemo-lymphocyticBurkitt lymphoma Burkitt lymphoma JCRB9014 3T3 L1 mouse embryo differentiate to adipocyteThe 3T3 L1 is a clonal subline of mouse 3T3 cells. JCRB9018 CHO-K1 hamster, Chineseovary used as a chromosome averation test JCRB9019 3T3-Swiss albino mouse embryo embryo fibroblasts embryo fibroblasts, contact-inhibited fibroblasts JCRB9020 BHK-21(C-13) hamster, Syriankidney kidney kidney JCRB9021 U937 human hemo-lymphocyticexpress many monocyte-likeReceptors characteristics for Fc & C3.Differentiation by chemicals JCRB9023 CCRF-CEM human hemo-lymphocyticperipheral blood, acuteperipheral lymphoblastic blood, acuteleukemia lymphoblastic leukemia JCRB9026 L1210 mouse hemo-lymphocyticlymphocytic leukemiclymphocytic cells leukemic cells JCRB9027 KB human HeLa-contaminantepidermoid carcinoma,epidermoid Oral, Hela carcinoma, markers. Oral, Hela markers. JCRB9029 MDCK (NBL-2) dog kidney kidney, epithelial likekidney, morphology epithelial like morphology JCRB9030 P3\X63-Ag8.653 mouse hemo-lymphocyticnon-secreting myelomanon-secreting cells, partner myeloma of hybridoma cells, partner of hybridoma JCRB9031 MOLT-4 human hemo-lymphocyticperipheral blood, ALL,peripheral T-cell lymphocytes. blood, ALL, T-cell lymphocytes. JCRB9032 SJK-237-71 mouse antibody-producinghybridoma hybridoma cell line producing monoclonal IgG1 to DNA polymerase alpha. JCRB9033 STK1 mouse antibody-producinghybridoma, hybridoma monoclonalhybridoma, IgG1 to monoclonalDNA polymerase IgG1 alphato DNA polymerase alpha JCRB9034 LLC-RK1 rabbit kidney an aneuploid cell linesusceptible to viruses,leuvella,vaccinia & herpes. JCRB9036 104C1 guinea pig fetal body fetal carcass, benzo(a)pyrene transformed, diploid JCRB9039 Pt K1 marsupial (potoroo,kidney ratKidney kangar Kidney JCRB9040 PK(15) pig kidney Kidney Kidney JCRB9041 T98G human neural G1 arrested when crowdedanchorage-independent,good to study cell prolife. JCRB9042 WI-26 VA4 human lung lung, SV-40 virus transformed.lung, SV-40 virus transformed. JCRB9044 Detroit 532 human skin Down's syndrome cell line JCRB9045 Detroit 539 human skin Skin, Down's syndrome,Skin, female Down's syndrome, female JCRB9046 GH1 rat pituitary Pituitary tumor Pituitary tumor, somatotrophin secreting JCRB9047 GH3 rat pituitary Pituitary tumor, MtT/W5,Pituitary Somatotropin tumor, MtT/W5, secreting. Somatotrophin secreting. JCRB9048 MOLT-3 human hemo-lymphocyticPeripheral blood, acutePeripheral lymphoblastic blood, acuteleukemia lymphoblastic leukemia JCRB9050 IMR-32 human neural N-myc amplification transplantable to nude mice JCRB9051 KG-1 human hemo-lymphocyticbone marrow, acute bonemyelogenous marrow, acuteleukemia. myelogenous leukemia. JCRB9052 Pt K2 (NBL-5) marsupial (potoroo,kidney ratkidney kangar kidney JCRB9053 L-2 rat lung adult, lung, female adult, lung, female JCRB9054 IMR-90 human lung fetal lung, diploid, female.fetal lung, diploid, female. JCRB9055 R2C rat testis Leydig cell testicularLeydig tumor,steroid cell testicular secreting tumor,steroid secreting JCRB9056 Y-1 mouse adrenal cortexadrenal tumor adrenal tumor JCRB9057 WI-38 VA13 sub 2 RA human lung lung, SV40 virus transformedlung, SV40 cell virus line transformed cell line JCRB9058 RPMI 2650 human nasal septumquasi-diploid squamousquasi-diploid carcinoma, squamous nasal septum. carcinoma, nasal septum. JCRB9059 3T6-Swiss albino mouse embryo embryo, collagen-secretingembryo, collagen-secreting JCRB9060 MRC-9 human lung fetal lung, diploid femalefetal lung, diploid female JCRB9061 PA-1 human teratocarcinomaascitic fluid cells, ovarianascitic teratocarcinoma fluid cells, ovarian teratocarcinoma JCRB9062 HS-Sultan human hemo-lymphocytic JCRB9063 WIL2-NS human hemo-lymphocyticB lymphocyte, non-secretingB lymphocyte, variant non-secreting variant JCRB9064 LC540 rat testis leudig cell testicular leudigtumor cell testicular tumor JCRB9065 G-401 human kidney Wilms' tumor (embryonal carcinosarcoma of kidney) JCRB9066 Chang Liver human HeLa-contaminantliver, HeLa markers This cell line was reported as a liver cell line but later this cell line was identified as a HeLa cell. JCRB9067 NRK-49F rat kidney normal kidney fibroblastnormal kidney fibroblast JCRB9068 293 human kidney transformed embryonal kidney by adenovirus (type5) JCRB9069 SW-13 human adrenal cortex adenocarcinoma, Adrenal cortex JCRB9070 G-402 human kidney renal leiomyoblastomarenal leiomyoblastoma JCRB9071 Daudi human hemo-lymphocyticBurkitt lymphoma Burkitt's lymphoma JCRB9072 RD human sarcoma rhabdomyosarcoma JCRB9074 G-361 human melanoma malignant melanoma,malignant melanin melanoma,production melanin production JCRB9075 NCTC Clone 1469 mouse liver liver liver JCRB9076 FHs 74 Int human intestine fetal small intestine, fetalnormal small intestine, normal JCRB9077 MMT 060562 mouse mammary spontaneous mammaryspontaneous tumor mammary tumor JCRB9078 De Gin human skin skin, osteoporosis skin, osteoporosis JCRB9079 Ran Nor human skin skin, osteoporosis skin, osteoporosis JCRB9080 C3H/10T1/2 clone 8 mouse embryo embryo, contact sensitiveembryo, contact sensitive JCRB9081 L6 rat muscular systemskeletal muscle myoblastskeletal muscle myoblast JCRB9083 LoVo human colon colon, adenocarcinomacolon, adenocarcinoma JCRB9084 Sp2/O-Ag14 mouse hemo-lymphocytichybridoma, non-secretinghybridoma, non-secreting JCRB9085 P3\X63Ag8U.1 mouse hemo-lymphocyticmyeloma derivative myeloma derivative JCRB9086 HeLa 229 human uterine cervixepitheloid carcinoma,epitheloid cervix. carcinoma, cervix. JCRB9087 RPMI 1846 hamster, Syrianmelanoma melanotic melanomamelanotic melanoma JCRB9089 CCRF S-180 II mouse sarcoma sarcoma 180 derivedsarcoma 180 JCRB9090 Ehrlich ascites mouse ascites Ehrlich-Lettre ascites,many carcinoma floating cells observed JCRB9091 Y3-Ag 1.2.3 rat hemo-lymphocyticmyeloma, kappa secretingmyeloma, kappa secreting JCRB9092 7D4 mouse x ratantibody-producinghybridoma, hybridoma anti-murinehybridoma, IL-2 receptors anti-murine IL-2 receptors JCRB9093 WEHI-3 mouse hemo-lymphocyticmyelomonocytic leukemia,myelomonocytic macrophage-like leukemia, macrophage-like JCRB9094 DLD-1 human colon colon, adenocarcinomacolon, adenocarcinoma JCRB9095 HEPM human embryo embryonic palatal mesenchyme,embryonic palatal limited mesenchyme life span JCRB9096 C6 rat neural glial cell tumor glial cell tumor JCRB9097 I-10 mouse testis leydig cell testicular tumorThis cell line is a clone of leydig cell testicular tumor H10119. Produces steroids such as progesterone and its reduced derivative. JCRB9098 AtT-20 mouse pituitary ACTH producing cellCells line are subcultured as intact aggregates. JCRB9099 SV-T2 mouse embryo SV40 virus-transformedSV40 BALB/3T3, virus-transformed embryo BALB/3T3, embryo JCRB9100 Indian Muntjac Indian Muntjakskin Muntjak is a primitive deer with diploid chromosome number of 7 in the male and 6 in the female, the lowest number yet described in a mammal. JCRB9101 CCD-14Br human lung bronchus, diploid bronchus, diploid JCRB9102 Detroit 525 human skin skin, Turner's Syndromeskin, Turner's Syndrome JCRB9103 KD human oral lip, fibroblast lip, fibroblast JCRB9104 Detroit 510 human skin skin, galactosemia skin, galactosemia JCRB9105 P3\X63Ag8 mouse hemo-lymphocyticresistant to 10^-4M 8-azaguanine,dieIgG1(gamma,kappa) in HAT secreting medium myeloma JCRB9106 MPC 11 OUAr mouse hemo-lymphocyticmyeloma myeloma JCRB9107 P3/NS1/1-Ag4-1(NS-1) mouse hemo-lymphocyticnon-secreting myelomanon-secreting myeloma JCRB9108 J774A.1 mouse hemo-lymphocytic monocyte-macrophage JCRB9109 P3.6.2.8.1 mouse hemo-lymphocyticIgG1 secreting myelomaIgG1 secreting myeloma JCRB9110 PC-3 human prostate glandadenocarcinoma JCRB9111 BeWo human placenta trophoblastic cell linethe first human endocrine cell type cultivated JCRB9113 HT-1080 human sarcoma The cells contain activated N-ras oncogene. JCRB9114 BRL-3A rat liver liver liver producing MSA(somatomedin-like) protein JCRB9115 SW837 human rectum Rectum, adenocarcinomaRectum, adenocarcinoma JCRB9117 BCL1 Clone CW13.20 mouse hemo-lymphocyticmurine B cell leukemia,murine BALB/c B cell leukemia, subclone 3B3 of BCL1 clone CW13.20. JCRB9118 SCC-4 human oral tongue,squamous celltongue,squamous carcinoma cell carcinoma JCRB9119 Ramos(RA1) human hemo-lymphocyticBurkitt lymphoma (EBVBurkitt negative) lymphoma (EBV negative) JCRB9122 SIRC rabbit cornea susceptible to rubella virus, toxicologcal usage JCRB9124 M.dunni(Clone III8C) pygmy mousetail Cloned at P14 usingSupports Terasaki theplates. growth of all 4 classes of MuLV. JCRB9125 PG-4(S+L-) cat neural Transformed with MoloneySupport murine Type sarcomaC retroviruses. virus,MMSV JCRB9128 Mv 1 Lu mink lung This cell line is useful for focus forming assays of murine and feline sarcoma virus. COMMENT celltype Ordering Comment pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pCMT-SAhygpA-NP22 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21 mousehomozygous mutant ES cells pT2F2-SAhygpA-NP21-Rev mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells pCMT-SAhygpA-NP21 mousehomozygous mutant ES cells *Contamination of HeLageneral cells cells has been suspected in this line. *Contamination of HeLageneral cells cells has been suspected in this line. This cell line is different from the CRL-8129 in ATCC although the name is same. spontaneous myeloid leukemia, differentiationgeneral into cells macrophage/granulocyte This cell line containsgeneral a DNA cells sequence for E6 of HPV type 16, but not type 18 and 33. (Tested at the IFO (PCR)). spontaneous myeloid leukemia, M-1-derivative,general macrophage-likecells phenotype malignant melanoma general cells useful for replication of flavivirus general cells Contains DNA sequencegeneral for cellsE6 oncogene of HPV type 18, but not type 16 and type 33. (Tested at the IFO (PCR)) kidney, epithelial-like general cells general cells general cells *Contamination of HeLageneral cells cells has been suspected in this line. This cell line containsgeneral Raus sarcomacells virus genome but does not release viral particles. (Neoplasma, 9, 104 (1962)). transformed from hamster fibroblast general cells fibroblast, contact-inhibited general cells susceptible to rubella virus general cells fibroblast, subclone of Balb/3T3 A31. Thisgeneral cell line cells exhibits contact inhibition. This line is equivalentgeneral to HL60RG cells (JCRB 0006). B-lymphoblastoid cells, EB virus-transformedgeneral cells leukemia, acute lymphoblastic general cells basophilic leukemia general cells lymphoid neoplasm, derived from P388 general cells established from normal blood, IgM secretinggeneral cells lymphoma, histiocytic general cells Contamination of Rajigeneral cells has cells been suspected in this line. This cell line contains EB virus genom. general cells general cells 3-methylcholanthrene-transformed C3H/10T1/2general cells WiDr cell line is suggestedgeneral to cells be derived from a human colon adenocarcinoma cell line HT-29 (Cancer Genet. Cytogenet., 27,125 (1987)) general cells adenocarcinoma, carcinoembryonic antigen-producinggeneral cells hepatoma, HBs antigen-positive general cells fibroblast, subclone of Balb/3T3-A31. Thisgeneral cell line cells exhibits contact inhibition. established from normal kidney, susceptiblegeneral for manycells viral species fetus lung normal diploid fibroblast general cells fetus lung normal diploid fibroblast general cells fetus lung normal diploid fibroblast general cells fetus lung normal diploid fibroblast general cells T cell differentiation factor-producing general cells general cells T cell differentiation factor producing general cells skin normal diploid fibroblast general cells general cells neuroblastoma, Td = 20 hrs. general cells lung, fibroblast, widely used in somatic geneticsgeneral cells fetus lung normal diploid fibroblast general cells 4G12 antibody, preferentially reacting withgeneral lung carcinoma-associatedcells antigen HGPRT-deficient F2408 cell line general cells HGPRT-deficient cell line from F2408. Thisgeneral cell line cells exhibits temperature sensitive phenotype for transformation by Moloney MSV. The transforming efficiency considerably decreases at 39 C compared to at 33 C. HGPRT-deficient cell line from F2408. Thisgeneral cell line cells exhibits temperature sensitive phenotype for transformation by Moloney MSV. The transforming efficiency considerably decreases at 39 C compared to at 33 C. thymidine kinase-deficient F2408 cell linegeneral cells HGPRT-deficient F2408 cell line general cells thymic stroma, keratin-positive general cells pituitary tumor, somatotrophin-secreting general cells general cells general cells general cells glial tumor, GFAP-positive general cells This line was cured ofgeneral mycoplasmal cells contamination by antibiotic-treatment at the IFO. thymoma, keratin-positive general cells thymoma, keratin-positive general cells leukemia, chronic megakaryoblastic general cells thymic stroma, keratin-positive general cells general cells general cells leukemic cell, maintainable only by transplantationgeneral cells N18TG2 x Fischer rat 18 day-embryonic generalneural retina cells general cells general cells chondrosarcoma, secreting basement membranegeneral cells matrix pituitary tumor, somatotrophin-secreting general cells medullary thyroid carcinoma, neurotensingeneral and calcitonin-producing cells normal endothelial cell, umbilical cord general cells malignant melanoma, metastasis to lymphgeneral node cells fibroblast transformed by c-Ha-ras oncogenegeneral cells pheochromocytoma, neuronal differentiationgeneral by NGFcells MSW113 antibody, recognizing a cancer-associatedgeneral cells olygosaccharide transformant of NRK cells by avian sarcomageneral virus cells B77 thymidine kinase deficient RAT-1 (F2408)general cell line cells transplantable to nude mice general cells A2B5 antibody, recognizing a glycolipid generalexpressed cells in neural tissue The DNA fingerprint generalprofile confirmed cells that this cell line derives from the same origin as U-251 MG. astrocytoma, GFAP-negative general cells The DNA fingerprint generalprofile confirmed cells that this cell line derives from the same origin as U-251 MG (KO). astrocytoma, GFAP-negative general cells normal mixed glial culture general cells leukemia, chronic megakaryoblastic, MEG-01s-derivativegeneral cells adapted to serum-free medium neuroblastoma, neuronal differentiation general cells general cells whole fetus, normal diploid fibroblast general cells N/A via Xenotech fibroblast, subclone of Balb/3T3 A31. Thisgeneral cell line cells exhibits contact inhibition. fibroblast, subclone of Balb/3T3 A31. Thisgeneral cell line cells exhibits contact inhibition. general cells This cell line containsgeneral a DNA cells sequence for E6 oncogene of HPV type 18, but not type 16 and 33. (Tested at IFO (PCR)). This cell line containsgeneral a DNA cells sequence for E6 oncogene of HPV type 18, but not type 16 and 33. (Tested at IFO (PCR)). This cell line and SKG-IIIbgeneral (IFO cells 50311) originated from the same patient. This cell line contains a DNA sequence for E6 oncogene of HPV type 16, but not type 18 and 33. (Tested at IFO (PCR)). This cell line and SKG-IIIageneral (IFO cells 50310) originated from the same patient. This cell line contains a DNA sequence for E6 oncogene of HPV type 16, but not type 18 and 33. (Tested at IFO (PCR)). This cell line does notgeneral contain cells a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). This cell line does notgeneral contain cells a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). This cell line does notgeneral contain cells a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). This cell line does notgeneral contain cells a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). general cells This cell line and RMUG-Lgeneral (IFO cells 50319) originated from the same patient. This cell line does not contain a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). malignant melanoma, metastasis to lymphgeneral node. cells 5-S-cysteinyldopa production. This cell line does notgeneral contain cells a DNA sequence for E6 oncogene of HPV type 16, 18 and 33. (Tested at IFO (PCR)). This cell line containsgeneral a DNA cells sequence for E6 of HPV type 16, but not type 18 and 33. (Tested at the IFO (PCR)). skin normal diploid fibroblast general cells acetabulum, fibrosarcoma general cells general cells glioma, GFAP-positive, S-100 and NSE-negativegeneral cells glioma, GFAP, S-100 and NSE-negativegeneral cells bronchial squamous carcinoma, metastasisgeneral to brain cells glioma, GFAP and S-100-positive, NSE-negativegeneral cells The DNA fingerprint generalprofile confirmed cells that this cell line derives from U-251 MG cell line. leukemia, acute lymphoblastic general cells leukemia, chronic myeloid general cells skeletal muscle myoblast general cells fibroblast, contact-inhibited general cells glioma, anaplastic, GFAP-positive general cells glioma, anaplastic, GFAP-positive general cells tubule cell, tsSV40 large T-immortalized general(ts mutant) cells endothelial cell, tsSV40 large T-immortalizedgeneral cells spleen stromal cell line general cells spleen stromal cell line general cells liver stromal cell line general cells liver stromal cell line general cells hepatocyte immortalized with the tsSV40general large T cells antigen gene. Permissive temperature is 33 C. hepatocyte immortalized by the tsSV40 largegeneral T antigen cells gene. Permissive temperature is 33 C. fibroblast, subclone of strain L general cells epidermoid carcinoma, high expression ofgeneral EGF receptorcells leukemia, acute lymphoblastic general cells widely used for production of recombinantgeneral proteins cells fibroblast, contact-inhibited general cells fibroblast, 3T3-Swiss derivative, adipocytegeneral differentiation cells fibroblast, contact-inhibited general cells skin normal diploid fibroblast general cells skin normal diploid fibroblast general cells susceptible to Vaccinia virus general cells susceptible to Vaccinia virus general cells susceptible to Vaccinia virus general cells astrocyte-progenitor cell line general cells C6 subline adapted to serum-free mediumgeneral cells NIL subline adapted to serum-free mediumgeneral cells This cell line is usefulgeneral for studying cells megakaryocytopoiesis. This cell line is usefulgeneral for studying cells megakaryocytopoiesis. neuroblastoma, from lymph node, smoothgeneral muscle cells marker-expressing neuroblastoma, from bone marrow, neuronalgeneral and cells Schwannian differentiation neuroblastoma, from lymph node, smoothgeneral muscle cells marker-expressing glioma, GFAP, vimentin and CD13-positivegeneral cells astrocytoma, anaplastic, GFAP, S-100, vimentin,general cells CD13 and HNK-1-positive general cells The DNA fingerprint generalprofile confirmed cells that this cell line derives from KNS-81. RC1 antibody, recognizing undifferentiatedgeneral neural cells cell-specific antigen glioma, FGF-9-producing general cells CNS stem cell line, HPV type 16 E7-immortalizedgeneral cells leukemia, chronic megakaryoblastic, MEG-01-derivativegeneral cells leukemia, acute monocytic, promonocyticgeneral leukemia cells cells leukemia, acute monocytic, NOMO-1-derivativegeneral adapted cells to serum-free medium leukemia, acute myeloid, myeloid leukemiageneral cells, cells responsive to G-CSF and M-CSF for growth Although this cell linegeneral was reported cells as immortalized cell line, the ampoules preserved in the cell bank hardly proliferated. leukemia, chronic myelogenous, megakaryoblasticgeneral cells cell line general cells epithelioid clone of NRK cells general cells fibroblastic clone of NRK cells, useful forgeneral transformation cells assays The ampoules preservedgeneral in thecells cell bank hardly proliferate. dark (horizontal) basal cell-like, keratin-positivegeneral cells chondrosarcoma, type 1, 2 and 3 collagens;general type cells 9 and 11 collagen mRNA; proteoglycan-producing glioblastoma, MDR1 and P-glycoprotein-expressing.general cells GFAP, vimentin and fibronectin-positive human MDM2 gene-introduced neonetalgeneral rat astrocyte, cells MDM2-expressing neonatal rat astrocytes, GFAP-positive general cells glioblastoma, GFAP and S-100-positive,general ACNU (acells cancer chemotherapy drug)-sensitive glioblastoma, GFAP and S-100-positive,general ACNU (acells cancer chemotherapy drug)-resistant neuroblastoma, HPRT-deficient Neuro-2ageneral cell line cells pheochromocytoma, HPRT-deficient PC-12general cell linecells leukemia, natural killer-like T cell line general cells Mycoplasmal contaminationgeneral cellswas eliminated with antibiotic treatment at the IFO. NK-like cell line from a patient with severegeneral chron cellsic active EBV infection, IL-2-dependent This cell line is used generalfor the preparationcells of conditioned medium for MG5 cells (IFO 50520). Cell type of this cell line has not been identified. microglial cell line from p53-deficient micegeneral cells general cells Maximum cell density=1-2x10^7/10D.general cells Do not culture more than 1 month. contact sensitive cell line general cells epidermoid carcinoma general cells Doubling time = 15 hrs.general cells RG:rapid growth. Abilitygeneral for the cells differentiation by TPA or DMSO reduced. The cell line may be generalused for cells the study of keratin fiber. Used for the preparationgeneral of hybridoma.cells The cell line release generalmonoclonal cells anti-11-deoxycortisol antibody(IgG). producing monoclonalgeneral antibody(IgM) cells to human blood cell antigen Production of monoclonalgeneral antibody cells for human red blood cell antigen. Release interleukin 1.general cells Target cell by cytotoxicgeneral T lymphocyte. cells Carry receptors for immunoglobulin and generalcomplement. cells IL-1 productivity is different from the similar cell line, J774A.1 distributed from the ATCC. Differentiation with NaBgeneral was cellstested by Riken Cell Bank (see picture, others(5)). Rosettes formation. High TdT. No Ig no generalEBV produc. cells Release IgE-mediatedgeneral serotin. cells The cell line has receptorsgeneral for cells growth hormone and etc. Production of somatomedin.general cells Same cell line in ECACCgeneral cells Only for researchers in Asian countries After CCRF-SB was generaltransplanted cells to new born Syrian hamster, cells were then transferred in vitro culture system again at 8 th transplant. STR-PCR showed the close similarity with the CCRF-SB. B-cell general cells Near diploid, no Ig-secreting, free of virusgeneral particle. cells hematopoietic cell line, Lambda L chain generalsecreting cells IgM secreting(light chain), positive for HLA2.7general cells peripheral lymphocyte general cells Mycoplasma contaminationgeneral wascells detected when submitted to NIHS and eliminated at 1986. produce colony-stimulating factor general cells general cells general cells general cells general cells general cells susceptible to viruses, rubella,vaccinia &general herpes. cells Mycoplasma contaminationgeneral wascells detected when submitted to NIHS and eliminated at 1986. general cells general cells general cells sensitive to CMV virus general cells N/A via Xenotech sensitive to asparginase. Dt=40hr, colony-formainggeneral cells efficiency in soft agar = 19% general cells general cells Hela markers observed.general In.Vitro.14.469.1978. cells Please notice that this J-111 cell line is different from the CRL-8129 in ATCC although the name is the same. general cells HLA:A2,A24,B5,Bw22general cells Y chr.invisible. Detected by Y specific DNAgeneral probe. cells Mycoplasma contaminationgeneral wascells detected when submitted at NIHS and eliminated at 1986. target cell for cytotoxic T cell assay general cells many floating cells are observed general cells general cells lung adenocarcinoma general cells Everyday medium changegeneral is cells necessary for good proliferation. Everyday medium changegeneral is cells necessary for good prolife-ration. Doubling time is 40hr.general Growth cells is not so good from thawing to 1 month. Inoculate about 10^6 cells to 60mm dish when thawing. STR-PCR indicated the HL60 is same as HL60(S) (JCRB0163), T cell lymphoblastic leukemia. mode=95-101general cells This cell line producesgeneral monoclonal cells antibody recognizing IgM expressed by any B-cells of mouse. The cell line can be applied to a clonal analysis. Lot of FCS affects criticallygeneral to cells growth of the cells. CD8 antigen is inducedgeneral by addition cells of TPA. Pre-preB ALL strain. Good for the researchgeneral of Ig gene.cells because of the chromosome translocation (2,14). Mycoplasma contaminationgeneral wascells detected when submitted to NIHS and eliminated in 1986. Mycoplasma contaminationgeneral wascells detected when submitted to NIHS and eliminated at 1986. Mycoplasma was eliminatedgeneral cellsby Oku, T at Dec. 1987. create clusters on growth general cells lung squamous cell carcinoma general cells Ph1 chromosome (+).general Histamine cells (+). This cell line was deposited to the ATCC, ECACC and DSM at 1990. This cell line was depositedgeneral tocells ATCC, ECACC and DSM at 1990. This cell line was depositedgeneral tocells ATCC, ECACC and DSM at 1990. general cells Cell ID data indicategeneral some funny cells results comparing from the KY821(JCRB0105). Other name was discardedgeneral because cells of the personal ID. Other name was discardedgeneral because cells of the personal ID was included. Cells are differentiated by dexamethasonegeneral or etc. cells HLA-DR,My 7, My 9,general OKM1 positive.cells Nonspecific esterase positive, Peroxidase negative, a-naftol ASD chloroacetate esterase negative, etc. by Dr. Tsuchiya. HLA-DR, My7, My9, generalOKM1 positive. cells Nonspecific peroxidase positive, peroxidase negative, a-naftol ASD chloroacetate esterase negative. by Dr. Tsuchiya. non screeting type for IgE. general cells E-rossette formation. D-J joinning. EBNAgeneral negative. cells monocytic cell line. Negative for ATLA. Positivegeneral for cells EBVCA and negative for EBNA. highly susceptible clone for HIV virus general cells Genetic ID was the samegeneral as cells the JCRB9021 U937 (EV=0.929). The cells were killed by anti-IgM but not generalIgD. cells Myeloperoxidase (MPO) release into cult.medium.general cells This cells are comminggeneral from NIHS0160cells after quality controls. This cells are comminggeneral from NIHS0161cells after quality controls. This cells are comminggeneral from NIHS0162cells after quality controls. N-ras mutation: G->C in codon 13. general cells Densly packed ilet-like colonies with smallgeneral polygonal cells cells and high AFP production observed. Receptors are examinedgeneral after cells decontaminaion of mycoplasmas. Cells were establishedgeneral through cells xenografted tumors in nude mice by Geneticin treatment to eliminate mouse fibroblast cells. Mouse cells observed when deposited. Cells having characteristics of astrocyte generalcells. These cells cells are grown in serum free condition. Cells obtained from Rikengeneral Cell cells Bank. Cells having characteristics of astrocyte generalcells when cells cell culture started. These cells are grown in serum free condition for long passages. Passage number was extreamly increased as compared with the JCRB0129.0 RCR-1.P3. Serum free culture started 1991. Cells adapted to grow in serum free medium.general cells general cells Cell growth inhibited by cell-cell contact.general cells transplantable rat ascites tumor cell line.general Rat established cells on 1952 and tumor was maintained by transplantation. Primary cell culture was established on 1971. Serum free cell line was established on 1972. transplantable rat ascites tumor P3 cell linegeneral cells transplantable rat ascites tumor P3 cell linegeneral and cells have been cultured continuously for long period in the serum free medium. Teromerase positive and a length of telomere is 5.1 kb. Td=50 hrs. Amylase and IgA productions were positivelygeneral elevated. cells dome formation observed general cells See CHO-K1 cell culturegeneral methods. cells Refer CHO-K1 cell culturegeneral methods. cells Transplantable to SCID mice and frequentlygeneral metastasize cells to SCID mouse lymph nodes. HTLV-1 positive small cell lung cancer cells.general cells Cells are originally contaminatedgeneral cells by mycoplasmas and decontaminated by the MC210 in the JCRB cell bank. Any comments for subculturegeneral cells methods. Need details of the culturegeneral method. cells STR-PCR data showed the same pattern with NCC16(NCC16 may be cross contaminated and will be replaced to NCC16-P11). general cells general cells general cells general cells Cell culture becomesgeneral difficult cells when inoculum size is lower than 1x10^4 cells/cm^2. Be care about overgrowth when inoculum size is over 3 x 10^4 cells/cm^2. general cells general cells general cells Sticky cell from lymph node. Serum free generalcell culture. cells Culture fruid of the LYM-1 strongly inhibitedgeneral a growth cells of AH-7974 and other several cell lines. The inhibition was strongly suppressed by heating. Culture fruid of the LYM-1 strongly inhibitedgeneral a growth cells of AH-7974 and other several cell lines. The inhibition was strongly suppressed by heating. from LYM-1 general cells Multipotent CNS stem cell line. Differentationgeneral in tocells neurons, astrocytes and oligodendrocytes. Epitherial-like morphology can be observed when the cells are cultured on the coated dishes. IgD, IgM positive, hairy B-cell line general cells Jurkat cell clone with a lack of surface expresshiongeneral cells of TCR alpha/beta/CD3 complex {5012, 5010} Cells are deconaminatedgeneral in thecells JCRB cellbank. Appearing of naturallygeneral occured cells transformation depends on serums and passage methods. smooth muscle cell line from p53 knock outgeneral mouse cells aorta 5% CO2, 37 C culture.general Original cells ampules were frozen with medium and 10% DMSO. Cells adheded less than 100%. Anchorage dependency is No. Original description. Adhesion efficiency general100%. Anchorage cells dependency is yes. Growth temperature is 37 C and CO2 concentration is 5%. Freezing medium contains 10% DMSO. Reference cell line forgeneral the M.P3(NIHS0228.2 cells JCRB0152.2 under preparation). Cells grow in serum freegeneral medium cells established by Takaoka,T. and Katsuta,H. Cells grow in serum freegeneral medium cells established by Takaoka,T. and Katsuta,H. MNNG-mutagenized 3Y1 cell derivativesgeneral with ts mutationcells grows at 34 C but the growth is arrested at 40 C. MNNG-mutagenized rat 3Y1 derivative cellgeneral line with cells ts mutation. Cells grows at 34 C but is lethal at 40 C. 3Y1 derived ts mutant cell line with MNNGgeneral treatment. cells Cells grow at 34 C and are arrested at G0 at 40 C. Cells continue proliferation at both temperatures in cell cycle. Cells will be availablegeneral in near cells future. high NK/LAK activity, IFN gamma productiongeneral etc. cells A rare large B-cell non-Hodgkin's lymphomageneral having cells a near-triploid cell population. Bone marrow mononuclear cells. general cells Please refer NIHS0246.1general for cells the STR-PCR data in the Cell_ID section. Bone marrow mononuclear cells. general cells A part of the populationgeneral of this cells cell culture attaches to the surface of culture dishes. Thus pipetting is necessary when subculture. general cells CD34+, CD33+, CD13+ general cells Mycoplasma-eliminatedgeneral cells cellsby MC-210. The NEC14 is unique out of 219 cell line (04/22/2001). STR-PCR results indicatedgeneral the cells HL60(S) is the same with HL60(JCRB0085) The HTC/C3 is uniquegeneral by STR-PCR cells (04/22/2001). The KHM-10B is uniquegeneral among cells 219 cell line on 04/22/2001 by STR-PCR. HMC-1-8 is a target cell of the T-cell killergeneral clone T(cHMC-1) cells derived from breast cancer established from pleural effusion. Low differentiated adenocarcinoma.general cells WKA/Hok rat. c-WRT-7general derivative. cells Rauscher leukemia virus infected. Derived from small cell lung carcinoma, classicgeneral type. cells Cells are prepared from heterotransplantation of the tumor into athymic BALB/c mice. Dense cored granule (neurosecretory granule) observed unde EM. Hard to observe dense core granules (neurosecretorygeneral cells granules) under electron microscopic observation. Doubling time was 45 hours reported originally. Cell culture initiated generalby cell dispersion cells culture method from suspension cells in ascites and cloned later. Passage is over 104 when deposited to the FDSC. Cells were uniqure confirmed by the STR-PCR method. Cells confirmed to begeneral registrated cells and ampules for distribution are under preparation. Cell culture started bygeneral explant cells culture method. Doubling time = 36 hrs. Rate of colony formation = 21.3%. Passage number is over 117 when deposited. Unique by STR-PCR(10/17/2001). The NCC16-P11 wasgeneral confirmed cells to be unique on 07/30/2001 while the NCC16 originally deposited was crosscontaminated with the PHK16-0b. The original NCC16 was rejected to resistrate to the JCRB cell bank. Cells were contaminatedgeneral by cellsmycoplasmas when deposited. They were removed by FDSC before sending to the JCRB. Unique bat the patterngeneral was similarcells to the KP-3L which is reported to be derived from the KP-3. Mycoplasmas were decontaminatedgeneral cells by the MC210 treatment in the JCRB cell bank. The cells are respondedgeneral to the cells progesterone. Mycoplasmas were decontaminated by MC210 in FDSC, 1990. The cell line GAK has an activity of 5-S-CDgeneral production. cells Cells are observed togeneral be unique cells from the STR-PCR analysis. Cells are observed togeneral be unique cells from the STR-PCR analysis. Cells are observed togeneral be unique cells from the STR-PCR analysis. Ovarian granulosa cell line with v-Ha-rasgeneral gene. Doubling cells time = 13 hrs. Ovarian granulosa cell line with v-Ha-rasgeneral gene. Doubling cells time = 35 hrs. Cells are tumorigenicgeneral in nude cells mice. Poorly defferentiated adenocarcinoma. The cell line was identified to be a unique cell line by STR-PCR experiment (2002.June). This cell line produces carcinoembryonicgeneral antigen(CEA), cells carbohydrate antigen 19-9 (CA19-9), cancer-associated antigen SPan-1, and expresses EGF receptor. Tumorigenic to nude mice (intramusclar transplantation). Normal rat liver epitherial cell line grew ingeneral a monolayer. cells Population doubling was 20-23 hrs at beggining but became 12.5 hrs later. Cells did not accumulate cytoplasmic glycogen, negative for glucose-6-phosphatase. Cells were unique bygeneral STR-PCR. cells This cell line is producing IgG1 against thegeneral rat neutrophil. cells No harmfull effect against the neutrophil. This IgG1 is used for the histochemical staining of the neutrophil. Mouse cell line producing IgM antibody againstgeneral thecells rat neutrophil. The antibody is harmfull to the rat neutrophil in vivo or in vitro with complement. Serum free cell culture.general When cells cells are treated with the trypsin inhibitor, 10^-7 M 6-amino-2-naphtyl p-guanidinbenzoate dimethanesulfonate(FUSAN) is used, cells should be washed by the serum free medium once. The FUSAN is toxic to the cell. EGF (1-100ng/ml) inhibited the cell growth.general The cellcells could not grow in soft agar but the EGF stimulated colony formation in the soft agar. The huH-1 cell line produce tumors in nudegeneral mice. cells Cells are producing HBs-antigen continuously in culture medium. Tyrosine aminotransferase activity was induced by dexamethasone as well as by butyryl c-AMP. general cells Melanin producing tumorgeneral cell cells line. general cells Resistant to 8-azaguanine.general cells general cells carcinoembryonic antigen producing. general cells Resistant to 6-TG. general cells rat skeletal muscle myoblast, TG-r, Cap-rgeneral cells Resistant to 8-azaguanine.general cells Resistant to BrdU. general cells Resistant to 8-azaguanine.general cells Resistant to thioguanine.general cells Resistant to thioguaninegeneral and cells chloramphenicol. Resistant to 8-azaguaninegeneral and cells chloramphenicol. fetus fibroblast transformed cell general cells Because of the HGPRTgeneral deficient cells strain, the cell line is good to prepare hybridoma. general cells Normal human fibroblastgeneral cells N/A via Xenotech general cells PDL=13 general cells N/A via Xenotech colon, adenocarcinoma general cells colon, adenocarcinoma general cells colon, adenocarcinoma general cells amelanotic melanoma, 6TG-r general cells general cells rat tracheal epithelial cells general cells The cell line was obtainedgeneral from cells 24 months old Fisher rat. The cell line was obtainedgeneral from cells 24 month old Fisher rat. Tumour markers, TA-4,general CA-4, cells TPA, placental ALP, produed. The cell line was contaminatedgeneral cells by mycoplasmas when deposited to the cell bank and they were eliminated in FDSC(JCRB). general cells general cells general cells ovary, undifferentiated carcinoma general cells Sysplatin registant. general cells Cell number of the suculturegeneral cells is estimated roughly. Cell clumps cannot be eliminated. general cells Possible model systemgeneral for de-differentiation. cells non differenciated cancer general cells general cells general cells Meium Suplements aregeneral 10mM cells Hepes, 2x10^8M Selenite, 1ug/ml insulin, 10^9M estradiol, 1mM EGTA and 10% fetal calf serum estrogen dependent Leydig cell tumor general cells Cells were prepared from the tumor. general cells general cells Eliminated mycoplasmageneral by MC-210. cells 10-week-old male F344/DuCrjgeneral cells strain rat. Male, F344/DuCrj rat.general cells Mycoplasma-eliminatedgeneral cells cellsby MC-210. Mycoplasmas eliminatedgeneral by MC-210cells in FDSC. Mycoplasma-eliminatedgeneral cells cellsby MC-210. Poorly differentiatedgeneral adenocarcinoma. cells Mycoplasma- eliminated cells by MC-210. Moderately differentiatedgeneral tubular cells adenocarcinoma. Mycoplasma eliminated cells by MC-210. 73 year-old, female. generalPartially cells mucinous. Secrete proteinase inhibitors, and CEA etc. Moderately differentiated.general cells 69 year-old, male. Moderatelygeneral cells differentiated. High tumorgenecity andgeneral metastasis cells in a F344 rat. Derived from primarygeneral focus. cells Cells identified to begeneral derived cells from a same individual by the Cell ID system. EV(T.T/T.Tn)=0.933. Derived from mandibulargeneral metastasis. cells Cells are differentiated into sympathetic generalneuron-like cells extensions when they are exposed to NGF. Cells are differentiated into sympathetic generalneuron-like cells extentions when they are exposed to NGF. Cells are differentiated into sympathetic generalneuron-like cells extensions when they are exposed to NGF. Cells are differentiated into sympathetic generalneuron-like cells extensions when they are exposed to NGF. The cell line grow in generalnon serum cells medium. αfeto protein production positive.(Myco+) The cell line keeps diploidgeneral range cells after repetitive cloning. No tumorgenic cell line. This cell line can be generalgrown in cells serum-free medium. Many serum proteins with alpha phyto protein are released into the medium. No protein productiongeneral observed cells in medium. hepatoma, non-differentiated, age 68, malegeneral cells Grow in serum free medium.general cellsHBs antigen produced. general cells Normality is maintainedgeneral only cellsby repeated cloning. general cells Cell to cell connectiongeneral is weak. cells Highly malignant. Easy to handle. Possibly applicable to the screening of anti-cancer reagents. High production of alpha-fetoprotein.general cells alpha-fetoprotein andgeneral albumin cells production is elevated. Osteoblastic cell line.general cells general cells normal liver, 14 days general cells Cells are derived fromgeneral Ac2F cellstransformed by 3'-methyl-4-dimethylaminoazobenzene. Cells were derived fromgeneral Ac2F cells transformed spontaneously. liver after treatment by 0.06 % DAB general cells liver after treatment by 0.06 % DAB for 33general days cells liver after treatment by 0.06 % DAB for 62general days cells 3'-Me-DAB treated cellgeneral line cells liver after 3'-Me-DAB treatment for 61 daysgeneral cells Chromosome numbergeneral 2n=42. cells The karyotype looks normal. This cell line is used as an in vitro model of naturally occuring cancer. Easy to get monoclonalgeneral cells. cells Good to use for the screening of anticancer reagent. general cells Doubling time is verygeneral slow (ca. cells 1 week). Secretes osteocalcin & responds to vitamingeneral D3. cells Tumorigenic cell line. Growth rate is verygeneral slow. cells Non tumorigenic, PCA-1(+),CD38(+),OKT9(+)general cells non-producing, transferrin receptors psitivegeneral cells A dexamethasone-responsive tyrosine aminotramsferasegeneral cells is expressed in this cell line. Change all medium asgeneral soon cellsas received. N/A via Xenotech indefinite growth and non-tumorigenic general cells N/A via Xenotech Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech Culture at 34 C becuasegeneral of thecells ts cell line. fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech lung, normal diploid fibroblast general cells PDL=Ca 50 general cells fetal lung, normal diploid fibroblast, TIG-1general cells N/A via Xenotech Refer attached instructiongeneral . cells skin, normal diploid fibroblast general cells Life span = PD41 general cells skin,normal diploid fibroblast general cells skin, normal diploid fibroblast general cells Normal skin fibroblast cells. PD at distribution,general 15-20 cells PDL. Normal human skin fibroblast cells. general cells general cells general cells general cells normal diploid human skin general cells Maximum PD = 53. Cells may be distributedgeneral around cells PD15-PD20. Maximum PD = 48. Cells may be distributedgeneral around cells PD15 - PD20. general cells NT general cells normal diploid fibroblast, PD35 general cells general cells The FCS requires carefulgeneral selection cells to keep quality. Spontaneous mutationgeneral rate cellsis relatively high. Culturing in the mediumgeneral with cells serum is required when cells were thawed. cervix, grow in serum free medium but latergeneral serum cells was used to maintain this cell line which is different from the serum free cell culture. general cells Cells grew when started at 1977 but didgeneral not grow cells for 2 years after then. Cells were kept by changing medium for two years and finally cells started to grow again. Now cells are growing well. Medium was converted to serum free at 1991. Non-transformed rat liver epitherial cell linegeneral from adultcells liver. Non-tumorigenic in newborn rats and in nude mice, Metabolizes benzo(a)pyrene. stomach cancer, signet ring cell carcinomageneral cells Mycoplasma contaminatedgeneral when cells submitted to the bank. GOTO cells cultured with serum free mediumgeneral for cellslong period by serial subcultures. Collagen-coated substratumgeneral cells is recommended. Reauires local high density of cells for the growth. general cells whole embryo, contact inhibited general cells general cells general cells Mycoplasma contaminatedgeneral when cells submitted to the bank. This cell line has neither invasive nor metastaticgeneral cellspotential and grew in synthetic medium PF86-1. squamous carcinoma, tongue, age 64, (M)general cells squamous carcinoma general cells EGF receptor is producedgeneral extensively. cells Use for metobolic cooperationgeneral cells assay. Plasminogen activator,general hyaluronic cells acid and alkaline phosphatase were highly produced. The KYM-1 is unique by STR-PCR among 219 cell lines on 04/22/2001. his is one of the limitedgeneral No. ofcells cell lines derived from human mammary carcinoma. Estrogen receptor negative. Easy to manipulate because of the susp. culture. T Using serum free mediumgeneral all cellsthe time is essential. This cell line is surpplied from Riken Genebankgeneral for cells the replacement to the JCRB0606:HeLa.P3(S). Definitly no serum addedgeneral to cellsthe culture to keep serum free condition. This culture has beengeneral kept by cells serial subculture for long period by Takaoka,T. at serum free condition. High growth rate. PE.general near 100 cells %. Easy to obtain mutant cell line. Good use for geneticalgeneral research. cells 4-carbamoylimidazoliumgeneral 5-olate cells resistant clone. mammary carcinoma general cells Good to analyze proteingeneral turnover. cells Because the ubiquitation of protein is anusual at nonpermissive temperature (39 C). Nucleus separation isgeneral performed cells while cytokinesis is blocked at non permissive temp. (39 C) resulting a poly nucleated cells. Mycoplasma was eliminatedgeneral cellsby antibiotics. Clone D-7 was taken by limiting dilution method. 6TG-r, HAT-s was confirmed. general cells culturable derivative of L5178+ general cells Incomplete description.general cells Decontaminated by generalBM cycline. cells Ha-ras mutation general cells Clone 16 of C3H10T1/2general is transformed cells by MCA. medium + 0.1 % pluronicgeneral F68, cells spiner culture applicable. JTC16 is an in vitro-adaptedgeneral cells AH7974 rat ascites hepatoma that was originally derived from AH-130 tumor induced by DAB. JTC16.P3 cell line was further adapted to grow in a protein and lipid free medium, but grow this cells by low amount of serum added. This cells were definitlygeneral adapted cells to the serum free condition for long time. Number of passages are extremely high. liver, no serum required general cells Telomelase was negative and a length of telomere was 2.0 generalKbases. cells Thymidylate synthase,whichgeneral cellsis a target of 5-fluorouracil, 5-fluorodeoxyuridene,methotrexate, is completely deleted in this strain. general cells Mycoplasma was eliminatedgeneral cellsand clone B12 was isolated by limiting dilution method. Vitamin A was effective for the induction of development. skin fibroblast, TK~,(M) general cells Abnormal Cell division observed at non perm.general temp. cells Micronucleation observed when cells aregeneral exposed cells to the non-permissive temperature(39 C). contains human chromosome #7 general cells contains human chromosome #1 general cells contains human chromosome 17pter>17q11::Xq11>Xqter general cells contains human chromosome 16pter>16q24::Xq26>Xqtergeneral cells HAT selection required general cells contains human chromosome 11pter>11q23::Xq26>Xqter general cells contains human chromosome Xpter>Xq26::3p12>3ptergeneral cells relating to research forgeneral NGF cells general cells SV40 transformed subline of 3Y1 general cells whole embryo, mouse polyoma virus-transformedgeneral cells 3Y1. Prepare many ampoulesgeneral when cells received cells and use new stock after 1-2 months continuous sub-culture. whole embryo, transformed 3Y1 by E1A generalof Ad12 cells virus whole embryo, transformed 3Y1 by MNNGgeneral treatment cells whole embryo,transformed 3Y1 by MNNGgeneral treatment cells whole embryo, transformed 3Y1 by MNNGgeneral treatment cells whole embryo,transformed 3Y1 by Rousgeneral sarcoma cells virus whole embryo, transformed 3Y1 by v-H-rasgeneral cDNA cells human glioma cell line established from generala surgical cells specimen of a patient with glioblastoma general cells uterus, cervical cancer general cells renal cell carcinoma general cells general cells general cells small cell carcinoma (Oat cell type) general cells small cell carcinoma (intermediate) general cells squamous cell carcinoma general cells general cells general cells general cells thyroid anaplastic carcinoma, undifferentiatedgeneral cells general cells C:G->G:C transversion at codon 248 of p53 gene general cells general cells squamous cell carcinoma general cells low molecular weight thiol protease inhibitor general cells Cells originally contaminatedgeneral cells with mycoplasmas and decontaminated MC210 in RERF. squamous cell carcinoma general cells neuroblastoma cell line from primary tumorgeneral cells neroblastoma cell line general cells signet ring cell carcinoma general cells MS-653-A is highly tumorigenic clone fromgeneral AS 653-HM cells tumor. Rat fibrosarcoma cell line induced by methylcholanthrene.general cells MS-653-G, a variant clone isolated by serial passage in low serum from MS-653-A, is less tumorigenic comared to clone A. Mycoplasma decontaminatedgeneral cells by Tsuruo at 1987. Multi registancy for antibiotics in cultured cell line derived from human. The kasumi-1 is uniquegeneral by STR-PCR cells amoung 219 cell line on 04/22/2001. Overexpression of Evi-1 protein, CD34+,general CD7+ cells Cells were obtained generalfrom tissue cells and were cloned later by the dilution method. Normal human embryogeneral fibroblast cells cell. N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech fibroblast, immortalizedgeneral by hTRT, cells derivative of OUMS-36 N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech fibroblast, immortalizedgeneral by hTRT, cells derivative of OUMS-36 N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech Human normal diploidgeneral cells transfected cells with hTRT gene N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech Immortalized normal generalhuman cellscell with hTRT gene. N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech fibroblast, immortalizedgeneral by hTRT, cells derivative of OUMS-36 N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech fibroblast, immortalizedgeneral by hTRT, cells derivative of OUMS-36 N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech Human normal fibroblastgeneral transformed cells with hTRT gene. N/A via Xenotech hTRT gene transfectedgeneral normal cells human embryo fibroblast N/Acell vialine. Xenotech fibroblast, immortalizedgeneral by hTRT, cells derivative of OUMS-36 N/A via Xenotech Cells line is unique showngeneral by cells the STR-PCR method. Cells registered as JCRB on 04/15/2002. No reference informedgeneral when cells deposited. P16 at deposit. general cells Cells were identified generalto be unique cells on 10/17/2001. Cear cell renal carcinoma cell line general cells general cells Mouse 3T3 irradiatedgeneral with X-ray cells were used as feeder cells when established this cell line. The cells lost their ability to defferentiategeneral to keratinize. cells The cells express cytokeratins 5, 8, 13, 18 and 19 {5064}. Mycoplasmas decontaminatedgeneral cells in the JCRB cell bank (NIHS0251, lot.02152002). Melanoma cell line established from metastasisedgeneral cells lymph node. Pigments were observed at early stages but faded later when established as a cell line. Established from human lung squamousgeneral carcinoma cells tissue grown in SCID mice. lung cancer (adeno carcinoma) cell line general cells human lung cancer, adenocarcinoma cellgeneral line. cells Mycoplasmas decontaminatedgeneral cells in the JCRB Cell Bank. Cell culture started ongeneral January cells 6, 1999. 39 year-old, male. Mycoplasma-eliminatedgeneral cells cells by MC-210. Non-metastatic epithelial tumor cells fromgeneral granulosa cells cell of mouse irradiated with 60-Co-gamma rays. Cells are producing estradiol and angiogenesis was observed when transplanted to mice. Cells grow in monolayer with 28-30 hrs' population doubling. Cells grow in monolayer with doubling timegeneral of 72 cells hrs. Non-metastatic characteristics. Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. (r-GPT = gamma GPT) Cell Bank will handlegeneral to get thecells approval but the depositor may contact to the requested person directly. No references available.general cells Cells were estabished through xenotransplantedgeneral cells tumor in nude mice Cells have been maintainedgeneral cellsby continuous cell culture without freezing at all. Cells are consisted from both melanin containiggeneral andcells melanin non-containing cells. Cells can be cloned by soft agar method. Melanin granules are observed in cells. Cells are transpantable on mouse hypodermicgeneral but cells not abdominal. Td=18.3 hours general cells Td=26.1 hours general cells Td=18.3 hours general cells The STR pattern of thegeneral OVSAYO cells was consistent with the OVMIU while it was expected to be unique. Td=26.1 hours general cells The STR pattern of thegeneral OVMIU cells was consistent with the OVSAYO while the OVMIU-II was expected to be same with the OVMIU. The STR pattern wasgeneral unique cells while the pattern is expected to be same with the OVMIU. Cells were transformedgeneral by pCDM8-p53 cells DNA (mp53, codon273N/A via arg-his) Xenotech at 21st PDL. Teratocarcinoma cell line with 6TG-r, thegeneral cell line cells show significant alterations in various malignancy-related phenotypes along extended passages in cell culture. general cells Mycoplasmas were notgeneral detected cells three months after the decontamination. The STR-PCR patterngeneral indicated cells to be a unique cell line. doubling time is 58 hours and multidrug generalregistance. cells Camptothecin resistant cell line. Purifiedgeneral DNA topoisomerase cells I was resistant to the camptothecin. Adriamycin-registant derived from NOMO-1general (IFO50474). cells Although the STR-PCRgeneral analysis cells showed this cell line is genetically same cell line as the HeLa, but this cell line will be kept in the catalogue list of the JCRB cell bank. general cells Cells were identified generalto be unique cells on 10/17/2001. Td = 95 hrs. AFP production and tumorigenesitygeneral cells is maintained in the cell line. Td=25 hrs. CEA related antigen observed.general HGF cellsproduction and tumorigenesity is maintained in the cell line. Clone from the IM95. A clone from the IM95,general produces cells higher level of HGF & VEGF. DD-762 was isolated directly from DD-761general established cells from the mouse mammary tumor. Td=80. Modal No. of chromosome=80. Cross contaminationgeneral of IHH-4 cells cell line is suspected. Original tumor appeared in thyroid. Cellsgeneral are adherent cells monolayer with small polygonal shaped. Multidrug registance. STR analysis indicatedgeneral that thecells cell line is unique (06/02/2004). Delivertive of the HARA cell. This cell linegeneral expresses cells PTHrP highly and the bone metastasis is induced extensively by the injection to the heart chamber of nude mouse. Hypercalcemia is induced in mice by hypodermic transplantation of the cell. Original name of thisgeneral cell line(MS-1) cells was changed to the MS-1-L because of the same name existence, CRL2279(mouse). Early subculture is recommendedgeneral cells when sustantial spaces are seen between cells under microscope. HPV16 transformed noraml human cells generalfrom cervix cells SV40 transformed human keratinocyte fromgeneral cervix. cells Cell line was unique.general cells Human primary cell line immortalized by pSV40general gene. cells general cells anchorage independent cell line treatedgeneral by MNNG cells Anchorage independent cell line transformedgeneral by cells MNNG. Temperature sensitive mutant, which are transformed below general34.5 C (heatcells sensitive). Temperature sensitive mutant, which are transformed below general34.5 C (heatcells sensitive). Anchorage independent cell line transformedgeneral by cells MNNG. Anchorage independent cell line transformedgeneral by cells MNNG. Anchorage independent cell line transformedgeneral by cells MNNG. Anchorage independent cell line transformedgeneral by cells MNNG. Anchorage independent cell line transformedgeneral by cells MNNG. Anchorage independent cell line transformedgeneral by cells MNNG. general cells general cells general cells general cells endometrial carcinoma general cells endometrial adenocarcinoma general cells general cells endometrial carcinoma general cells endometrial carcinoma general cells endometrial carcinoma general cells endometrial adenocarcinoma general cells general cells general cells Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6, E7, and hTERT. general cells Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6, E7, and hTERT. general cells general cells Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6, E7, and hTERT. Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6, E7, and hTERT. general cells general cells Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the bmi-1, E6, and hTERT. endometrial carcinoma general cells endometrial carcinoma general cells Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the bmi-1, E6, and hTERT. endometrial carcinoma general cells Co-operative researchgeneral with Dr. cells Furue,M. recommended because of the special characteristics of the RSMG cells. Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E7 and hTERT. Doubling time for about 60 hours. A roundgeneral cell proliferates cells like stripes. Because vacuoles are recognizable in the cytoplasm, secretion production is suggested. Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6, E7 and hTERT. Doubling time for about 40 hours. The cellgeneral of the cells spindle type and the small-round type exist together. Cell's adhesion is a little weak. Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6, E7 and hTERT. Co-operative researchgeneral with Dr. cells Furue,M. recommended because of the special characteristics of the RSMG cells. endocervical adenocarcinoma general cells Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E7 and hTERT. Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the bmi-1, E6 and hTERT. Human bone marrow-derived mesenchymal stem cells whichgeneral were infected cells with recombinant retroviruses expressing the E6 and E7. Complex type germ cell tumor of human embryonic testis origin.general cells N/A via Xenotech

Complex type germ cell tumor of human embryonic testis origin.general cells N/A via Xenotech

Complex type germ cell tumor of human embryonic testis origin.general cells N/A via Xenotech MPO+, CAE+, NBE-. general cells Complex type germ cell tumor of human embryonic testis origin.general cells N/A via Xenotech general cells general cells small round-cell morphology, part is multinucleategeneral cells cell. small round-cell morphology, part is multinucleategeneral cells cell. general cells general cells general cells small round-cell morphology, part is multinucleategeneral cells cell. general cells small round-cell morphology, part is multinucleategeneral cells cell. small round-cell morphology, part is multinucleategeneral cells cell. general cells general cells small round-cell morphology, part is multinucleategeneral cells cell. small round-cell morphology, part is multinucleategeneral cells cell. HEC-1-B is the samegeneral cell line cells with the HEC-BE. small round-cell morphology, part is multinucleategeneral cells cell. small round-cell morphology, part is multinucleategeneral cells cell. cell line having the human behta-galactosidase gene general cells general cells general cells general cells general cells squamous cell carcinoma general cells general cells small cell carcinoma general cells Both NIHS0245(TK) generaland JCRB0157(TK) cells are different cell line from this TK. general cells Cell growth is slow. Whengeneral cell cells growth becomes faster, please check a characeteristics of the cell. general cells Producing anti Digoxin IgG2b (k) isotypegeneral (RIA 170/46000) cells Producing anti Digoxin IgG1 (k) isotype (RIAgeneral 120/130000) cells general cells general cells Producing IgG gamma1 and k general cells Producing IgG gamma2a, and k. general cells Producing IgG gamma1 and k general cells Producing IgG gamma1 and k general cells Producing IgG gamma1 and k general cells Producing IgG gamma1 and k general cells Producing IgG gamma2b and k general cells Producing IgG gamma2b and k general cells Producing IgG gamma1 and k general cells Producing IgG gamma2b and k general cells Producing IgG gamma2b and k general cells Producing IgG gamma1 and k general cells Producing IgG gamma2a and k general cells Producing IgG gamma 2a and k general cells Producing IgG gamma1 and k general cells Producing IgG gamma1 and lambda general cells general cells Cells were originally generalcontaminated cells by mycoplasmas and decontaminated in the JCRB Cell Bank. general cells general cells general cells general cells general cells general cells general cells Producing IgG1 lambda. general cells producing mAb HPSV178, against the C-terminalgeneral cells portion of PrPSV (residues 214-230). general cells general cells general cells general cells general cells general cells general cells HeLa clone. genetically-modified cells Immature cells with azurophilic granules.general cells general cells general cells general cells general cells Dt = 30 hr. Large primitive blasts with giantgeneral cells cellscarrying multilobed nuclei. general cells This cell is that stably express human androgen receptor, reportorgenetically-modified gene (androgen cells response element linked to luciferase), and Renilla luciferase gene. general cells The cell line is negative for E-rosettes andgeneral surface cells immunoglobulin. general cells Dt=48-60hr. The cell line produces plasminogengeneral cellsactivator. general cells Cells grow without forming clumps with Dt=72general hrs. cells general cells general cells general cells general cells Producing IgG1lambda. general cells general cells general cells Producing IgG1 lambda. general cells general cells Producing IgG1 lambda. general cells general cells general cells Producing IgG1 lambda. general cells general cells The cell line was established from the transplantedgeneral cells Balb 3T3 mouse. The cell line have a characteristics of inducing leukocytosis and hypercalcemia with high G-CSF and PTHrP levels. Td=95 hrs. Adherent to the culture flasks. Cells are secreting IgD. general cells general cells kappa IgG (nonsecretory), CD38, CD44,general and CD54 cells are positive. Non-Hodgkin's lymphoma of large-cell type. Loss of chromosomegeneral 18 cellsobserved. Cell line having high metastasis potencialgeneral to lung. cells Lewis lung carcinoma derived cell line enhancedgeneral cells lung metastasis ability. general cells Lewis lung carcinoma derived cell line enhancedgeneral cells intravasating ability. adhered to a tissue culture dish general cells Producing rat IgG 2b and kappa general cells Highly metastatic cell line. general cells Fibroblast, subclone of Balb/3T3-A31. general cells The FCS requires carefulgeneral selection cells to keep quality. Fibroblast, subclone of Balb/3T3-A31. general cells Producing IgM(k) Recloned from P13-7. general cells Producing IgM(k). Recloned from P18-3.general cells Producing IgM(k). Recloned from P20-13.general cells Producing IgM(k). Recloned from F12-1.general cells Producing IgM(k). Recloned from F12-18.general cells Producing IgM(k). Recloned from F23-20.general cells Producing IgM(k). Recloned from F31-2.general cells Producing IgM(k). Recloned from F31-19.general cells Producing IgG1(k). Recloned from RP8-2.general cells Producing IgG1(k). Recloned from RP8-18.general cells Producing IgG1(k). Recloned from RF29-1.general cells Clear cell carcinoma. Td = 46.8 hrs, CA-125general positive, cells M type LDH, PAS, Alcian blue positive, mirror ball pattern observed. GFAP (glial fibrillary acidic protein) positive,general NF-L cells and NF-H (neurofilament) positive. The cells are forming loosely aggregatedgeneral cell clumps. cells Hamster T-cell antigen positive. 44, XX(hamster). GFAP (glial fibrillary acidic protein) positive,general NF-L cells and NF-H (neurofilament) positive. GFAP (glial fibrillary acidic protein) positive,general NF-L cells and NF-H (neurofilament) positive. GFAP (glial fibrillary acidic protein) positive,general NF-L cells and NF-H (neurofilament) positive. Producing rat IgG 2b and kappa general cells human glutamine synthetase and CYP3A4 introduced genetically-modified cells pMSCV-luc transfected MCF-7 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected BT-549 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected Hs578T cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected SK-MEL-28 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected COLO 679 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected MM-RU cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected MKN45 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells hybridoma producing monoclonal antibodygeneral against cells HBs antigen. hybridoma producing monoclonal antibodygeneral against cells HBs antigen pMSCV-luc transfected DLD-1 clone#1 cells. Luciferase stablyluciferase-expressing expressing cell line. cancer cells pMSCV-luc transfected HT-29 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells Contact to Dr. Taira,T.general to get cells information of this cell line. Producing rat IgG 2b and kappa general cells astrocytoma, GFAP-posotive luciferase-expressing cancer cells pMSCV-luc transfected DU-145 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected A-498 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected KM12 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected G-401 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells small round-cell morphology, part is multinucleategeneral cells cell. Feeder cells (mouse fibloblast) treated with Mitomycin-C (#PMEF-H;Millipore) and IL-6 are necessary for proliferation. Producing mouse IgG 2b and kappa general cells pMSCV-luc transfected SK-MEL-2 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells HLA-DR, CD10, CD20, and CD19 were positivegeneral andcells CD2 was negative. t(1;19)(q23;p13), E2A-PBX fusion gene general cells pMSCV-luc transfected Mewo cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected 786-0 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells CD7+, CD10+, CD56+, CD38+, CD3-, CD4-,general CD8- cells pMSCV-luc transfected SW620 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected Caki-1 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells CD10+, CD19+, CD20+, HLA-DR+, CD33+general cells pMSCV-luc transfected K562 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells general cells t(14;18)(q32;q21), bcl gene rearrangement general cells CD10+, CD19+, CD20+, CD22+, HLADR+general cells pMSCV-luc transfected PC-3 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected NCI-H460 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells pMSCV-luc transfected HCT-116 clone#2 cells. Luciferase stablyluciferase-expressing expressing cell line. cancer cells general cells t(11;19)(q23;p13.3), MLL gene rearrangement general cells CD34+, CD33+, CD10+, CD19+, HLA-DR+general cells general cells pMSCV-luc transfected A549 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells CD13+, CD33+, c-kit+, GPA+ general cells CD33+, CD15+, CD4+, CD56+, HLA-DR+general cells Luciferase stably expressing cell line (MKN1; Human stomach,luciferase-expressing adenosquamous carcinoma cancer cells cell line). Same cell line in ECACCgeneral cells Only for researchers in Asian countries Luciferase stably expressing cell line (BT-20; Human breast cancerluciferase-expressing cell line). cancer cells pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing 6-thioguanine resistant cancer cell cellsline. Cellular Products: mucin; pancreas cancerluciferase-expressing specific antigen (pancreas cancer cellscancer associated antigen); carcinoembryonic antigen (CEA), The cells do not express the cystic fibrosis transmembrane conductance regulator (CFTR). Luciferase stably expressing cell line (BT-474; Human breastluciferase-expressing cancer cell line). cancer cells The line was derivedluciferase-expressing from tissue from the cancersame patient cells as COLO 201. This cell line including cancer stem cells general(0.75%). cells Luciferase stably expressing cell line (AsPC-1; human pancreaticluciferase-expressing adenocarcinoma cancer cell line). cells Cell culture in collagen I coated dish. genetically-modified cells Cell culture in collagen I coated dish. genetically-modified cells The cells are poorly differentiated. The cellsluciferase-expressing overexpress Her2-neu cancer but cells are negative for expression of p53. The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR). pLL3.7-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Luciferase stably expressing cell line (MKN74; Human moderatelyluciferase-expressing differentiated tubular cancer adenocarcinoma cells cell line). pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells general cells HCC1954 is positive for the epithelial cellluciferase-expressing specific marker Epithelial cancer Glycoprotein cells 2 and for cytokeratin 19, and is negative for expression of estrogen receptor (ER) and progesterone receptor (PR). pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Cellular Products: carcinoembryonic antigenluciferase-expressing (CEA), keratin cancer cells highly aggressive malignancy general cells Luciferase stably expressing cell line (IM95; Human gastric cancerluciferase-expressing cell line). cancer cells pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Derived from stomach cancer, signet ringluciferase-expressing cell carcinoma. Tumorigenic cancer cells in the cheek pouches of immunosupressed hamsters and tumor developed was diagnosed as poorly-differentiated adenocarcinoma. Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLZ low cells activity, TK+/-) Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLZ low cells fidelity, TK+/-) The tumor cell line is derived from pancreaticluciferase-expressing tissue originally. cancerAdenocarcinoma cells cell line. The cells can be transplantable to nude mouse. pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Human cell line derived from B cell leukemia.genetically-modified (MSH-, POLZ KO/KO, cells TK+/+) pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells pLL3.7-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Human cell line derived from B cell leukemia.genetically-modified (MSH-, POLZ CD/CD, cells TK+/+) Luciferase stably expressing cell line (MDA-MB-361; Human luciferase-expressingbreast carcinoma cell cancerline). cells Luciferase stably expressing cell line (NIH/3T3; Mouse embryonicluciferase-expressing skin cell line cancer cells This cell line producesgeneral monoclonal cells antibody against human transferrin. Immunogen was human holo transferrin. Antibody's subclass; IgG2b. Does not cross react with bovine transferrin. general cells Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLK KO->steablecells transfectant of pEF6-Polk, TK+/-) The cells are negative for expression of luciferase-expressingestrogen receptor (ER) cancer and progesterone cells receptor (PR) pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing Oncogene: myc +; srccancer +; abl cells +; erb +; ras +; sis - Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLZ low cells activity, TK+/-) genetically-modified cells Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLZ low cells fidelity, TK+/-) pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing This lung adenocarcinoma cancer cellshas an acquired mutation in the EGFR tyrosine kinase domain (E746 - A750 deletion). genetically-modified cells genetically-modified cells Human cell line derived from B cell leukemia.genetically-modified (MSH-, POLK catalytically cells dead, TK+/+) Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLK catalyticallycells dead, TK+/-) pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Human cell line derived from B cell leukemia.genetically-modified (MSH+, POLK KO->stablecells transfectant of pEF6-Polk D198A/D199A, TK+/-) pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing cancer cells Mouse embryonic fibroblasts (control MEFs).general cells general cells Mouse embryonic fibroblasts prepared from IkB kinase (IKK-i)general deficient cells mice. Mouse embryonic fibroblasts prepared from TANK-binding kinasegenetically-modified 1 (TBK1) deficient cells mice. Human uterine endometrium vascular endothelial progenitor-derivedgenetically-modified immortalized cells cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. Carcinoembryonic antigen-producing luciferase-expressing cancer cells Human uterine endometrium vascular endothelial progenitor-derivedgenetically-modified immortalized cells cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. Human ovary cancer cell line derived from mesonephros. general cells Tissue was classified as a metastasis of luciferase-expressingadenosquamous carcinoma cancer ofcells the pancreatic duct. Human uterine endometrium vascular endothelial progenitor-derivedgenetically-modified immortalized cells cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. Human uterine endometrium vascular endothelial progenitor-derivedgenetically-modified immortalized cells cell line which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. Immortalized human umbilical cord blood-derived mesenchymalimmortalized stem cells. mesenchymal stem cell general cells Luciferase stably expressing cell line (SK-OV-3; Human ovarianluciferase-expressing cancer cell line). cancer cells Immortalized human adipose tissue-derived mesenchymal stemimmortalized cells. mesenchymal stem cell Human poorly differentiated cholangiocarcinoma cell line establishedgeneral cells from biliary tract. Delivertive of the HARA cell. This cell linegeneral expresses cells PTHrP highly and the bone metastasis is induced extensively by the injection to the heart chamber of nude mouse. Hypercalcemia is induced in mice by hypodermic transplantation of the cell. Highly differentiated genetically-modifiedimmortalized human cells cholangiocyte cell line. Only for users in academic organizations. Human umbilical cord blood-derived mesenchymal stem cellsgenetically-modified which were infected cells with recombinant retroviruses expressing the E6, Bmi-1, and hTERT. In publishing the researchgeneral results cells to be obtained by use of the cell lines, an acknowledgment to the Dr. Banchob Spira (Khon Kaen University) is requested. Luciferase stably expressing cell line (RERF-LC-KJ; Human lungluciferase-expressing cancer cell line). cancer cells pLVSIN-luc transfected MDA-MB-231 cells. Luciferase stablyluciferase-expressing expressing cell line. cancer cells Human adipocite-derived mesenchymal stem cells which weregenetically-modified infected with recombinant cells retroviruses expressing the E7 and hTERT. Distribution restrictedgenetically-modified to Japan domestic cellsuser, or only academic oversea users.The following reference shoud be cited at the pubulication of paper.Matsumura et al. Transplantation 77: 1357-1365, 2004. general cells general cells In publishing the researchgeneral results cells to be obtained by use of the cell lines, an acknowledgment to the Dr. Banchob Spira (Khon Kaen University) is requested. general cells Mouse bone marrow-derived osteoblast-like cell line. general cells GFAP (glial fibrillary acidic protein positive)general cells Human adipocyte-derived mesenchymal stem cells which weregenetically-modified infected with recombinant cells retroviruses expressing the E6, E7, and hTERT. general cells general cells general cells Luciferase stably expressing cell line. (HSC-1: A cell line of aluciferase-expressing squamous cell carcinoma cancer of cellshuman skin.) general cells luciferase-expressing cancer cells sensitive to mouse conoravirus infectiongeneral cells The distribution is limitedgenetically-modified to academic Japan cells domestic usersOnly and for usersacademic in non-profit oversea instituteusers. The following reference should be cited at the publication of papers. general cells general cells Luciferase stably expressing cell line. (HSC-5 : A cell line derivedluciferase-expressing from human skin cancersquamous cells cell carcinoma having anaplastic epithelioid features.) Luc expressing rat renal cell carcinoma cell line. luciferase-expressing cancer cells Luciferase stably expressing cell line (HLF; Human Hepatomaluciferase-expressing Cell Line). cancer cells Luciferase stably expressing cell line (Hep G2: Human Hepatomaluciferase-expressing Cell Line). cancer cells SK-OV-3 cells are resistant to tumor necrosisluciferase-expressing factor and to several cancer cytotoxic cells drugs including diphtheria toxin, cis-platinum and adriamycin. Luc expressing rat renal cell carcinoma cell line. luciferase-expressing cancer cells This cell line produce monoclonal antibodygeneral against cells human transferrin. pLVSIN-luc transfected HuH-7 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells Human cell line derived from uterine carcinosarcoma. general cells This cell line produce monoclonal antibodygeneral against cells human transferrin. This cell line produce monoclonal antibodygeneral against cells human transferrin. Human cell line derived from human glioma. general cells Human cell line derived from human glioma. general cells Human clonal cell line derived from human recurred glioma. general cells Human cell line derived from human glioma. general cells Luciferase stably expressing cell line (OVCAR-3; human ovarianluciferase-expressing cancer). cancer cells Luciferase stably expressing cell line (HLE; Human Hepatomaluciferase-expressing Cell Line). cancer cells This cell line produce monoclonal antibodygeneral against cells human transferrin. Human immortalized cell line derived from MRC-5 cells. genetically-modified cells This cell line produce monoclonal antibodygeneral against cells human transferrin. This cell line produce monoclonal antibodygeneral against cells human transferrin. This cell line produce human transferrin.general cells This cell line produce monoclonal antibodygeneral against cells human transferrin. This cell line produce human transferrin.general cells This cell line produce monoclonal antibodygeneral against cells human transferrin. This cell line produce human transferrin.general cells Luciferase stably expressing cell line (SK-BR-3 : breast cancerluciferase-expressing cell line) cancer cells cell freezed by 10% generalDMSO+90%FBS. cells cell freezed by Cryoprotectivegeneral cells Medium. DR-EcoScreen is for evaluation of a rapid in vitro aryl hydrocarbongenetically-modified receptor tarnscriptional cells activation assay. cell freezed by 10% generalDMSO +cells 90% FBS. cell freezed by Cryoprotectivegeneral cells Medium. Mouse hybridoma producing mAb (IgG1) to hemagglutinine general(HA) of vaccinia cells virus. Luciferase stably expressing cell line (HuH-6; Human Hepatomaluciferase-expressing Cell Line). cancer cells Mouse hybridoma producing mAb to hemagglutinine (HA) of generalvaccinia cells virus pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSOgeneral + 90%cells FBS). pREP4-cont transfected CHO-S cells (cell freezed by Cryoprotectivegeneral Medium).cells Luciferase stably expressing cell line (JHH-5; Human hepatocellularluciferase-expressing carcinoma (Ed.I) cancer established cells from small liver cancer). bortezomib-resistant maultiple myeloma cell line. general cells endotoxin sensitive human peripheral blood cell line (Believedgeneral to be cellsderived from U937 cells). Human cell derived from anaplastic embryonal rhabdomyosarcoma.general cells Mouse hybridoma producing mAb to vacciniageneral virus cells Human cell line derived from cholangiocarcinoma.general cells Control cell line used for the establishment of mouse homo mutantmousehomozygous ES cell lines. mutant ES cells The cells contain activated N-ras oncogene. pLVSIN-luc transfectedluciferase-expressing HT-1080 cells. cancer Luciferase cells stably expressing cell line. luciferase-expressing cancer cells pLVSIN-luc transfected B16-F10 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells first establish cell line in vitro from humanluciferase-expressing cancer cells MTA is required. luciferase-expressing cancer cells pLVSIN-luc transfected MIA PaCa-2 cells. Luciferase stably luciferase-expressingexpressing cell line. cancer cells This cell line expressesluciferase-expressing PTHrP highly and cancerthe bone cells metastasis is induced extensively by the injection to the heart chamber of nude mouse. Hypercalcemia is induced in mice by hypodermic transplantation of the cell. squamous carcinoma, tongue, age 64, (M)luciferase-expressing cancer cells pMSCV-luc transfected. Luciferase stably expressing cell line.luciferase-expressing 6-thioguanine resistant cancer cell cellsline. malignant melanoma, melanin production, pLVSIN-luc transfectedluciferase-expressing G-361 cells. Luciferase cancer cells stably expressing cell line. Established from human lung squamousluciferase-expressing carcinoma tissue grown cancer in SCID cells mice. Secretes osteocalcin & responds to vitaminluciferase-expressing D3. cancer cells Lewis lung carcinoma derived cell line enhancedluciferase-expressing lung metastasis cancer ability. cells pLVSIN-luc transfected H1781 cells. Luciferase stably expressingluciferase-expressing cell line. cancer cells Human fibroblast cell Line with mutation generalof LDL receptorcells LDL receptor mutation, Intron 12, c.1845+2general T>C, cells Homozygote (born from consanguineous marriage), Receptor negative type Human ovarian clear cell adenocarcinomageneral cell line. cells A cell line into whichgenetically-modified human Syndecan-4 cells gene has beenOnly transfected. for users in non-profit institute Approval required. Forgenetically-modified users in non-profit cells organization only 293 cell line into whichgenetically-modified human E-Cadherin cells and Syndecan-2Only gene for users have in been non-profit transfected. institute Approval required. Forgenetically-modified users in non-profit cells organization only XY female, Androgengeneral insensitivity cells syndrome Choroid plexus papilloma cell line of Syriangeneral hamster cells induced by BK virus. XY female general cells XY female general cells XY female general cells EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. XY female general cells EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. XY female general cells EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. EBV transformed B-cell lymphoblastoid cellgeneral line fromcells parent of human XY female (XYFMGG04D). EBV transformed B-cell lymphoblastoid cellgeneral line fromcells parent of human XY female (XYFMGG04D). EBV transformed B-cell lymphoblastoid cellgeneral line fromcells human XY female. MTA is required. genetically-modified cells Human well differentiated tubular adenocarcinomageneral cells cell line established from biliary tract. Human poorly differentiated cholangiocarcinomageneral cells cell line established from biliary tract. Human well differentiated tubular adenocarcinmageneral cells cell line established from biliary tract. (with micropapillary foci) Cells are tumorigenicluciferase-expressing in nude mice. Poorly cancer defferentiated cells adenocarcinoma. Human well differentiated tubular adenocarcinomageneral cells cell line established from biliary tract. The depositor's approvalgeneral is required. cells Human adenosquamous carcinoma cell generalline established cells from biliary tract. Burkitt lymphoma cell line general cells Burkitt lymphoma cell line general cells general cells B cell leukemia cell line general cells general cells general cells Immnoglobulin phenotype kappa+,lamda-general cells Immnoglobulin phenotype kappa+,lamda+general cells Immnoglobulin phenotype kappa-,lambda-general cells B cell leukemia cell line general cells Human lung adenocarcinoma cell line withgeneral a micropapillary cells pattern. B cell leukemia cell line general cells lacking expression of immunoglobulin chains.general cells B cell leukemia cell line, Ig negative, ALL-L3general cell cellsline, t(8;14)(q24;q32) Immnoglobulin phenotype and cell surfacegeneral marker cells information are included in established paper. B cell leukemia cell line, ALL-L2 cell line,general hypercalcemia cells Human chromosomegeneral was selected cells by G418. Tagged site 1p34-p36. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by G418. The human chromosome #3 is derived from the cell line NTI-4. Human chromosomegeneral was selected cells by G418. The human chromosome #4 is derived from the cell line MRC-5. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by G418. Tagged site 6q25-26. Human chromosomegeneral was selected cells by G418. The human chromosome #7 is derived from the cell line NTI-4. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by l-histidinol. Human chromosomegeneral was selected cells by G418. Tagged site 10q22. The human chromosome #10 is derived from the cell line established at Tottori University. Human chromosomegeneral was selected cells by G418. Tagged site 11p11. The human chromosome #11 is derived from the cell line MRC-5. Human chromosomegeneral was selected cells by G418. Tagged site 12q12. The human chromosome #12 is derived from the cell line NTI-4. Human chromosomegeneral was selected cells by hygromycine B. Human chromosomegeneral was selected cells by hygromycine B. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by G418. Tagged site 19p13. The human chromosome #19 was derived from the cell line MRC-5. Human chromosomegeneral was selected cells by G418. Human chromosomegeneral was selected cells by hygromycine B. Human chromosomegeneral was selected cells by hygromycine B. Human chromosomegeneral selected cells by blasticidene S hydrochloride. Tagged site Xp11.2. The human chromosome X was derived from KM primary cells. Prepared from CRL 1588.general cells Prepared from CCL 1.general cells EV=1.000 against othergeneral HeLa cells cells, like HeLaP3, HeLa229, and etc. Prepared from CCL 2. Prepared from CCL163.general cells Prepared from CCL 171.general Population cells doubling is 23 at passageN/A via No.18. Xenotech Prepared from CRL1555.general cells Prepared from CCL 2.2.general cells Prepared from CCL 86.general cells The 3T3 L1 is a clonal subline of mousegeneral 3T3 cells. cells Prepared from CCL 61.general cells Prepared from CCL 92.general cells Prepare from CCL10.general Difco tryptose cells phosphate broth 29.5 g/l. Prepared from CRL1593.general cells A maximum of 1-2 x general10^6 cells/ml cells is obtainable. Prepared from CCL219.general cells Prepared from CCL 17.general KB cells cells contains HeLa marker chromosomes and exhibits type A G6PD. Nature, 259, 211, 1976; In Vitro, 14, 469, 1978. Prepared from CCL 34.general cells Prepared from CRL1580.general cells Prepared from CRL1582.general cells Prepared from CRL1645.general cells Prejpared from CRL1652.general cells Prepare from CCL 106.general The cellshorse serum requires careful selection as to quality. Prepared from CRL1405.general cells Prepared from CCL 35.general cells Prepared from CCL 33.general cells Prepared from CRL1690.general The cells cell line was identified to be unique. Protease resistant prion protein detected. Prepared from CCL 95.1.general cells Prepared from CCL 54.general Population cells doubling is unknown. These cells have a total life expectancy of about 25-30 serial subcultures from tissue of origin. Prepared from CCL 84.general Population cells doubling is unknown. These cells have a total life expectancy of about 25-30 serial subcultures from tissue of origin. Prepared from CCL 82.general cells Prepared from CCL 82.1.general cells Prepared from CRL1552.general cells Prepared from CCL127.general cells Prepared from CCL246.general cells Prepared from CCL 56.general cells Prepared from CCL 149.general cells Prepared from CCL186.general Population cells doubling is 24 at passage No.8. Prepared from CCL 97.general cells Prepared from CCL 79.general cells Prepared from CCL 75.1.general cells Prepared from CCL 30.general cells Prepared from CCL 96.general cells Prepared from CCL 212.general Population cells doubling is 28 at P4. May be prepared fromgeneral CRL1572. cells Originally thought asgeneral a plasma cells cytoma but later identified as a Burkitt's lymphoma. Prepared from CRL8155.general A maximumcells of 1-2 x 10^6 cells/ml is obtainable. Prepared from CCL 43.general cells Prepared from CRL1441.general cells Prepared from CCL 13.general cells Prepared from CRL1570.general cells Prepared from CRL1573.general cells Prepared from CCL105.general cells Prepared from CRL1440.general Cells cells are identified to be unique at 10/17/2001. Prepared from CCL213.general cells Prepared from CCL136.general cells Prepared from CRL1424.general cells CCL 9.1. general cells Prepared from CCL241.general Culture cells medium w/ EGF 30ng/ml = doubling time 65 hr, w/o EGF = 168 hr. Cells of passage 20 can undergo 15 additional population doublings. Prepared from CCL 51.general cells Prepared from CRL1133.general cells Prepared from CRL1135.general cells Prepared from CCL226.general cells Prepared from CRL1458.general cells Prepared from CCL229.general cells Prepared from CRL1581.general cells Prepared from CRL1597.general cells Prepared from CCL 2.1.general cells Prepared from CCL 49.general cells Prepared from CCL 8.general cells Prepared from CCL 77.general cells Prepared from CRL1631.general cells Prepared from CRL1698.general DMEM cells w/ 4.5g/L glucose, 0.1 mM non essential amino acids, 1 mM sodium pyruvate, 300 micro g/ml L-glutamine. Prepared from TIB 68.general cells Prepared from CCL 221.general cells Prepared from CRL1486.general Population cells doubling was 25 atN/A passage via Xenotech 7. Prepared from CCL 107.general cells Prepared from CCL 83.general cells Prepared from CCL 89.general The cellscell line grows as floating clusters of cells. Prepared from CCL163.1.general cells Prepared from CCL157.general cells Prepared from CCL203.general Population cells doubling was 15 at passage 5. Prepared from CCL 65.general Population cells doubling is unknown. MEM contains non essential amino acids, sodium pyruvate and lactalbumin hydrolysate (0.1%). Cell line was unique(EV=0.690). Prepared from CRL1295.general Population cells doublings were about 38-40 at passage 3. Prepared from CCL 72.general Population cells doubling is unknown. MEM contains non essential amino acids, sodium pyruvate, lactalbumin hydrolysate (0.1%). Prepared from TIB 9.general cells Prepared from TIB 15.general cells Prepared from TIB 18.general cells Prepared from TIB 67.general cells Prepared from TIB 8.general cells general cells Prepared from CCL 98.general Riken cells cell bank informed us that the Y chromosome observed in this cell line. The cells contain activated N-ras oncogene. general cells Additional Informationgeneral - modified cells Eagle's medium with 10 or 20% tryptose phosphate broth (2). Dulbecco-Vogt (3). Rectum, adenocarcinoma general cells murine B cell leukemia, subclone 3B3 ofgeneral BCL1 clone cells CW13.20. Culture medium--A 1/1general mixuture cells of Ham's F12 and Dulbecco's modified with 0.4ug/ml hydrocortisone, 10%FBS. Burkitt lymphoma (EBV negative) general cells susceptible to rubella virus, toxicologcal generalusage cells Supports the growth of all 4 classes of MuLV.general cells Support Type C retroviruses. general cells This cell line is useful for focus forming assaysgeneral of cells murine and feline sarcoma virus. JCRB No. Cell Name ANIMAL TISSUE GENETICS Chinese JCRB0030 CHL/IU(IVGT) lung hamster This line is derivative of the WIL-2 cell line. The cells are heterozygous at the JCRB1435 TK6(IVGT) human spleen thymidine kinase (TK) locus, and can be used to quantitatively detect forward mutation at 3 loci.

JCRB1771 KKK-D049 human liver, gallbladder

JCRB1772 KKU-452 human bile duct

JCRB1775 KKK-D068 human liver, gallbladder

Chromosome number JCRB1776 OCUG-1-Luc#5 human liver, gallbladder distribute in a broad range from 52 to 139.

JCRB1777 KKK-D131 human liver, gallbladder

JCRB1778 KKU-023 human bile duct

JCRB1779 KKK-D138 human liver, gallbladder

JCRB1782 BALM-7 human blood B cell leukemia cell line Karyotype information JCRB1783 BALM-6 human bone marrow included in established papers JCRB1784 BALM-8 human blood B cell leukemia cell line JCRB1785 BALM-9 human blood B cell leukemia cell line JCRB1787 BALM-9K human blood B cell leukemia cell line

JCRB1788 BALM-9KL human blood B cell leukemia cell line

JCRB1790 BALM-9N human blood B cell leukemia cell line Karyotype information JCRB1791 BALM-13 human bone marrow included in established papers JCRB1792 KU-Lu-MPPt3 human lung EGFR exon19 del E746-A750 Karyotype information JCRB1794 BALM-9L human peripheral blood included in established papers B cell leukemia cell line, Ig negative, ALL-L3 cell line, JCRB1795 BALM-16 human blood t(8;22)(q24;q11), hypercalcemia, mRNA expression of PTHrP Karyotype information JCRB1796 BALM-18 human peripheral blood included in established papers

JCRB1797 BALM-20 human blood B cell leukemia cell line

JCRB1803 BALM-26 human bone marrow L5178Y TK+/- Mouse TK+/- heterozygotic JCRB0709.2 mouse lymph node 3.7.2c(IVGT) subline of the L5178Y. CHARACT COMMENT celltype Order type Standard cell line for chromosome Same as the cell line in Only for researchers in Asian general cells aberation test. ECACC countries

Same as the cell line in Only for researchers in Asian general cells ECACC countries

Human well differentiated tubular adenocarcinoma cell line general cells established from biliary tract. Human poorly differentiated cholangiocarcinoma cell line general cells established from biliary tract. Human well differentiated tubular adenocarcinma cell line established general cells from biliary tract. (with micropapillary foci) Cells are tumorigenic in Luciferase stably expressing cell luciferase- nude mice. Poorly line (OCUG-1; human gall bladder expressing defferentiated carcinoma). cancer cells adenocarcinoma. Human well differentiated tubular adenocarcinoma cell line general cells established from biliary tract. Human well differentiated The depositor's approval is cholangiocarcinoma cell line general cells required. established from biliary tract. Human adenosquamous carcinoma cell line established from biliary general cells tract. general cells

B cell leukemia cell line general cells

general cells general cells Immnoglobulin phenotype general cells kappa+,lamda- Immnoglobulin phenotype general cells kappa+,lamda+ Immnoglobulin phenotype kappa- general cells ,lambda-

B cell leukemia cell line general cells

Human lung adenocarcinoma cell general cells line with a micropapillary pattern. B cell leukemia cell line general cells

lacking expression of general cells immunoglobulin chains.

B cell leukemia cell line, Ig negative, ALL-L3 cell line, general cells t(8;14)(q24;q32) Immnoglobulin phenotype and cell surface marker information are general cells included in established paper. B cell leukemia cell line, ALL-L2 cell general cells line, hypercalcemia Not available (Contact JCRB if general cells customer need it)